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Tarled degrees of isoniazid resistance within strains
of tubercle bacilli from sputum and pulmonary cavities - Stewart,
Sheila M. (1956) iimer. Rev. Tuberc., J£3, 390.
Reprints of these papers are filed in the appendix at
the end of volume 1.
The liquid medium tests for P.A.S. resistance and some
of the routine resistance tests reported in this thesis were
carried out in the Oity Hospital laboratory, Edinburgh.
HISTORICAL INTRODUCTION
la 1882 Robert Koch demonstrated that a bacterium,
later to be designated Mycobacterias tuberculosis, was the
causative organism of tuberculosis. Although this discovery led
to the introduction of methods to reduce the dissemination of the
disease, it was about 00 years before treatment with specific anti-
tuberculous drugs were first used.
Paul Ihrlieh (1913), "father of the science of chemotherapy;*
predicted the use of chemical substances in the treatment of bacterial
infections. These compounds, known as chamotherapeuti© agents, can
be defined as chemical substances which have the capacity to inhibit
or destroy micro-organisms in vitro and in vivo at concentrations
tolerated by the host. Hhrlieh confined most of his chemotherapeutic
work to diseases of protozoal or spirochaetal origin, and did little
work on bacterial infections. He did however carry out some
experiments in vitro with Bechhold {Bechhold and Shrlieh 1906) on
the germicidal activity of phenol derivatives.
The first successful treatment of a bacterial infection
in vivo with chemotherapeutic agents was reported by Morgenroth and
Levy (1911), using ethylhydroeuprein in pneumococcal infections in
mice. But the substance proved too toxic for human use. There
followed many reports of other animal experiments but no real advance
was made in the treatment of human Infections until the introduction
of the sulphonamide compounds by Domagk in 1955.
The first chematherapeutic compounds reported with
anti-tuberculous /
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anti-tuberculous activity were the sulphones (Buttle et al., 1937;
Hist et al., 1940; Feldman et al., 1940) and the thiosemiearbazones
(Damask et al., 1946). Neither of these series of substances have
been widely used in clinical practice owing to toxicity at effective
doses.
In 1946 Lehmann showed that £-araino salicylic acid (P.A.S.)
retarded the increased absorption of oxygen by tubercle bacilli
brought about by benzoic or salicylic acid (Bernheim 1940). Lehmann
also demonstrated and Youmans (1946) later confirmed that P.A.S.
possessed bacteriostatic activity for the tubercle bacillus. The
successful use of P.A.S. in clinical practice followed shortly
afterwards (Tallentin, 1946; Magley and Logg, 1948; Swedish National
Association against Tuberculosis, 1950) and it is still one of the
major drugs in use in the treatment of tuberculosis.
A second chemical substance, which is also used extensively,
is ise-nicotinic acid hydrazide (isoniazid). It was originally
described by Meyer and Mally (1912), but its potentiality as an
anti-tuberculous drug was not appreciated until 1951 when its activity
in vivo was reported by Fox (1951). Further reports followed
(Grunberg and Schnitzer, 1952; Robitzek et al., 1952; Steenken and
Wolinsky, 1952; and others).
In the treatment of antibacterial infections a further
group of substances has proved of great use to the clinicians - the
antibiotics. An antibiotic has been defined by 'aksman (1953) as
"a /
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"a chemical substance produced by micro-organisms which has the
capacity, in dilute solution, to inhibit the growth of, or even to
*
destroy, other micro-organisms*. The first antibiotic to be used
therapeutically was penicillin. Its activity was first reported
by Fleming in 19£9 and developed by workers in Oxford (Florey et al.,
1943; Florey et al., 1949).
m 1944, Scliats, Bugie and Waksman reported the isolation
of an antibiotic substance from Streptomyces griseus which possessed
marked anti-bacterial activity in vitro. This substance, known as
streptomycin, was found to have relatively low toxicity for man in
doses necessary for clinical effectiveness (Hinshaw and Feldman, 1945).
it was the first anti-tuberculous drug to be used extensively, and is
indeed still one of the major drugs in use in the treatment of this
disease.
One of the major disadvantages of the use of chemo-
:therapeutic agents and antibiotics has been the emergence of drug-
resistant bacilli. This has often proved an unsurmountable obstacle
in clinical practice and is particularly evident in the treatment of
tuberculosis.
The first reports of streptomycin-resistant organisms were
given by Youmans et al. (1946), D'Ssopo and Steinhaus (1947), Pyle
(1947), Musahenheim et al. (1947), Sadusk and Swift (1943), Wolinsky
et al. (1943), Crofton and Mitchison (1948) and the Medical Research




of tubercle bacilli to P.A.S., commented that at that time no
resistant strains had been isolated from patients under treatment
with the drug. Later in the same year, however, the first reports
of the emergence of P.A.3. - resistant organisms were made. Home
(1949) described a fall in sputum positivity in patients treated with
P.A.S., and a subsequent rise after some months of treatment. He
suggested that this probably indicated the development of "drug-fast"
strains, although no resistance tests were done in his series.
Eastlake and Barach (1949), Delaude et al. (1942) and Cartenssn (1950)
were the first to report the development of P.A.S.-resistant bacilli
in patients under treatment, and since then many other workers have
confirmed their findings (Nitti et al., 1950 a and b; Daddi et al.,
1949, 1950; ¥eran et al., 1950; Rist et al., 1951 ana others).
Reports of the emergence of isoniaaid-resistant bacilli were made
shortly after its use in clinical trials (Rowen and Collins, 1952;
Hobby and Lenert, 1952; Knox et al., 1952; Medical Research Council,
1952b; Mitehison, 1952; Petit, 1952).
Ehrlich (1915) in advocating the use of more than one drug
suggested that "Ah advantage of combined therapy is that under the
influence of two different medicines the danger of rendering the
parasites immune (to arsenic), which naturally would be a very great
obstacle in connexion with further treatment, is apparently greatly
minimised." The use of combinations of two of the standard drugs,
s
that is, streptomycin, P.A.S. and isoniazid, in the treatment of
pulmonary tuberculosis suggested by Demerec (1943) on theoretical
grounds /
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grounds was shown to be superior, both clinically and bacteri©logically,
to treatment with any one drug alone (Medical Research Council, 1950,
1952a, 1953a; Teaapel et al., 1951; Dye et al.» 1953; U.S. Public
Health Service, 1953; Pitts et al., 1953; U.S. Veterans Administrations
1953; Mount and Ferebee, 1954). 'Ms greater efficiency with
combined treatment was however only found when the patients'
organisms were sensitive to the drugs in use. If the bacilli were
only sensitive to one of the drugs being given, the effect of
treatment was similar to that found vjhen that drug was given alone
(Turnbull et al., 1953; Medical Research Council, 1953a, 1953c, 1955},
It was therefore of great importance to be able to detect in vitro
degrees of bacterial resistance which would be of clinical significance
in order to help to elucidate failures in treatment.
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SOOPS OF THE PRESENT THESIS
Th© present work is divided into three seotions. The
first deals with methods for detecting resistance to streptomycin,
P.JL.S. and isoniazid in tubercle bacilli, as applied to hospital
laboratories doing control work on treatment. fixe methods and
•variations within the methods are analysed in correlation with
details of the patients' previous therapy and sputum examinations,
in order to determine the most efficient techniques for the
detection of degrees of resistance that are of clinical significance.
The second and third sections deal only with isoniaaid-
resistant organisms. In section II investigations into the
variations in resistance within the sputum are correlated with the
case histories in an attempt to determine their significance.
Variations within the lung are also reported.
In the third section, soiae observations are made concerning
the virulence of isoniaaid-resistant bacilli, the results being
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{©) Comparison of results by liquid and solid medium on strains
isolated after treatment (Streptomycin and P.A.S.)
(d) Tests for the significance of low degrees of resistance
(Streptomycin, P.A.S. and isoniazid)
(i) 5h.ll and rise in sputtmi positivity
(ii) Development of resistance to a second drug
(iii) Persistent sputum positivity
(iv) Clinical and radiological deterioration.
(3) Discussion.
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REVUBW OF THE UTBRATUHE
As long as the treatment of tuberculosis was confined to
the use of single drugs, the detection of resistant bacilli in the
laboratory was mainly of use as an explanation of clinical failure
and also to determine the usefulness of giving a second course of
treatraent. But with the widespread use of drug combinations, it
became of great importance to be able to detect degrees of resistance
which were of clinical significance. The large volume of published
work concerning methods for the detection of drug resistance in
tubercle bacilli and their significance is in itself an indication
of the complexity of the subject.
The techniques suggested have varied widely both in the
medium used, the inoculum, the time and method of reading the tests
and in the definition of "resistant'' organisms. The methods are
termed "direct" resistance tests when the drug-containing medium is
inoculated with the concentrate of the specimen concerned. In
"indirect" tests, a primary growth is first obtained on solid medium,
and the drug tubes are inoculated from this growth with or without
intermediate sub-culture.
The media used may be classified as follows;-
(1) Semi-synthetic liquid medium containing albumin and
polyoxyethylene sorbitan monocleatc (fween 80) (Dubos and Davis, 1946).
(2) Coagulated egg-glycerine medium (lowenstein-Jensen,
Mackie and McCartney, 1953; American Trudeau Society, 1952)
(3) Youmans' semi-synthetic medium (Toumanr,1946}
(4) /
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(4) Igg-agar medium (Herrold, 1951 a and b)
(5) Semi-synthetic medium of Praskauer and Beck (1894)
(5) Slide culture techniques (Pryee, 1941)
In all these methods the drugs are incorporated in the medium. In
the case of the coagulated egg media, they are added before
inspissation. In some series the slopes of egg-glycerine medium
were flooded with the drug solutions after inspissation, before
inoculation (Coletsos et al. 1950; Coletsos 1953).
More recently McCabe and Gould (1954) and Knox and
Woodruffe (Knox, 1955; Ebox and Woodruffs, 1957) have described
media which allow a more rapid growth of tubercle bacilli. But no
series of pre-treatment or resistant cultures have been reported by
these methods so far.
The inoculum used varies considerably from author to author.
In tests in liquid, media a sub-culture in the medium from the primary
growth on egg-glysriae medium is used. Indirect tests on solid
medium are made from liquid medium sub-cultures or on suspensions of
the growth from the primary culture. Birect tests are carried out
on the concentrated specimen.
The results of resistance tests may be given as the
minimum concentration of the drug that completely or partially
inhibits the growth of the organism. Alternatively the end-point
of the titration may be taken as the highest concentration allowing
growth equivalent to that in the control tube. In some cases the
results /
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results are given as a resistance ratio, that is the ratio of the
minimum inhibitory concentration for the test organism to the
minimum inhibitory concentration for the standard sensitive strain,
H57K7.
A summary is given in tables 1, 2 and 3 of the main series
reporting methods for the detection of resistance in tubercle
bacilli to streptomycin, P.A.S. and isoniazid respectively. These
tables are confined to those reports in which either a series of
pre-treatment cultures or definite criteria for resistance have been
given.
It will be seen that, where authors are using the same
medium, similar results are usually reported for pre-treatment
strains. In most of the solid medium techniques, such strains are
inhibited by the lowest concentration of the drug tested.
The definitions for "resistance" vary considerably in
the different series. For example, strains tested for streptomycin
resistance in Dubos and Davis medium may be considered to be
resistant if (a) their growth is inhibited by 10 jug. per ml,
( Bernstein et al., 1950} , (b) if they will grow in medium containing
10 yag. per ml. (Fisher, 1948 a, bj Wolinsky, et al., 1948; Fielding,
1951). or (e) if they are at least four times as resistant as the
standard strain (an inhibitory concentration of 2 to 4 /ig. per ml.)
(Orofton and Mitchison, 1948; Mitchison, 1949).
Although /
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Although many authors have indicated that resistance to
streptomycin, P.A.S. and isoniazid is of clinical significance, as
Judged by the effect of treatment on sputum, positivity (Crofton and
Mitchison, 1948; Horns, 1949; Stsenksn et al., 1952; Wallace et
al., 1954), by the development of resistance on drug combinations
{Turnbull et al., 1953; Medical Research Council, 1953 a, 1953c,
1955) and clinical progress (Muschenheim et al., 1947; Past et al.,
1951; Wallace et al., 1954), the criteria for resistance in many
of these series was not very clear. There are no published series
in which a close correlation has been given between the in vitro
resistance tests and details of the case histories.
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METHODS-
The methods used in the present study to determine
resistance of tubercle bacilli to streptomycin, P.A.S. and
isoniazid were those most widely used at the time the work was
begun, namely serial dilution techniques in Dubos and Davis * liquid
medium and in coagulated egg-glycerine medium.
In an attempt to assess the significance of the results
obtained by these two techniques, the following investigations were
carried out:-
(a) Strains from patients who had never received treatment
with the drug were tested in order to determine the normal range
of the readings.
{b) Strains from patients who had received treatment with the
drug were used to evaluate variations in techniques of the tests
and to compare the relative efficiency of the two methods.
(e) The significance of low degrees of resistance was assessed
by investigating the effects of treatment on patients whose organisms
were of a low degree of resistance.
Media
Tween - albumin liquid medium. The Tween - albumin
liquid medium used was that originally described by Dubos and Davis
(1946) as modified by the Medical Research Council (1953d). The















The casein hydrolysate was prepared as follows {Medical Heseareh
Council, 1943):-
To 200 g. of commercial casein in a litre conical beaker was added
a mixture of 170 ml, of concentrated hydrochloric acid with 110
ml. of distilled water. This was stirred quickly with a glass rod
to obtain a uniform suspension before the casein had time to swell
and become solid. The mixture was autoclaved at 120°C. for three-
quarters of an hour. After cooling, the mixture was made neutral
with 40 percent sodim hydroxide and filtered through pulp on a
Buchner funnel. The filtrate was diluted to one litre and one
percent chloroform was added, It was stored in the dark.
and the solution of casein hydrolysate added. The mixture was
autoclaved at 10 lb. per sq. in. for 10 minutes. Immediately
before use, 4 ml. of a seitz-filtered 9$ solution of bovine albumin
fraction V was added to 100 ml. medium, to give a final concentration
of O#30$.
Bubcs medium without Tween. In some tests, the Tween
80 was omitted from the medium.
medium was prepared according to the formula given by Mackie and
McCartney (1953). A mineral salt solution was prepared with the
following constitution:-
The salts were dissolved one at a time in distilled water
Iffv/enstein-Jensen medium. Lbwenstein-Jensen egg-glycerine
Potassium /
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Distilled water 100 ml.
To 600 ml. of this salt solution were added 30 g. potato
starch, and the mixture was heated until it cleared. It was then
kept at 56°C for one hour. Hens' eggs, not more than ? days old,
were broken into a flask and the whole shaken mechanically for 15
minutes. The fluid was then filtered through four thicknesses of
sterile surgical gauze. One litre of the filtered egg fluid was
added to 600 ml. of starch-mineral salt solution. 20 ml. of a 2
percent solution of Malachite Green, which had been incubated at
37°C for 24 hours before use, was added, to the 1,600 ml. of egg-
starch-salt solution.
Stock solutions of the drugs. Stock solutions of the
drugs were prepared in sterile distilled water and stored at 0°G.
They were replaced by fresh solutions monthly. The concentrations
of these solutions were as follows;-
Streptomycin (as sulphate) 200,000 ug. per ml.
P.A.S. (sodium salt) 10,000 ug. per ml.
Isoniazid 10,000 ug. per ml.
The P.A.S. and isoniazid solutions were not seitz-filtered as no




I^reparation of the drug-containing tubes. from the
stoek solutions two-fold serial dilutions of the drugs in sterile
distilled water were prepared at 15 times the final concentrations
required in the medium. These were added in a dilution of 1 in 15
to hulk quantities of the medium, and after thorough mixing by hand,
the drug-medium solutions were dispensed, in 1/4 oz. (7 ml.) screw-
capped. containers, approximately 5*0 ml. being put into each bottle.
The final concentrations of the drugs used were as follows:-
streptcaercia;- 4*Gyug. per ml. by two-fold dilutions to
0 •12 ,ug. per"ml. In s csae tests concentrations of 32 and 128 ug.
per ml. were also included.
In the tests carried out in medium without Tween 80, the final
concentrations used were 16 jog. per ml. by two-fold dilutions to
0*5 ug. per ml.
P.A.S. (sodium salt):- 2•0 ug. per ml. by two-fold
dilutions io 0*G5yUg. per ml. Tubes containing 8 and 32 ,ug. per
ml. were also included in some tests. When the medium without
Tween 80 was used, the concentrations were 32/\lb> per ml. by two¬
fold dilutions to 0*007 /Ug. pes* ml.
Isoniazid tests were not done in Davis and Dubos medium,
as this method had already been shown to be inaccurate (Mitchison,
1953; Pansy et al., 1953).
Inoculum:- The primary growth of the organisms on
Ltfwenstein-Jensen medium was sub-cultured into 3*0 ml. Tween-albumin
medium and incubated at 37°0 for 10 days. Approximately 0*1 ml. of
this culture was transferred to a second bottle containing 3*0 ml.
of medium. After a further 10 days' incubation, this second sub¬
culture was used to inoculate the sensitivity sets. The size of
the /
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the inoculum varied according to the drug helng tested. Ibr
streptomycin tests, one drop of neat culture {0*02 ml.) was added
to each 3*0 ml. quantity of drug-medium mixture. In the P.A.S.
tests, it was found (Medical Research Council, 1953d) that if the
neat culture was used for the inoculum, sensitive strains grew at
high concentrations of the drug. Therefore in these tests an
equivalent sized drop (0*02 ml.) of a one-in-ten dilution of the
10-days culture was used.
All tests were incubated at 37 °G. Tests for streptomycin
resistance were read after 10 and 14 days' incubation. Those for
P.A.S-. resistance war© read after 14 days' incubation only, as the
growth was too light at 10 days' due to the small inoculum used.
For both drugs, the end-point was taken as the minimum concentration
cf the drug that inhibited macroscopic growth.
In each batch of tests one culture of the standard
H37Rv strain of Mycobacterium tuberculosis (human type) was included.
The results v^ere expressed as resistance ratios, tnat is, the ratio
of the minimum inhibitory concentration for the test strain to the
minimum inhibitory concentration for the standard strain.
The standard strain was normally inhibited by 0*25 to
0*5 jig, streptomycin per ml. and 0-06 to 0*5/Ug. P.A.S, (sodium)
per ml. in medium containing Tween 80, and by 1*0 ug. streptomycin





Preparation of drug-containing slope'. dilutions of the
drugs were prepared in sterile distilled water from the sterile
stock solutions at concentrations 10 times those required in the
medium. The dilutions were added to the medium in bulk quantities
in a dilution of one part per 10 parts medium. After mixing by
hand, the medium was dispensed in approximately 2 ml. quantities in
1/4 oz. (7 ml.) screw-capped bottles. The drug-medium mixture was
then inspissated in the sloped position at 75 - 80°C for one hour.
The actual concentrations of the drugs in the medium before
inspissation were as followsj-
Strep cornygin: - 64 ug. per mi. by two-fold dilutions to
1 yjug. per ml.
P.A.S. (sodium salt):- 32 /ig. per ml. by two-fold dilutions
to 0*25 jug", per ml.
Isoniazid:- 0*2, 1*0, 5, 10 and 50 ;ug. per ml. In some
tests a concentration of 0*Q6 7ug, per ml. was also included.
With each set of dilutions of each drug, a slope was
included which was prepared with sterile distilled water instead
of drug dilution. This tube acted as a control on tile growth of
the inoculum.
Inoculum;- A suspension of the organisms was prepared by
shaking a loop-ful of a 3-6 weeks primary growth on a Lowenatein-
Jensen slope in 0*3 ml. sterile distilled water with glass beads in
a mechanical shaker for 30 minutes. A 3 mm. loopful of the
resulting /
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resulting suspension was streaked up the centre of the slope, care
being taken not to dip the loop into the water of condensation at
the foot of the slope. The same inoculum was used for all drugs.
All tests were incubated for four weeks at 37°0. The
end-points for the streptomycin and P.A.S. tests were taken as the
lowest concentration totally inhibiting the growth ("no growth"
end-point), inhibiting the growth of 20 or more colonies ("20-colony"
end-point) and inhibiting the growth of 100 or more colonies ("100-
colony" end-point). The end-points for the isoniazid resistance
tests on pre-treataent cultures were the same as those used for the
streptomycin and P.A.S. tests given above. For all other cultures,
the results were expressed as the concentration allowing any degree
of growth (the "no growth" end-point), allowing the growth of 30
or more colonies (the "20-colony" end-point) and allowing the growth
*
of 100 or more colonies (the "100-colony" end-point).
One culture of the standard sensitive strain, H37RV, was
included in each batch of tests. The results of the streptomycin
and P.A.S. tests were expressed as resistance ratios to the standard
H37Rv strain. Those for isoniazid were given as the minimum
concentration inhibiting growth (within the definitions given above)
for pre-treatment strains, and as the highest concentration allowing
the growth of other strains.
The standard strain (H37RV) was normally inhibited by 1
to 4 yug. streptomycin per ml., and 0*5 to 2 jag. P.A.S. (sodium salt)
per ml. The standard strain was usually inhibited by 0*2 jug.
isoniazid per ml. but irregularily by 0*06 /ug. per ml.
19
miaaw ■:
N0EE1AX DISTBIBUTIOH OF Rh'SISTA&CE OF PRS-TRJS/i'lli 'aNT STRAINS
Streptomycin*
Liquid medium with Tween 80. Forty-nine pre-treatment
cultures from 49 patients, that is, 49 strains, were tested for
streptomycin resistance in liquid medium with Tween 80. The
detailed results after 10 and 14 aays? incubation, expressed as
minimum, inhibitory concentrations in jig. streptomycin per ml* and
as resistance ratios to the standard H 37Rv strain art given in
table 4, and are summarised in table 5. In this series, the
standard strain was inhibited by 0*25 to 0*5 jug. per ml. at 10 days
and by 0*25 to 1*0 ug. per ml. at 14 days.
There was no significant difference between the 10 days
and 14 days readings. The majority of the strains were inhibited
by 0 •25 jftg. per ml* and were at least as sensitive as the standard
strain. In 19 of the 49 strains, no growth occurred at the lowest
concentration tested after 14 days* incubation and consequently no
absolute readings could be obtained. It was therefore not possible
to submit these results to statistical analysis. All the strains
tested, were inhibited by 0*5 jug. per ml. or less and were not mors
than twice as resistant as the standard strain. Therefore a
minimum inhibitory concentration of 1*0 jug. per ml. or over or a
resistance ratio of four or above would indicate an increase In
resistance /
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resistance outwith the normal range of pre-treatment sensitive
cultures for both 10 days and 14 days readings.
Solid medium. Table 6 shows the results of solid medium
resistance tests to streptomycin on 51 pre-treatment strains. These
are summarised in table 7. The results, after 2 and 4 weeks*
insulation, are expressed as minimum inhibitory concentrations and
as resistance ratios, taking as the end-point of the titrations
total inhibition of growth (no growth end-point), inhibition of 20
or more colonies (20-colony sad-point) and inhibition of 100 or more
colonies (100-colony end-point). It will be seen that no growth
occurred even on the control tubes at the end of 2 weeks' incubation
in El of the 51 strains tested. This incubation period would
therefore seem to be too short to allow of growth of many strains
after primary isolation. All of the remaining 30 cultures, from
which a reading was possible, required less than 16 jig. per ml. for
inhibition of growth by any end-point and none was more than four
times as resistant as the standard strain.
After 4 weeks* incubation all but one of the 51 strains
were inhibited by 8*0^jug. per ml. or less regardless of the end-point
taken. This single strain was inhibited by 16 yug. per ml. The
majority of the cultures were not more than twice as resistant as
the standard strain. A resistance ratio of four was however
obtained from two cultures with the "no growth" or "20-colony"
end-point and from four with the 100-oolony end-point.
The /
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The results of the analysis of variance for the minimum
inhibitory concentrations and for the resistance ratios for the
three end-points after 4 weeks1 incubation is given in table 8.
The cultures in which an absolute reading was not possible (i.e. with
m.i.e. of less than 1*0 jag. per ml, or a resistance ratio of less
than ^) have not been counted in the analysis. Therefore the
final results may be slightly higher than if a full titration had
been done on these strains. The table shows that, at the 9®
percent level, the lowest reading outside the normal range is a
minimum inhibitory concentration of 16*0 yug. per ml. for all end-
points. b&en expressed as a resistance ratio, the lowest figure
is 4 for the "no growth" end-point for P«0*01 or 0-02. When the
"20-colony" and "100-colony" end-points are considered, the readings
are 8 and 4 for P»0*01 and 0*02 respectively.
ff.A.S.
Liquid medium with Tween 80. Fifty-two pro-treatment
strains were tested for P.A.S. resistance in liquid medium with
Tween 80* The results after 14 days' incubation, expressed as the
minimum inhibitory concentrations in jag. P.A.S. (sodium? per ml.
and as resistance ratios, are given in table 9 and summarised in
table 10. As a one in ten dilution of the inoculum was used for
these tests, the growth after 10 days incubation was too weak to
allow of a reading at that time. The standard strain was inhibited
by 0-06 to 0-6 ;ig. sodium P.A.S. per ml. in this series.
All /
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All but two of the 52 cultures tested were inhibited by
0*25 jag. per ml. or less. In the remaining two strains the minimum
inhibitory concentration was 0-5 jug. per ml. Two strains were
four times as resistant as the standard strain. The remaining 50
cultures were not more than twice as resistant as the H 37Rv strain,
tfcen the analysis of variants is applied to these results,
the variance is found to be 0*9212 for the minimum inhibitory
concentration readings and 1-1086 for the resistance ratios. The
corresponding figures for the standard deviations are C-916C and
1*009 respectively. The lowest readings outside the normal range
at the 99 percent level are a m.i.c. of 0-5 jug. per ml. or a
resistance ratio of 8. At the 98 percent level a ratio of 4 is
just significant.
Solid medium. Table 11 shows the results of solid
medium resistance tests to P.A.S. on 52 pre-treatmeat cultures. The
results, for the "no growth", "20-colony" and "100-colony" end-points,
are expressed as minimum inhibitory concentrations of F.A.S. (sodium)
per ml. and as resistance ratios, These are summarised in table 12.
In twelve of the cultures less than 100 colonies grew after
2 weeks1 incubation. Of the remaining 40 strains, all but one were
inhibited by not more than 2*0 jog. sodium P.A.S. per mi, and all
were less than eight times as resistant as the standard strain.
There was no significant difference between the readings using the
three different end-points.
After /
After 4 weeks' incubation, one strain required 8«0 jug. per
mi. for inhibition of any degree. The remaining 51 cultures were
inhibited by 4*0 jug. per ml. or less. No strain was mere than four
times as resistant as the standard strain except for one which was
8 times as resistant at the 100-colcny end-point.
Table IS shows the analysis of variance for the 4 weeks*
readings. VJhere the tirtration was too low for an end-point to be
found, the results have been ignored in the statistical analysis.
At the 99 percent level, a minimum inhibitory concentration of 16*0
jug. per ml. at the "he growth" end-point, or 8*0 jag. per ml. at the
"20-colony" or 100-colony" end-points, and a resistance ratio of
Q by all end-points were found to be the lowest readings outside the
normal range.
Iscniazid.
Tests for isoniazid resistance were only made on solid
medium. The readings on 102 pre-treatment strains after two and
four weeks* incubation, given in table 14, are summarised in table
15. The results are expressed as the minimum inhibitory concentrations
of isoniazid in ug. per ml. completely inhibiting growth("no growth"
end-point), inhibiting the growth of 20 or more colonies ("20-colony"
end-point) ana that inhibiting the growth of 100 or more colonies
(**100-colony" end-point).
In eleven of the strains, the growth consisted of less than
100 colonies after two weeks' incubation. Using the "no growth"
end-point, /
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end-point, one culture required 1-0 ,Ug. per ml. for inhibition and
one 5*0 ug. per ml. The remaining strains were all inhibited by
0*2 jug. per ml. After 4 weeks1 incubation, taking the £0 and 100
colony end-points, all of the 102 strains were inhibited by 0-2^ug,
per ml. When the "no growth" end-point was used, 6 strains required
1*0 jug. per ml. for inhibition, two 5-0 jug* per ml. and one 10*0 tig.
per ml.
50 pre-treatment strains were tested for resistance to
0*06 jug. per ml. in addition to the normal range of concentrations.
In 12 of these strains, a growth of 20 or more colonies occurred on
the slope containing 0*00 ,ug. per ml. after 4 weeks* incubation.
These results suggest that by tnis technique a growth of
20 or more colonies on the slope containing 0*2 jag. isoniazid per ml.
or more indicates a strain of greater resistance than that found in
the normal pre-treatment range. Growth at 0*06 jug. per ml. occurred
too frequently in the normal sensitive population for this concentration
to be of use in detecting resistance.
Comparison of different series of pre-treatment strains examined in
two separate laboratories.
In order to ascertain whether there was any variation in
the normal pre-treatment readings found in different laboratories
using the same techniques, the results of the present series were
compared with series reported from the Postgraduate Medical School
(by courtesy of Dr. D. A. Mitchison). These comparisons are
confined /
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confined to streptomycin and P.A.S, resistance tests in liquid
medium with Tween 80 road at 14 days and in 3olid medium read at 4
weeks using the 20-colony end-point. The results are given in
table 16*
The range of minimum inhibitory concentrations varied
between the laboratories for the same drug and medium. In contrast,
the range of resistance ratios for each drug in a given medium was
very similar. It seems therefore, that in order to obtain comparable
figures between laboratories it is necessary to express the results
as resistance ratios to a standard sensitive strain rather than as
absolute concentrations of the drug.
For this reason, all the results for streptomycin and P.A.S.
resistance tests in this thesis are expressed as resistance ratios to
the standard H37RV strain. The isoniazid tests, carried out by the
method recommended by the Meaieal heseareh Council, are given as the
concentration of the drug allowing the growth of 20 or more colonies.
This method has proved satisfactory in clinical use (see later in
this thesis) and has not therefore been altered.
summary.
Table 17 gives a summary of the readings found to be outside
the normal range of pre-treatanent strains for the various methods
considered above. Although accuracy at the 99 percent level would
be desirable for the streptomycin and P.A.S. tests, in practice the
98 percent level is more useful. Ey this reading two strains per
hundred /
hundred would be classified as resistant which were actually sensitive
to the drug# If however two or more cultures were tested from a
patient, the probability of both showing falsely as resistant would
be only one in 250 cases. Therefore the readings for P * 0*02 have
been used in comparing the efficiency of the various methods to
detect resistant strains.
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STRAINS ISOLATED FECM PATIENTS AFT1R TREATS? '-NT.
In order to determine which of the above methods and
criteria were most satisfactory for detecting resistance in tubercle
bacilli, readings obtained with strains isolated from patients after
treatment with the drugs were compared. where discrepancies occurred,
the details of these cases were analysed to decide which method gave
the truest indication of the clinical response to the drug.
Streptomycin.
Liquid medium.. The 10 days* and 14 days' readings of
streptomycin resistance tests in liquid Dubos medium with Tweea on
100 strains isolated from patients who had received the drug are
given in table IS and summarised in table 19. Fifty-eight cultures
were sensitive and 37 were resistant at both the 10 days' and 14 days'
readings. The remaining five strains were all sensitive by the 10
days* reading but resistant by the 14 days' reading. In three of
these five cases (3R 13, SS 46 and SB 74) at least three other
cultures isolated from each patient had given resistance ratios of
8 or more to streptomycin. In the remaining two cases, (SR 50 and
SB 53), resistance was suspected, as the sputum had remained
persistantly positive on treatment with intermittent streptomycin
and daily P.A.S., although resistance had not been demonstrated
in vitro.
On these results, the 14 days* readings seemed preferable
to /
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to the 10 days' reading for detecting streptomycin resistance in
liquid medium with Tween 80.
Solid medium. The results of streptomycin resistance
tests on solid medium on 100 strains isolated from patients who
had received treatment with the drug are given in table 20. The
readings, using the "no growth", "20-colony" and "100-colony" end-
points are summarised in table 21. Of the 40 cultures sensitive
by the 20-colony end-point, 39 were also sensitive by the no-growth
and by the 100-colony end-points. The discrepant strain (SR142)
was from a patient whose organisms had become isoniazld resistant
during treatment with daily streptomycin and isoniazld, and in whom
a resistance ratio of greater than eight for streptomycin had been
found on four previous occasions.
The remaining 60 cultures were all resistant by the 20-colony
end-point. Of these, all but two (SR115 and SR 115) were also
resistant by the "no growth" end-point. One of these two cultures
(SR 113) had been isolated from a patient whose bacilli had developed
resistance to isoniazid on daily streptomycin and isoniazid, and from
whom cultures with resistance ratios of greater than eight by the
liquid medium had been isolated previously. The second culture
(SR 115) was not inhibited by 64*0 jug. streptomycin per ml., but
owing to a growth of less than 20 colonies of the standard strain
in the 64 jag. per ml, tube, the ratio was "greater than 1". Three
other cultures from this patient had given resistance ratios of 4 on
the /
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the solid medium test. It was therefore probable that in faot the
bacilli were resistant to the drug.
Only one of the 60 strains resistant by the 20-colony
end-point appeared sensitive by the 100-colony end-point (8R 178),
In this patient isoniazid resistance had developed on treatment with
daily streptomycin and isoniazid.
To summarise» there were three strains which gave a
resistance ratio of four or over with the 20-colony end-point, hut
which were sensitive by either the "no growth" or 100-colony end-
points. In all these oases there was reason from the previous
ohesaotherapeutic history of the patients and from previous resistance
tests to expect the strains to be streptomycin resistant. On the
other hand, only one strain, which on analysis was expected to be
resistant, was demonstrated to be so by the "no growth" and 100-colony
end-points but not by the 20-colony end-point.
The differences between the readings by the various end-
points were slight, but they suggested that the 20-colony end-point
was slightly more sensitive than the other two in detecting
resistant organisms. Therefore this end-point only has been used
for the remainder of the work reported here. A resistance ratio
of four or above on two or more cultures from the same patient has




Liquid medium. Owing to the low inoculum used for the
P.A.S. resistance tests in liquid medium, and the consequent slow
appearance of growth, no 10 days' readings were possible. Therefore
the readings after 14 days' incubation was used. A resistance
ratio of four has been taken as indicating resistant organisms, since
this was shown to be outwith the normal range at the 98 percent
level.
Solid medium. Details of the readings of P.A.S. resistance
tests on 100 cultures isolated from patients who had received
treatment with the drug are given in table 22. The results are
summarised in table 83. All of the 52 cultures which were sensitive
by the 20-colony end-point were also sensitive by the "no growth"
end-point. Three of these 52 cultures were apparently resistant by
the 100-colony end-point; one strain (PR 71} was from a patient who
had been treated with P.A.S. alone for nine months, and from whom
three previous cultures had been isolated which gave a resistance
ratio of greater than 8 on solid medium. The second strain (PR 64)
was isolated from a patient whose organisms had become resistant to
streptomycin on treatment with intermittent streptomycin and P.A.S.
followed by daily streptomycin and P.A.S., but in whom resistant
organisms had not been demonstrated in vitro. The bacilli were
therefore considered to be of "doubtful" resistance. The third
strain (PR 5) was from a patient in whom sputum conversion had
occurred with treatment with daily streptomycin and P.A.S, followed
by /
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by intermittent streptomyoin and P.A.S. The bacilli were therefore
probably sensitive in this case.
Of the 48 cultures which were resistant by the 20-colony
end-point, one was sensitive by the "no growth" end-point (FRl) and
two by the 100-colony end-point (PR 56 and PR 98} , Strains PR 1
and PR 98 were in fact known to have given resistance ratios of
greater than 8 on previous resistance tests, The third strain
(PR 56) was sho?m to be sensitive on repeat testing.
The differences between the readings are not therefore
very marked. There is a slight bias towards the 20-colony end-point.
This end-point has therefore been used, strains being considered
resistant if a ratio of eight or over is obtained.
Isoniaald,
Solid medium. Table 24 gives the readings, for the three
end-points, of isoniazid resistance tests in solid medium on 50
strains isolated from patients who had been treated with the drug.
A comparison of the results is given in table 25. One strain (ER 5}
appeared sensitive on the 100-colony end-point but resistant by the
20-colony end-point. Other cultures from this patient had repeatedly
shown growth on medium containing 50 ug. isoniazid per ml., and
subsequent treatment with daily streptomycin, P.A.S. and isoniazid,
when her bacilli were also resistant to the former two drugs, failed
to convert her sputum.
Owing /
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Owing to the wide scatter of the readings of pre-treatment
strains using the "no growth" end-point (see table 15), a reading of
10 jag. per ml. is necessary to indicate resistance. By this
criterion, 26 of toe 48 strains resistant by toe 20-colony end-point
would have been classified as sensitive. The case histories and
other resistance tests had shown all of these 48 strains to be
resistant.
Although there was no difference between the 20-colony
and the 100-colony end-point results, the 20-colony end-point has
been chosen for routine use in order to have a uniformity in the
readings for streptomycin, P.A.S. ana isoniazid tests. The wide
variations of pre-treatment cultures with the "no growth" end-point
made this reading of little practical use. Strains have been
considered resistant to isoniazid if a growth of 20 or more colonies
was obtained on the slope containing 0*2 ng. per ml,
.Summary,
To summarise, the 14 days reading in liquid medium
streptomycin tests and the 20-colony end-point readings for all solid
medium tests after 28 days' incubation were found to give the closest
correlation with the ehemotherapeutic histories and with the clinical
response of the patients.
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COMPARISON OF RESULTS OF RESISTANCE TESTS ON SOIXD
AND IN LIQUID MEDIA
In order to determine which of the methods discussed
above was the most satisfactory for use in detecting the presence of
streptomycin and P.A.S. resistant bacilli, tests were carried out in
liquid medium and in solid medium on the same cultures. As a
discrepancy was demonstrated between the results of tests on these
two media, some strains were also tested in liquid medium without
Tween 80. The results in this mediraa were compared with those in
liquid medium with Tween and with those on solid medium.
Streptomycin.
The detailed results of streptomycin resistance teste
carried out in liquid medium with and without Tween 80 and in solid
medium are given in table 26.
Liquid medium with Tween 80 and solid medium. A comparison
of the readings of resistance tests on solid medium and in liquid
medium with Tween on 53 strains from patients who had received the
drug is given in table 27. A resistance ratio of 4 is taken to
indicate resistance by either method. 17 of the strains were resistant
and 19 sensitive in both media. Of the remaining 17 cultures, 15
were resistant whan tested in solid mediua, but sensitive in liquid
medium with Tween. All but 4 of these 15 strains had a resistance
ratio of 8 or over on solid medium. Only two strains were resistant
on /
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on liquid medium, but sensitive on solid medium. An analysis of
tile strains showing discrepancies between the two media is given in
table 28. It will be seen that 13 of the 15 cultures resistant on
solid medium only were in fact expected to be resistant by virtue of
the previous treatment of the patient from whom the strain was
isolated or from previous resistance tests on other cultures. In
two, the presence of resistant organisms was classed as "doubtful"
although the previous treatment was such that resistant organisms
were very likely to have developed. Of the two strains that appeared
sensitive on solid medium but resistant by liquid medium, one was in
fact resistant, the organisms having become isoniazid resistant on
treatment with daily streptomycin and isoniazid. Subsequent
cultures were also shown to be resistant on solid medium- The
other strain was likely to be sensitive to the drug, as the patient
had not received any treatment before the culture was isolated from
the sputum, and subsequent treatment with daily streptomycin and
isoniazid was ccraplately satisfactory. Two other cultures tested
from this patient on liquid medium were fully sensitive to the drug.
These results suggest therefore, that the solid medium test
is more efficient than the test in liquid medium with Tween for
detecting streptomycin resistant organisms.
Liquid medium without Tween and solid medium. A summary
of the readings of tests on solid medium and in liquid medium without
Tween are given in table 29. A resistance ratio of 4 was taken as
indicative /
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indicative of the presence of resistant organisms in either medium.
Of the 31 cultures tested, 10 were sensitive and 17 resistant by
both methods. An analysis of the remaining 4 cultures is given in
table 30. It will be seen that in three cases, (SR 824, SR 888,
SR 230), the bacilli were expected to be resistant by previous
chemotherapy or because of the results of previous resistance tests.
In the remaining case (case SR201) resistance had not previously
been demonstrated, but the previous treatment of the patient was
such that resistant organisms were very likely to have developed.
Therefore the solid medium test seemed slightly preferable
to the liquid medium without Tween, although the differences were not
very marked.
Liquid medium with and without Tween. The results of
tests in liquid medium with and without Tween are summarised in
table 31. A ratio of 4 is taken as indicative of resistance in
both media. The results in the two media were in agreement in 26
cases, 14 being sensitive and 12 resistant. All of the remaining
5 cultures were resistant in medium without Tween but sensitive in
medium with Tween. in analysis of these five cultures is given in
table 32. All were expected to be resistant.
Therefore, although the numbers are small, results of
these comparisons suggest that medium without Tween is more
satisfactory than that containing Tween, but that neither medium is




The results of P.A.S, resistance tests on solid medium and
in liquid medium with and without Twoen 80 on 71 cultures isolated
from patients who had been treated with the drug are given in detail
In table 33 *
Liquid medium with Tween and solid medium* The results
of tests carried out in solid medium and in liquid medium with Tween
80 are summarised in table 34. A resistance ratio of 4 is taken as
indicative of resistance in the liquid medium with Tween and of 8 in
the solid medium. Of the 71 strains tested, 27 were resistant and
25 sensitive by both methods. Of the reraaining 19 cultures, 17 were
resistant on solid medium only, and two were resistant only in liquid
medium. Ah analysis of these 19 cultures is given in tab^e 35.
Of tlie 17 cultures resistant on solid medium only, 15 were
expected to be resistant. The other two were of doubtful resistance,
details of therapy and previous tests not being available. Of the
two cultures resistant on liquid medium only, one was likely to be
resistant, since the bacilli became resistant to streptomycin when
the patient was treated with daily streptomycin and P.A.S. The
other was of doubtful sensit Lvity.
These results suggest that the solid medium is superior to
the liquid medium with Tween 80 in detecting P.A.S, resistance.
Liquid /
37
liquid medium without Tween and solid medium. The results
of tests on strains in liquid medium without Tween 80 and on. solid
medium are compared in table 36, A ratio of 4 in liquid medium
without Tween 80 and of 8 in solid medium has been taken as indicating
resistance. In 43 of the 57 cultures tested, the results by the two
methods were in agreement, 13 being sensitive and 30 resistant. All
of the remaining 14 cultures wore resistant in liquid medium but
sensitive in solid medium. A detailed analysis of these strains is
given in table 37. Jive were expected to be resistant, three were
"doubtfully" resistant end six were sensitive. Therefore, in both
media, some strains failed to show a correlation with the clinical
details of the case.
Liquid medium with and without Tween. Table 38 gives a
summary of the results of testa for P.A.S. resistance in liquid medium
with and without Tween 30. A resistance ratio of 4 is taken to
indicate the presence of resistance in either medium. 13 cultures
were sensitive and 18 resistant by both methods. All of the
remaining 26 strains were sensitive in medium containing Tween 80
but resistant in medium without Tween. An analysis of these cultures
is given in table 39. 17 of the strains were expected to be resistant,
two were of "doubtful" resistance and six were sensitive. In one
case, details were not available.
Therefor©, although the liquid medium without Tween did in
some cases indicate resistance in an apparently sensitive strain,
that /
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that mediiM seemed preferable to the medium with Tween for detecting
P.A.S. - resistant strains.
Summary,
The results reported here show that Lowenstein--Jensen
.
medium is superior to Dubos medium with or without Tween 80 for
detecting strains of tubercle bacilli resistant to streptomycin or
P.A.S. A comparison of the solid medium and liquid medium tests
with those carried out in liquid medium without Tween show that the
tests in the absence of Tween agree more closely with the solid medium
ones than do those with Tween. This suggests that Twsen 80 is partly
responsible for the suppression of resistance in liquid medium tests.
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SICWIFIOAKCS OF LOW flSGBSSS OF RESISTANCE,
Many of the methods advocated for the routine testing of
drug resistance ignore the lower levels of resistance. These have
nevertheless been found by present methods to be outwith the normal
range of sensitivity of pre-treatment strains. The levels concerned
are resistance ratios of 4 and 8 to streptomycin and 3 and 16 to
P.A.S. and a maximum concentration of 0*2 and 1.0 jug. isoniazid per
ml. allowing the growth of 20 or more colonies. In order to assess
the significance of these low levels, 136 cases whose organisms were
known to be resistant to one or more drug were investigated. The
cases were mainly those which had been included in research trials
of the Medical Research Counoil or were later admitted to local trials
of viomycin or pyrazinamide. There was therefore no selection of
cases. Full bacteriological details were not available on all cases.
Where there was sufficient information, the following criteria were
used to indicate that a patient's organisms were failing to be
affected by the drug ana that the degree of resistance detected was
therefore of clinical significance
1) Initial fall in sputum positivity after the start of
treatment followed by a rise at the time of emergence of resistance to
the drug.
2) The development of resistance to a second drug during
combined therapy, when the organisms were known to be resistant to
the /
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the first drug at the start of treatment.
3} Persistent sputum positivity of at least six months'
duration tram the start of treatment, when the bacilli were known to
be resistant to the drugs being given by the end of treatment.
4) Clinical or radiological deterioration while under
treatment with the drug ox drugs in question.
In the 136 oases investigated, the bacilli were resistant
to streptomycin in 111, to P.A.S. in 105 and to iscniazid in 101.
Of these, the percentage with organisms of a low degree of resistance
was 30, 34 and 36 respectively. These figures can be taken as
representing the incidence of organisms of low degrees of resistance
in an average resistant population, since the 136 cases were not
selected in any way.
If organisms of a low degree were not of clinical
significance, it would be expected that the incidence of patients
excreting only bacilli of low degrees of resistance in cases which
presented evidence of clinical significance of resistance as judged
by the above criteria would be markedly less than in the average
resistant population. Therefore the incidence of oases with
organisms of a low degree of resistance showing signs of significance
of resistance has been compared with the incidence of such oases in
the average resistant population.
Pall and rise of sputum positivity.
A summary of the results of resistance tests on cultures
isolated /
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isolated "before and after treatment together with the sputum
positivity before and during treatment, for cases resistant to
streptomycin, P.A.S. ani isoniazid are given in tables 40, 41 and 4S
respectively. Detailed examples for each drug are given in figures
1, 3 and S«
The incidence of low degrees of resistance to streptomycin,
P.A.S, and isonxaaid in cases in which a fall and rise in sputum
positivity was demonstrated, is compared in table 45 with the
percentage of cultures of low degrees of resistance in the average
resistant population. It will be seen that the incidence of
bacilli of low degrees of resistance was similar in the cases in
wiiich a fall and rise was demonstrated to that in the average
resistant population.
Development of resistance to a second drug.
In table 44 are given the details of resistance tests and
treatment for IB patients whose organisms developed resistance to
one of the standard drugs on combined therapy. In all cases the
bacilli were resistant to all but one of the drugs before the start
of treatment, although this information was not available at that
time. The organisms were fully sensitive to the remaining drug.
The incidence of organisms of low degrees of resistance to
streptoraycin, P.A.S. or isoniazid in these cases is compared in
table 45 with that in the average resistant population. for
streptomycin and P.A.S. the incidence is of the same order in both
groups. /
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groups. The number of cases of Isoniazid resistance is too small
to allow of a direct comparison, but it is to be noted that in two
patients whose organisms were resistant to 0*2 and 1-0 jug. per ml.
respectively pre-treatment, resistance to a second drug developed.
It therefore seems that resistance on oombinei therapy can occur with
low or high degrees of resistance.
Persistant sputum positivlty.
The details of <54 cases in which the sputum remained
persistently positive throughout treatment of at least 6 months 1
duration are given in table 46. The results are summarised in
table 47. The incidence of organisms of a low degree of resistance
in patients in whoa the sputum remained positive during treatment was
of the same order as that found in an average resistant population.
Therefore chemotherapy failed to convert the sputum in spite of the
presence of bacilli of only low degrees of resistance.
Clinical and radiological deterioration.
The reports of clinical and radiological deteriorations
are those of the clinicians in charge of the oases. The details of
the eases are given in table 43, and the results summarised in table
49. It will be seen that the incidence of bacilli of low degrees
of resistance was of the same order in cases in which clinical or





Tlx© results reported hex*© suggest tlxat organisms of a
low degree of resistance to streptomycin, P.A.S. or isoniazid are
as significant bacteriologioally and clinically as those of higher
degrees. Therefore the criteria for resistance adopted in the




A wide variety of methods Slave been reported for the
detection of drug resistance in tubercle bacilli. ^ the time
this work was started in 1953, the most common ones in use were
serial dilution, techniques :i.n liquid medium with Tween 80 and in
coagulated egg medium. The results were usually reported as the
minimum inhibitory concentrations of the drug that would completely
or partially inhibit the growth of the test organism, or as a
ratio of the inhibitory level of the test organism to that of a
standard sensitive strain.
As has already been pointed out by Bist et ai. {1951) and
Canetti {1955}, the criteria to be satisfied before a strain was
considered resistant varied greatly even when similar methods of
testing and reporting were used {see also tables 1, 8 and 3). fhis
has led to wide misunderstanding in the interpretation of resistance
tests and also in the assessment of the efficiency of different
chemotherapeuti o regimes in preventing tile emergence of resistant
bacilli.
In the present series the results of tests carried out by
tile same techniques on pre-treatment cultures in different laboratories
showed some variation when the results were expressed as minimum
inhibitory concentrations. There was, however, good agreement when
the readings were given as resistance ratios to the standard 337Kv
strain. /
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strain. This suggests that the variations, probably due to minor
differences in technique and media, affect the control strain in a
similar manner to the test organism and are therefore neutralised
when the ratio is used. All results for streptomycin and P.A.S.
resistance tests in this thesis have therefore been expressed as
resistance ratios. The results of isoniazid resistance tests have
been reported as the minimum concentration of the drug inhibiting
the growth of 20 or more colonies. This method was that adopted
by the Medical Hesearch Council for the trials of chemotherapy in
tuberculosis {1952b;1953d). Many of the cases used here were
included in those trials, and the method was found to be quite
satisfactory. This may be partly due to the stability of isoniasid
in the medium (Goulding et al.» 1952; Mitehison, 1952) and therefore
to the easier reproducibility of results. The present series
confirmed that the 20-colony end-point recommended by the Medical
Research Council was the most satisfactory.
In interpreting the results of tests carried out by various
methods, it is important first to test a series of strains from
patients who have never received the drug. There are however
occasionally cases whose organisms are resistant to one or more drug
(Harold, 1951; Arany, 1952; Thomas et al., 1954; Murdoch and Grant,
1955; Fox et al., 1957; Mitchison and Selkon, 1957) before the
start of treatment due to infection with resistant bacilli. Such
cultures should be excluded from a pre-treatment series, since they
have /
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have in fact been in contact with, the drug at an earlier time. in
the present series three such strains had to be discarded,
from, the results of pre-treatment cultures, it is possible
to determine the lowest readings which are outwith the normal
variation of sensitive strains for the conditions of the test under
consideration. For practical purposes a result which will occur
only twice in 100 strains has been considered to signify an increase
in resistance beyond normal biological variation. It is realised
that in so doing a few sensitive strains will initially be classed
as of low degrees of resistance. A repeat teat on the same culture
or the simultaneous testing of other cultures from the same patient
will, however, differentiate the true sensitive strain from one of
a low degree of resistance.
The aim of any resistance test designed for use in a
clinical laboratory is the detection of all degrees of resistance that
are of clinical significance. In assessing the value of the different
methods it is therefore important to correlate the bacteriological
findings with the clinical data of the patients. This has not been
done in reported series. In the present work, the results obtained
by the different methods have been compared. tohere a discrepancy
occurred, the details of the eases have been investigated in an attempt
to ascertain which result was most closely related to the clinical
findings.
The effect of the duration of incubation of both solid and
liquid medium tests was investigated. In the liquid streptomycin
tests, /
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tests, a higher proportion of strains was found to be resistant after
14 days' than after only 10 days' incubation. This is in agreement
with the work of Mitohison (1950a) who showed that the late appearance
of resistance was correlated with the percentage of resistant bacilli
present in the original culture. In the solid medium tests, a
number of cultures failed to grow on the resistance test after 14
days' incubation. Therefore, although a provisional report of
resistance could sometimes be given at this time, 28 days' readings
were found to be more satisfactory for routine use.
Pyle (1947) showed that there were present in a sensitive
strain small numbers of bacilli resistant to streptomycin. similar
findings were also made regarding isoniazid (Middlebrook, 1952). It
is therefore reasonable to expect small lumbers of colonies to occur
on drug-containing slopes from sensitive strains. This has already
been shown for isoniazid tests (Medical Research Council, 1953d).
Comparisons of the readings for streptomycin, P.A.S. and
isoniazid resistance tests, taking no growth, 20 colonies and 100
colonies as the end-points respectively, have confirmed that up to
20 colonies may occur on drug-containing slopes. Therefore the
"no growth" end-point was considered unsatisfactory for use. Little
difference was found between the 20-colony and the 100-colony end-
points. For the streptomycin and P.A.S. tests, the result were
slightly in favour of the 20-colony end-point. Therefore, since
uniformity is a definite advantage in a routine laboratory, the




Having decided on the optimum criteria for streptomycin and
P.A.S. resistance for each of the two media, the results by the two
methods were compared. Tests carried out in both media simultaneously
showed that the solid medium was more efficient in detecting
streptomycin and P.A.S. resistant organisms than was the liquid medium
/if - i -f
with Twees 80. These findings are in agreement with those of Holt
'
H ; ; S
and Cruiefcshanle(1949} who showed that 15 strains which had a
resistance ratio for streptomycin of 2 to 4 in hobos medium with Tween
7 : •
80, were capable of growing on solid medium containing 30 jug.
streptomycin per ml. Vhere discrepancies occurred, between the two
methods in the present series, the results of solid medium tests
showed a closer correlation with the case histories.
Tarions workers have shown that the presence of Tween 80
in Dubcs and Davis liquid medium enhanced the anti-tuberculous activity
of streptomycin (Fisher. 1948b; Wllliston and Ifouraans, 1349). It
was however suggested (Fisher, 1348b; Medical Research Council, 1948)
that the addition of 0-3 percent bovine albumin to the medium partly
neutralised the effect cf the Twoen, while still permitting of a
dispersed growth.
The testing of some cultures in liquid medium with and
without Tween 80 in the present series showed that the results in
the medium without Tween were more closely related to the solid
medium tests, and therefore to the clinical findings, than were those
in liquid medium with Tweon. This suggests, as would be expected
from the work: of Fisher (1948a) that the failure to demonstrate
resistance/
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resistance in the liquid Medium with Tweeu was largely due to the
presence of the Tween 80, in spite of the presence of the bovine
albumin.
The main disadvantages of the solid medium tests commented
on by Rlst et al (1951) and Canetti {1955} are the lack of
standardisation of the inoculum and the heating cf tht3 medium after
the addition of the drug. With regards to the inoculum, it has been
shown that solid medium tests for streptomycin (Villiston and Youmans,
1949}s P.A.S. {Belauds et al. 1949: Hist, 1951) and isonlazid
{Mitchison, 195a; Leoocq and Llnz, 1952) are relatively unaffected
by variations in inoculum, between 104 and 1Q3 bacilli. Further,
many strains that are highly resistant to isoniazid grow poorly or
not at all in semi-synthetic liquid medium (Fisher, 1952), thus
making tests in this medium for any drug unreliable on such strains.
The heating of coagulated egg medium has been shown to
cause a breakdown of streptomycin into inactive products (drummoad
et al., 1951). T.A.S. {Drumnond et al., 1951) and isoniazid
{Mitchison, 1952; Ooulding, 1952) would appear to be more stable.
When a breakdown does occur, it may be variable and not accurately
estimatable. If however the results are expressed as resistance
ratios to a standard strain, a culture of whieh is Included in each
batch of tests, the actual concentrations of the drug in the tubes
inoculated from the test and standard strains should be identical.




One of tile advantages of tlie solid medium, method, apart
fraa tlie greater efficiency in detecting resistant bacilli, is that
contaminants are mere readily detected by colonial characteristics
than by tlx® turbidity in liquid medium. Further, as pointed out fey
Rist et al. (1951) and Oanetti (1955), an approximate assessment of
the proportion of the population resistant to the varying concentrations
can fee made fey noting the amount of growth present in each tube. fm
significance of such variations is discussed in Section II of this
thesis*
In many of the methods recommended for testing for resistance
in tubercle bacilli, readings just above the upper limits of normal
pre-treatment strains are not considered to 'be resistant (C'Esopo and
Steinhaua, 1247; kolinsky et ai., 1948; Bernstein et al., 1950;
Medical Research Council, 1952fe» 1953d)* In order to determine the
significance of these low degrees of resistance, various factors
have been considered in the present; work.
It has been shown that a rise in sputum positivity frequently
occurs with the emergence of bacilli resistant to streptomycin (Crofton
and Hitchison, 1948; Mitohison, 1950b), P.A.S. (horns. 1949) or
isoniaaid (Joiner et al., 1952, 1953; Steenken et al., 1952; Ccates
et ai., 1953; Collard et al., 1953; medical Research Council, 1953c;
"vilallaoe et al., 1954; Wide look and Robins, 1954). Uo such rise is
seen in patients whose bacilli remain sensitive to the drug (Medical
Research Council, 1955®) . In the present series the incidence of
patients /
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patients whose bacilli were of a low degree of resistance was as
frequent in oases in whom an increase in the bacterial content of
the sputum was demonstrated with the emergence of organisms resistant
to streptomycin, P.A.S. or isoniaiiid as in the average resistant
population. These results indicate that even when only a low degree
of resistance was detectable, the drugs were ineffective in preventing
the aaultiplication of the bacilli in vivo.
If adequate doses of combined drugs are given, and if the
patient's organisms are sensitive to the drugs in use before the
start of treatment, resistant bacilli will only emerge in a very
small percentage of oases (Medical Research Council, 1953 a, b and o)«
If however the organisms are resistant to one of the drugs before the
start of treatment, resistance to the second drug will probably develop
as frequently as if the "sensitive" drug were being given alone
(Turnbull at al., 1955; Medical Research Council, 1953c). In the
present work, the development of resistance to a sscox^d drug was
shown to occur with bacilli of both low and high degrees of resistance.
This suggests that when a patient s organisms are of a low degree of
resistance to a drug, that drug is likely to be as ineffective in
preventing the emergence of resistance to a seoond drug as when the
bacilli are highly resistant.
The Medical Research Council (1953c) showed that conversion
of the sputum to negative by the end of six months' treatment occurred
in 32 percent of patients receiving daily streptomycin and P.A.S. and
in /
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in 94 persent of those treated with daily streptomycin and isoniazid,
provided that the bacilli were sensitive to both drugs at the start
of treatment. h&ere resistance to one or both drugs is present,
the sputum may never become negative (Medical Research Couneil, 1955c).
The present work has shown that sputum positivity can persist
regardless of the degree of resistance present.
In the reported series of cases treated with daily
streptomycin in combination with isoniazid or P.A.S. (Medical Research
Council, 1953a)$ clinical or radiological deterioration only occurred
in 1 to 2 percent of the patients. In the present series,
deterioration was reported while on treatment from a number of cases
whose organisms had always been known to be of a low degree of
resistance. This again suggests that the drugs were unable to
control the infection even though only a low degree of resistance
was detected.
To summarise, a comparison of the efficiency of resistance
tests to streptomycin and P.A.S. in Dubos and Davis* liquid medium
with Tween 80 and in coagulated egg medium has shown that the solid
medium is the more sensitive test. Results by this latter method
for streptomycin, P.A.S. and isoniazid are in close agreement with
the clinical findings in the patients. Tests for the clinical and
bacteriological significance of organisms of low degrees of resistance
suggest that all degrees of resistance outwith the normal range of
pre-treatment cultures are of imporfence.
SECTION II
STUDIES ON VARIATIONS IN DECREE OF ISONIAZID
RESISTANCE.
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INTRODUCTION AND REVIEW OF THE LITERATURE
It lias been shown that when bacterial resistance to
streptomycin (Pyle, 1947; Mitchison, 1950b) or to isoniazid (Tampsett,
1954) occurs in patients suffering from pulmonary tuberculosis,
organisms of varying degrees of resistance may be isolated from a
single sample of 3putum. Canetti and Saenz (1951) found that there
may be variations in the degree of resistance of tubercle bacilli
isolated from different lesions within the same lung. In all these
reports, there were cases in which sensitive and resistant bacilli
were demonstrated within the same specimen.
The presence of sensitive organisms in the lung and in
the sputum of patients who are also harbouring resistant bacilli
raises the question of the clinical significanee of low percentages
of resistant organisias. Canetti (1955) suggests, as regards
isoniazid, that to withhold treatment with the drug from such
patients may be depriving them of an effective drug. On the other
hand, if the low percentages of resistant bacilli are significant,
the use of combined treatment in such cases may mean the loss for
the patient of a second drug to which his bacilli were fully
sensitive.
The source of these variations is not yet ascertained. It
has been suggested that they may arise as a result of the development
of mutants of varying levels of resistance (Demeree, 1948; Mitchison,
1951). The work of Canetti and S&enz (1951) suggested that the
finding /
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finding of bacilli of low degrees of resistance or of full-sensitivity
in the presence of more highly resistant bacilli may be due to
resistance having reached different levels in the different lesions
Ui<-
atAtime the examination va3 made.
Variations in the degree of resistance of organisms in
the sputum may also be a result of the reversion of the degree of
resistance in the bacterial population. That such a reduction
can occur in the degree of isoniazid resistance of organisms in the
sputum after the end of treatment was shown by Nitti (1952), Ashino
(1953) and Petit (1953 a and b). This reversion was thought
possibly to be due to the multiplication of sensitive organisms
which had lain dormant but viable in the presence of the drug
(Sohaeffer, 1954) or to a bach-mutation from the resistant population
(Barnett et al., 1953a). Some workers (Medical Research Council,
1954) have suggested that apparent reversion may be due to variations
in the resistance test or in the sampling of the bacterial population
rather than to a genuine reduction in the degree of resistance.
There have been no reports on the significance of either
the presence of sensitive and resistant bacilli simultaneously in
the lung or of the reversion of resistance in the sputum.
SCOPS OP TEE PRESENT WORK
In an attempt to ascertain the significance of low
percentages of Isoniazid-resistant organisms in the sputum of
patients with pulmonary tuberculosis, variations in the degree of
isoniazid resistance in the baciliary population of the sputum
have been estimated. These results have been correlated with
previous isoniazid therapy and with the effect of further treatment.
Variations in the resistance of cultures fro® different lesions in
the same lung ar® reported. Observations on the reversion to lower




Tile method consisted essentially of inoculating a series
of L^wenste in-Jensen plates containing varying concentrations of
isoniaaid with serial dilutions of the sputum concentrate, A plate
which did not contain any drug was included in each series in order
to give the total viable count. The numbers of organ!asm resistant
to the various drug concentrations were thus determined. Owing to
the tendency of Myoo. tuberculosis to clump, the colony counts
represent "viable units" rather than individual organisms.
Preparation of plates:- fourfold dilutions of isoniazid
in sterile distilled water were added to Loweastein-Jensen medium in
the proportion of one part of dilution to 100 parts of medium to
give final drug concentrations ranging from 84 jug. per ml. by four¬
fold dilutions to 0*06 jug# per ml. The isoniassld-egg medium mixture
was then poured into 9*0 cm. Petri dishes, approximately 30 ml*
being used for each plate. The plates were inspissated at between
75° and 30°C in a hot air inspissator for one hour. Before use, the
plates were dried in an incubator at 37°C. A disk of sterile filter
paper was then placed in the lid of the Petri dish to prevent any
water of condensation from dropping onto the surface of the medium.
Preparation of the sputum dilutions:- A morning specimen
of sputum, to which had been added an eq.ua! volume of 4 percent
sodium hydroxide, was mechanically shaken with glass beads for ten
2uinutas /
58
minutes at room temperature. The mixture was then kept at 37°C for
twenty to thirty minutes, depending on the tenacity of the sputum.
It was subsequently centrifuged at 2,500 r.p.m. for twenty minutes.
After the supernatant fluid had been removed and the deposit made
neutral to phenol red with 8 percent hydrochloric acid, approximately
25 ml. of sterile distilled water were added to the container and
the mixture was re-centrifuged as before. The resulting concentrate
was homogenised by staking with 2 ml. of sterile distilled water in
a mechanical shaker for ten minutes. A series of tenfold dilutions
of the horaogenate was then prepared from which the plates were
inoculated immediately.
The contents of lung cavities were treated in the same
manner as the sputum.
Inoculation of plates:- The plates were inoculated with
pasteur pipettes which delivered 50 drops to the ml. Two plates
of each drug concentration and two control plates were inoculated
from each specimen on a flat sheet of plate glass. One drop of one
of four consecutive sputum dilutions was placed on the surface of
each of the four quarters of every plate. The actual dilutions of
the sputum concentrate used depended on the degree of positivity of
the sputum. In most cases, dilutions of 1 in 10 to 1 in 10,000
were used for the control plates and the undiluted homogenate and
dilutions of 1 in 10 to 1 in 1,000 were used for the plates containing
the drug. After inoculation the plates were left undisturbed at
rocm temperature for 18 to 24 hours protected from sunlight. The
plates /
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plates were then inverted, the filter papers removed and paraffin
wax was poured into the rim to prevent evaporation during incubation.
The plates were incubated for six weeks at 57°C.
Recording,; of results: - Counts were made from each plate
at the lowest dilution of the sputum giving discrete colonies. The
numbers of organisms resistant to the various drug concentrations
were expressed as percentages of the total viable population. The
results of the population studies have been classified according to
the following table:-
PERCENTAGE OF TOTAL court resistant to
POPULATION ISONIAZID - jug./ml.
STUDY
GRADING NIL 006 0-25 10 4 «0 16 *0 64 0
SENSITIVE 100 0*05 0 0 0 0 0
LOW VARYIN G 100 C05 0-69 0-69 0-89 0 0
-69
LOW UNIFOBW a 100 70—100 70-100 70-100 0-100 0 0
or b 100 70-100 70-100 0-100 0 0 0
ow o 100 70-100 0-100 0 0 0 0
HI (Si VARYING 100 0*05- 0-100 0-100 0-100 0-89 0-69
100
HIGH UNIFOIM loo 70-100 70-100 70-100 70-100 70-100 o-ioo
Routine resistance tests.
The routine isoaiazid resistance tests referred to in this
section were carried out by the method referred to on page . .V£ of
Section /
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Section 1. Sputum cultures were tested at G«2, 1*0, 5, 10 and 50
Jttg. isoniasid per ml. I&wenstein-Jensen medium. The results were
expressed as the highest concentration that allowed the growth of
twenty or more colonies after £8 days' incubation.
Examination of lung specimens for variations in the degree of
isoniazid resistance between lesions.
Specimens for examination were obtained at operation or
post mortem.
Sampling of lesions:- The specimens were examined within
six hours of operation or within twenty-four hours of the patient's
death, except in one case (case 11) in which post mortem examination
was delayed for seventy-two hours. The main sites of the disease
were located by means of a recent radiograph. Samples were taken
from each of these and also from a number of lesions which were not
visible on the radiograph. Precautions were taken to minimise the
spread of tubercle bacilli from one site to another by the use of
separate sterile instruments for each lesion and by making small
incisions through only part of the lung at any one time. The
contents of cavities were removed. Caseous fooi were cut out and
macerated with scissors in a sterile Petri dish.
Isolation of tubercle bacilli:-- The specimens were
suspended in a small volume of sterile distilled water and an equal
volume of 4 percent sodium hydroxide was added. After the addition
of sterile glass beads, the mixture was shaken mechanically for ten
minutes /
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minutes and taen incubated at 57°C. for twenty minutes. After
centrifuging at 2,500 r.p.m. for twenty minutes, the supernatant
was poured off and the deposit was maae neuteal to phenol red with
8 percent hydrochloric acid. Twenty-five mi. of sterile distilled
water were added and the material was contrifuged as before. The
supernatant was poured off. The deposit was inoculated onto three
Lowenstein-Jensen slopes by means of a pasteur pipette. Cultures
were incubated at 37°C. They were examined weekly.
Isoniazid resistance tests:- Isonlazid resistance tests
were carried out on positive cultures from all lesions within two
weeks of the first appearance of growth. If more than one culture
from a lesion was positive the srope with the heaviest growth was
used for the resistance test. If only a few colonies appeared,
the growth was spread over the slope and was reincubated for a
further two weeks. 'The cultures were tested by the method described
for sputum on page . 1?. of section 1. The concentrations used were
0*2, 0*5, 1*0, 2*5, 5, 10, 25 and 50/ug. per ml. The tests were
read after 28 days* incubation and the results were expressed as the
highest concentration of the drug allowing the growth of 20 or more
colonies.
Isoniazid treatment.
All the patients referred to in this section were treated
with isoniazid in a dosage of 200 mg. daily with the exception of




Population Studies on patients who had nover received isoniazid.
The results of population studies on sputum, from 10
patients, who had never received isoniazid, are given in table 50.
It will be seen that in only one (case X 6) of the 10 cases was
any growth fcuni on the lowest concentration tested, i.e. 0*06 /lg.
per ml. In that case only one in 4,000 of the organisms grow at
this concentration, and no growth occurred at higher concentrations.
In all the cases, the routine test showed that the strains were
sensitive to 0»3 jag, isoniazid per ml., the lowest concentration
tested.
Population Studies on patients who had received isoniazid therapy
and whose organisms were known to have been resistant to the drug
by the routine test.
The details of the results of the population studies
together with the results of the routine resistance tests, details
of previous isoniazid therapy and of previous sputum resistance
tests in 45 cases are shown in table 51 and figure 4.
Comparison of the results of the population studies and
those of the routine resistance tests. Table 52 snows the
correlation between the results of the population studies and those
of the routine resistance tests. The population study results are
expressed /
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expressed as the highest concentration allowing any degree of growth.
The results of the routine resistance tests are given as the highest
concentration allowing the growth of 20 or more colonies after 28
days' incubation. The figures within the diagonal, squares represent
those studies in which the results of both tests were in agreement.
Those to the right of this diagonal are cases in which growth
occurred at a higher concentration in the routine test than in the
population study, and those to the left cases in which growth in
the routine test occurred at a lower concentration. Since a two¬
fold variation is within the experimental error of the routine
method, only those results which are at variance by more than one
concentration are considered as discrepancies.
The analysis of the five cases which showed this dis-
:orepancy is given in table 53, the detailed results of the growth
on the routine test also being given. In two of the cases {cases
7 13 and V 29} the routine test showed growth at higher concentrations
than that on the population study. This may have been due to the
picking off of an odd colony of a higher degree of resistance when
the suspension for the routine test was prepared. These more highly
resistant bacilli may have occurred too infrequently to be detected
in the population study. The weight of growth on the drug-containing
slopes in the routine test was high in both cases. Therefore it is
unlikely that the growth at higher concentrations on the routine test
is due to the detection of very small numbers of highly resistant
bacilli /
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bacilli from the heavier inoculum. In both of these cases the
tests were carried out when previous serial routine tests on sputum
had suggested that a mixed bacterial population might be present,
(see page65) In case V 13 resistance was just developing, and in
case V 29 a reversion in the degree of resistance was taking place.
In two of the three cases (cases V 6 and V 17) in which
growth occurred in higher concentrations in the population study
than in the routine test, the percentage of the organisms resistant
to the higher concentrations of the drug was only 0*04 and 0*02
percent respectively. In one of these cases (case "Is 6) reversion
to full sensitivity" had occurred in the sputum, and it is likely
that the routine test was failing to detect the low numbers of
resistant organisms. Although growth of more than 0*1 per cent
of the total population at 0*06 jug. isoniazid per ml. is probably
outwith the normal range in the population studies, this is not
the case in the routine test (see section 1, page . ), In the
second case, (case V 17) reversion to a lower degree of resistance
was occurring, and the population study confirmed that only small
numbers of highly resistant organisms were present. Therefore it
is likely that in this case also the routine test failed to detect
the low numbers of organisms resistant at the higher levels of the
drug.
In the third case (case V 20), 10 percent of the bacilli
were resistant to 4 ug. per ml. and 0*7 percent to 16 yug. per ml.
on the population study, although the routine sputum tests had
repeatedly /
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repeatedly given a reading of 1»0 ug. per ml. It is possible that
the more highly resistant organisms may have died out during sub¬
culture .
To sun®arise, of the 43 sputa tested, all but five showed
a close correlation between the result of the two tests, although
the percentage of growth at the .maximum concentrations was less
than 0*1 percent in some cases. In only one case was there any
suggestion that organisms of a high degree of resistance had died
out or been overgrown by the more sensitive bacilli during the
primary culture cn Lowenstein-Jensen medium. Nevei'theless the
population study may be a slightly more sensitive test for detecting
small numbers of bacilli of low degrees of resistance than is the
routine test.
Correlation between the results of population studies ana the stage
of development of isoniazid resistance in the sputum as shown by
routine sputum resistance tests.
The possible results of serial isoniazid resistance tests
on cultures from the sputum of a patient during treatment with
isoniazid alone and subsequent periods off the drug is shown in
figure 5, Initially the organisms will be sensitive to the drug
(1). As resistant organisms emerge, an increase in the readings
will be observed (3). In the majority of cases the bacilli
untimately become resistant to 50 jug. per ml. (5a), but in some
patients the bacilli never grow at concentrations above 1*0 jug. per
ml. (3b)« If treatment with the drug is stopped, the bacilli may
retain /
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retain indefinitely the high or low degree of resistance reached
by the end of treatment. In such cases the organisms are said to
have remained at a "high" (3a) or "low" (3b) plateau of resistance
respectively. In same eases, however, a reversion (4) to lower
degrees of resistance (5) or to full sensitivity (6) may occur.
In table 54 the results of the population studies, on
the sputa from 52 patients, grouped according to the classification
given on page 59, are correlated with the stage of resistance as
shown by routine resistance tests on successive cultures isolated
from the sputum up to the time the population study was carried out
(figure 4).
Hone of the 10 cases whose bacilli were sensitive to the
drug had ever received isoniazid therapy. All of the seven tested
at the time "that resistance was first developing had mixed populations.
Eleven cases had shown a high level of resistance for 3 to 25 months.
In four of these (cases 7 31, 7 36, V 42 and 7 45) all the organisms
were of a high level of resistance. In the remaining seven cases,
there was a mixed population, including some highly resistant bacilli.
All the organisms were found to be of a low degree of resistance in
five of the nine cases in which the sputum cultures had remained at
a "low" plateau and had never shown a high degree. Three of the
remaining four cases had a mixed population, but did not contain
any highly resistant bacilli. In the ninth (ease 7 20; table 51)
only 0'7 percent of the organisms were resistant to 16 hS* P®?
Only one case (case V 28) was tested while reversion to
a /
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a lower degree of resistance was occurring. The organisms in the
sputum showed variations in dogree, including bacilli of a high
degree of resistance. isight cases were tested in which reversion
to a lower degree of resistance had occurred. In six of these all
the organisms were of a low degree of resistance, no highly resistant
bacilli having been detected. In the remaining two cases, the
resistance of the bacilli varied. In only one of these (case V 21)
trere organisms of a high degree of resistance found. In this
latter case, only single colonies grew on the higher concentrations
of the drug. The assessment of the stage of development of
resistance was made on only three recent resistance tests. It is
possible therefore that the highly resistant organisms were present
only irregularily in the sputtm.
.Finally sputa were tested from six patients whose routine
resistance tests had shown reversion to complete sensitivity. Four
of these were fully sensitive on the population study, no growth
being obtained at 0*06 yog. per ml. The remaining two (oases V 5,
7 6) contained some organisms of a low degree of resistance. The
percentage of bacilli growing at 0*06 jug. per ml. was 15 and 0*3,
and at 0*25 yug. per ml., 0*02 and 0*04 respectively. Therefore in
these oases reversion to complete sensitivity had not occurred.
affect of duration of isoniazid therapy on the population study
result.
By the time this work was started, it was known that in
a /
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a high percentage of cases of pulmonary tuberculosis the bacilli
would become resistant to the drug if the patients were treated with
isoniazid alone. It was therefore not ethical to treat patients
in this way. In many of the cases on whom the population studies
were carried out, the previous treatment with isoniazid had con¬
sisted of more than one course of the drug with breaks of varying
periods. In only five cases was the population study carried out
when the patient had been on isoniazid continuously since the first
development of resistance. The results of these studies together
with the duration of isoniazid therapy are given in table 55. In
this small series there is no correlation between the duration of
therapy and the pattern of resistance in the population study.
Although there are only so few cases, the variations are so great
that it seems unlikely that with larger numbers any correlation
would be shown.
Effect of the duration since the last treatment with isoniazid on
the results of the population studies.
In order to avoid the complications of repeated periods
on and off the drug, this correlation has been limited to the seven
cases who received a single course of the drug, followed by a single
continuous period off isoniazid. The results are shown in table
56. It will be seen that in all of the five cases who had received
less than seven months treatment (cases V 2, V 6, Y 11, Y 19 and
Y 33) the organisms had been shown to be highly resistant by the
routine /
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routine test during treatment. In three of these (oases 7 8,
7 6, and 7 11) the routine test had ahown reversion to sensitivity,
though this was confirmed by the population study in only one case
(case 7 3). The fourth case (case 7 19) showed reversion to a
low degree of resistance by the routine tost and the population
study. These four cases had been off treatment for 17, 10, 30
and 15 months respectively. In the fifth, (ca3© 7 53) no reduction
was detected. This patient had only been off treatment for six
months.
The remaining two eases (cases 7 9 and 7 17) had received
treatment for 14 and 17 months respectively. They had been off
the drug for 33 and 36 months by the time the population study was
carried out, In the first (case 7 9) reversion to sensitivity had
occurred in the sputum, though organisms of a low degree of resistance
were detected on the population study. In the second case reversion
to a lower degree of resistance had also occurred.
It would therefore seem that, even after prolonged
treatment, reversion to a lower degree of resistance and even to
full sensitivity may occur although a high degree of resistance was
found during treatment.
There seemed to be no correlation between the therapy on
which resistance developed and the degree of resistance to which
the strains subsequently reverted. In all but one of the cases
(case 7 17) reversion to a lower degree of resistance occurred
while the patient was either off all therapy or while receiving
drugs /
70
drugs to which his organisms were known to be resistant. In case
Y 17 the patient was receiving pyrazinamlda, tetracycline and
streptomycin, but her bacilli were resistant to streptomycin and
pyrazinamide.
effect of further treatment with isoniazid in cases on whom
population studies had been carried out.
Further treatment with isoniazid alone or in combination
with other drugs, or with isoniazid derivatives that were known to
act- as isoniazid, was given to eighteen of the cases on whom
population studies had been carried out. Table 57 shows the
percentage of the organisms resistant to the lower concentrations
of isoniazid together with the details of the subsequent treatment
given, sputum positivity before and during treatment and the results
of resistance tests to isoniazid and to a second drug, where
applicable, before and after treatment.
In only two cases (cases V S and Y 4) were the organisms
shown to be sensitive both by the population studies and by the
routine test. In one of these (case Y 2) treatment with daily
streptomycin, P.A.S. and isoniazid was given for one and a half
months, at which time the patient left hospital against medical
advice. The bacilli were known to be resistant to both streptoraycin
and P.A.S. before the start of treatment. The sputum, which was
only positive on culture before treatment, converted to negative.
$0 change In the isoniazid resistance occurred during this short
period. Later, however, the patient returned to hospital with a
strongly /
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strongly positive sputum. He was treated with daily P.A.S, and
iscniazid. There was no effect on the sputum positivity, hut the
hacilli became resistant to 5C jug. isoniazid per ml. In the second
case with isoniazid sensitive organisms on the population study
(case Y 4), treatment with daily P.A.S. and isoniazid was given,
although the bacilli were irregularly resistant to P.A.S. before
the start of treatment. A reduction in sputum positivity did
oocur but, with the emergence of bacilli highly resistant to
is ciliaz id, the organisms again became numerous. A population
study repeated at the end of treatment confirmed that the bacilli
were again highly resistant.
In four of the cases (cases Y 5 f 8, 7 9 and Y 12) in
which the routine test showed a low degree of resistance, less than
70 percent of the population was resistant to 0*06 and 0*25 ,ug.
iscniazid per ml. Three of these (cases Y 8, Y 9 and Y 12) were
treated with pyrazinamide and isoniazid daily. In one of these
three (case Y 9) there was a marked fall in sputum positivity
followed by a rise when the bacilli became resistant to pyrazinamide;
in only one (case Y 12) did the degree of resistance to isoniazid
increase by the end of treatment. No reduction in sputum positlvdty
occurred in the third case (case Y S) treated with pyrazinamide and
isoniazid, although the organisms later developed resistance to
pyrazinamide. There was no alteration in the degree of resistance
to isoniazid during treatment in this case. The fourth case (case
Y 5) whose sputum contained only bacilli of a low degree of
resistance was treated with oaytetracycline, 5 g. daily, with
isoniazid 200 mg. dally. The sputum, which had been strongly
positive /
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positive before the start of treatment. converted to negative, but
ultimately became positive again with the emergence of bacilli
highly resistant to isoni&zid.
It seems therefore that although in the three cases
treated with pyrazinamide, the effect on the sputum positivity
was probably due to the pyrazin&mide, in the? fourth case there was
a definite effect which could only be due to isoniazid. The
ultimate failure of treatment in this case might well have occurred
on the oxytetracycline-isoniazid treatment even if the organisms
had been sensitive to isoniazid at the start of treatment.
Six cases (cases ¥ 11, V 17, "T 19, ¥ 23, 7 25 and ¥ 29}
were re-treated in whom the pre-treatment population study showed
that all the organisms were of a low degree of resistance. Three
of these cases (case V 17, V 25 and V 29) were treated with "Dipasio",
an equimolecular chemical combination of P.A.S. and isoniazid. In
none was there any effect on the positivity of the sputum. In only
one of them (case V 17) was there an increase in the degree of
isoniazid resistance during treatment. Two of the remaining three
cases (cases ¥ 11 and V 19) were treated with daily streptomycin,
P.A.3. and isoniazid, although their bacilli were known to be
resistant to streptomycin and P.A.S. before the start of treatment.
In ease ¥ 11 no effect from re-treatment was demonstrated. In case
¥ 19, the organisms were of a low degree of resistance to streptomycin
and P.A.S. Streptomycin and P.A.S. population studies carried out
before /
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before the start of combined treatment showed that all the organisms
were resistant to 16 yug. streptomycin per ml. and to 1*0 yog, sodium
P.A.3. per ml. Ho growth was however obtained on a plate containing
16 «g. streptomycin, O'SS^tg. isoniazid ana i«0 jag. sodium P.A.S. per
ml. simultaneously. After the start of treatment, the cultures
became negative, but. while still on treatment, the sputum later
became strongly positive with the emergence of bacilli highly
resistant to isoniazid. In the sixth case (case V 25), treated
with daily pyrazinamide and isoniazid, sputum conversion occurred,
but the positivity returned with the emergence of pyrasinamide-
resistant bacilli. Therefore in only one of these six cases was
there any apparent effect from the isoniazid treatment, and in
that case it might have been at least partly due to streptomycin
and P.A.S.
Variations in resistance of the organisms in the sputum,
including highly resistant bacilli, were demonstrated in six cases
before re-treatment (cases V 21, 7 28, 7 53, 7 40, 7 41 and V 27).
All but one of these cases were treated with wDipasic"5 the sixth
case (case V 27) was treated with daily pyrazinamide -and isoniazid.
In no case was there any effect on sputum positivity as a result of




Results of population studies on lung cavities.
The results of population studies on the contents of ten
lung cavities from 8 patients are shown in table 58. It will be
seen that the patterns of variation in resistance are similar to
those found in the sputum.
Variations in the degree of resistance of cultures isolated from
different lesions within the same lung.
Table 59 and figure 6 show the results of isoniazid
resistance tests on cultures from 125 individual lung lesions from
15 patients. In the first nine patients it will be seen that the
degree of resistance of cultures from the lesions lay within three
consecutive concentrations of isoniazid. This variation is within
the experimental limits for the method, and therefore in these
patients the resistances can be considered to be uniform. In five
of these cases (1, 2, 5, 5 and 6) the organisms were of a low degree
of resistance, averaging 1*0 jag. per ml. and in one (case 4) the
organisms were resistant to 5 jag. per ml. In the remaining three
patients (cases 7, 8 and 9) with uniform resistance, the organisms
were all highly resistant to isoniazid.
In four patients (cases 10, 11, 12, 13) the degrees of
resistance in the lung showed a greater variation than could be
accounted for by the method.
The /
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Tiie last culture tested from the sputum was of a similar
degree of resistance to the maximum found in the lung lesions. In
two (oases 11 and IS) of the four patients in which a variation in
the degree of resistance was present within the lung, organisms of
maximum degree of resistance were isolated from both cavities and
caseous foci. In the other two cases, (cases 10 and 13) the
maximum degree was found in the cavities in one and in the caseous
foci in the other.
A comparison of the variations in degree of resistance of
cultures from the lung lesions with the results of resistance tests
on serial cultures from sputa to the time of the examination of the
lung, based on the information in figure 6, is given in table 60.
In 5 of the 6 cases in which reversion to a lower degree had been
noted in the routine tests, cultures from all the lung lesions were
of a low degree of resistance. A uniformly high degree of resistance
in the lesions was found in three (cases 7, 8, 9) of the four cases
(cases 7, 8, 9 and 12) examined when the sputum cultures had shown
a high degree of resistance for 10, greater than 2, 5 and 16 months
respectively. In two (cases 10 and 13) of the three cases In
which resistance was developing or where reversion to a lower degree
was occurring, variation was found in the resistance of cultures




The presence of small numbers of resistant mutants within
a strain of tubercle bacilli sensitive to the drug was first
demonstrated by Pyle (1947). She showed that in strains sensitive
to streptomycin approximately one in 10^ of the bacilli were
resistant. Similar work with isoniazid-resistant bacilli (Middle-
:brook, 1958; Ssybalski and Bryson, 1958) revealed the presence of
one resistant bacillus per 10® sensitive organisms. It was
postulated that these resistant mutants could form the nucleus of
a resistant strain which would develop in the presence of the drug,
since they would then be at a biological advantage. Following the
original work on streptomycin resistant strains, Pyle (1947) and
Mitchison (1950b) showed that organisms of varying degrees of
streptomycin resistance can be found within a single specimen of
sputum from a patient whose organisms are resistant to the drug.
That strains resistant to isoniazid could also consist
of bacilli of varying degrees of resistance was suggested by Fust
and Eohni (1955) and Mlddlebrook and Oohn (1953) and was later
shown by Tompsett (1954). Few studies were however carried out
on the lines of those done by Pyle and Mitchison with streptomycin,
since the greater control in the use of the drug and the avail-
:ability of other drugs which in combinations with isoniazid
prevented /
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presented the ©mergence of resistant bacilli made the use of
isoniazid alone unethical. Therefore knowledge of the constitution
of isoniazid-rosistant strains is confined largely to investigations
carried out when resistance has already developed.
The present work shows that although strains resistant to
isoniazid by the routine tests may consist entirely of organisms
of any given degree of resistance (within the limits of experimental
error), they are commonly composed of bacilli of varying degrees of
resistance. Occasionally only small numbers of the resistant
bacilli are present, the remainder being sensitive to the drug.
The amount of variation that my occur in the sputum is to a certain
extent predictable by the examination of serial isoniazid resistance
tests on sputum cultures.
These results have not addea to the knowledge of the mode
of development of isoniazid resistance. The presence of varying
degrees of resistance in the sputum may, in a particular patient,
be a reflection of variations between individual lesions or of
variations within a single lesion, or both. Canetti and Saenz
(1951) shewed that tubercle bacilli with varying degrees of
streptomycin resistance can be found within different lesions in
the same lung5 other workers (Armstrong and talker, 1949; dye and
Standley, 1951; Medlar et al., 1951) have confirmed these findings.
Similar variations have been found in the present series with
isoniazid-resistant strains. The source of these variations may
be /
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be due to a number of factors. Mantbei et al,(1953) found that con¬
centrations of isoniazid may vary in the lesions within the same
lung. Singh and Mitohison (1954) showed that, when organisms were
exposed to varied concentrations of isoniazid in vitro the higher
the concentration of the drug the greater the degree of resistance
of the surviving organisms. It is therefore possible that variations
between lesions may be due to the development of bacilli of varying
degrees of resistance in the lesions as a result of the contact of
the organisms with differing concentrations of the drug. The
variations in concentration may be due to varying penetration into
the lesions, or to the breakdown of the drug into biologically
inactive products at varying rates.
Canetti and Saenz (1951) also showed that cavitated lesions
contained organisms of a higher degree of resistance than did solid
foci. They suggested that this was due to the higher bacterial
content of the open lesions, and the consequent higher mutation rate.
The present results have not shown any consistently raised degree
of isoniazid resistance in the eases examined.
It is not possible to use the sputum studies as a complete
reflection of the developing resistance of a limited bacterial
population, owing to these variations between lesions. Population
studies on the contents of cavities in a limited number of cases
has shown that variations of resistance can also occur within a
single lesion, although such variations are not so marked as that
often seen in the sputum. Only one lesion was examined daring the
first /
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first course of treatment. In this oase all the organisms were
of a low degree of resistance. Two lesions examined from a patient
whose bacilli had reverted to sensitive after the end of treatment
contained only sensitive bacilli. This was the only case examined
who had received a single course of treatment followed by a period
off the drug. The remaining cases, who had had periods on and off
the drug, showed varying degrees of heterogeneity.
It is possible that variations within a single lesion may
be due to the presence of mutants of varying levels of resistance
in the initial population, which will be able to multiply in the
presence of the drug. Therefore the population may remain a
mixture of varying degrees of resistance. When the drug is with¬
drawn, the highly resistant bacilli, which have been shown (Mitchison
1953b) to multiply less rapidly than those of lower degrees of
resistance xn&3r be overgrown by the less resistant bacilli, or by
sensitive organisms which may have lain dormant but unaffected by
the drug (S-chaeffer 1954) . It is also possible that the highly
resistant organisms may be less virulent than those of lower degrees
of resistance and therefore more lihely to die out in the absence
of the biological advantage which they would have in the presence of
the drug. In either case, a heterogeneity of resistance would occur
for some time.
It might be thought that with prolonged therapy all the
bacilli would develop a high degree of resistance. But it is
possible that if low degrees of resistance are sufficient to protect
the /
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til© org&niLsaa from the effect of the drug, such mutants would have
no need to develop higher degrees of resistance. In the present
series, only a few patients had received one continuous course of
isoniazid prior to the examination of the sputum for variations in
resistance. There was no suggestion that the pattern of variation
of resistance found in the sputum was correlated with the duration
of isoniazid therapy.
Clinical significance of low percentages of resistant organisms
There has been considerable discussion as to the clinical
significance of low percentages of resistant organisms in the
sputum. It has been suggested {Canetti, 1955) that small numbers
of organisms of low degrees of resistance may not be of significance,
and may even be ignored by the clinician. That these bacilli
represent only a small proportion of the total bacterial population
can be assessed by the use of solid medium routine tests, although
such readings can only give approximate results, since the inoculum
is not accurately standardised. The question however remains as
to the use of such resultsto the clinician.
Of the 18 patients in the present series who were re-treated
with isoniazid following the population studies, twelve were treated
with the drug alone or in combinations with drugs to which the
organisms were already resistant. In two of these in whom all the
bacilli in the sputum appeared fully sensitive to isoniazid, the
results of treatment on sputwi positivity and on isoniazid resistance
were /
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were similar to those expected during treatment with isoniazid alone
in patients whose organisms were sensitive to the drug (Medical
Research Council, 1952 a,b, 1955c). Only one other case of these
twelve ghowed any suggestion of a possible effect from treatment.
In the sputum of this case 73 percent of the bacilli were resistant
to 0*06 ja.g. isoniazid per ml. and 28 percent to 0*25 jug. per ml.
Althou^i all the population was resistant to both streptomycin and
P.A.S. at concentrations of 16 ug. and 1*0 ^ig. per ml. of Lowenstein-
Jensen medium respectively, no growth occurred on medium containing
16 jug. streptomycin, 0-25 ng« isoniazid and 1-0 jag. sodium P.A.S.
per ml. simultaneously. The bacilli were of a low degree of
resistance to all three drugs, and it is possible that in this ease
there was additive or synergistic action on the combined therapy.
This action was not however equivalent to that of the three drugs
in combination on sensitive bacilli in man, since the patient's
sputum later became strongly positive and his organisms developed
high degrees of resistance to all three drugs.
Only six cases were re-treated with therapy under which
the effect of the isoniazid could be truly assessed. live of these
received pyrazinamide plus isoniazid and one was given five grams
of oxytetracycline daily with isoniazid. In a series of cases
treated with pyrazinamide plus isoniazid (McDermott et al., 1954)
in which the bacilli were sensitive to both drugs before the start
of treatment, sputum conversion occurred in 90 percent of the oases.
Isoniazid /
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Isoniazid resistance was found in only one of the 55 cases treated.
No pyrazinami&e resistance tests were done. Although in the present
cases a reduction in sputum positivity occurred in three of the five
cases treated with pyrazinamide plus isoniazid this was probably due
to pyrazinamide alone (Yeager et al., 1952; Schwartz and Moyer,
1953). The subsequent increase in positivity with the development
of pyrazinamide resistance suggests teat, in the presence of isoniazid
resistance, the combination was less effective than in cases with
sensitive bacilli. This was so in spite of tee fact teat, pre-
treatraent, three of these cases had only 6, 65, and 6? percent of
bacilli resistant to the lower concentrations of the drug respectively.
It is also interesting to note that the bacilli in these cases
would have come within the range of isoniazid resistance which Perry
and Moyes (1955) suggested would be of maximum sensitivity to
pyrazinamide. Yet, as has also been shown by Donnerberg et al.
(1957), the therapeutic effect was less than that reported in cases
with fully sensitive organisms.
From these limited results, it would seem that the presence
of small numbers of isoniazid resistant bacilli in the sputim of
oases with pulmonary tuberculosis are usually sufficient to reduce
the efficiency of combined therapy, although there may be some
transient activity.
Reversion to drug-sensitivity.
Although the reversion of resistance In tubercle bacilli
hy /
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by the routine resistance test has been reported by many (Nitti
1952; Ashino 1953; Petit 1953a and b) it has been suggested
(Medical Research Council 1954) that the apparent reduction in
the degree of resistance of cultures from the sputum may be due
to chance variations in the routine test or in the population
being tested. In their series they found that, although a
reduction in the degree of resistance occurred in some patients
after the end of treatment, there were a number in which an
increase of resistance was reported. They were handicapped by
only having three-monthly sensitivity tests, and also by the fact
that the patients concerned were under the care of physicians in
many different centres. Therefore it would not be easy for a
careful follow-up of the treatment given since the end of the
original course of therapy to be made. Personal experience has
shown that unless a detailed examination of case records is iaade,
short periods of drug treatments, which may be sufficient to affect
bacterial resistance, are often omitted from the case summaries.
The results of the population studies in the present
series would suggest that in fact reversion does occur in some
cases, and that although the commonest form is a reduction to a
lower degree of resistance, occasionally reversion to complete
sensitivity may take place. The correlations between the results
of population studies and of the routine resistance tests show that
in the large majority of cases, highly resistant organisms will be
detected /
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detected by both tests simultaneously. Therefore where a
population study showed that all the organisms were of a low
degree of resistance, and this is borne out by repeated tests
on sputum cultures, it is reasonable to conclude that highly
resistant organisms present on earlier routine tests are no
longer present in the sputum. It might be argued that the
lesions containing the organisms of a high degree of resistance
have become walled off and are no longer contributing to the
sputum. But cultures from individual lesions in a case in whom
this reversion in resistance had been shown to have occurred in
the sputum before the lung was examined {see Table 59) have con-
jfirmed that in no major lesion were highly resistant baeilli
present. It therefore seems proof that reversion to a lower
degree of resistance and even to full sensitivity can occur. As
has been pointed out above, this is more likely to occur after
long periods off the drug.
If reversion is a back-mutation, it might be expected
that it wouia oceur most frequently when the bacilli were
multiplying rapidly, that is during periods when the patients were
untreated or receiving treatment which was not reducing the rate
of multiplication of their organisms. In the present series, no
reversion was seen during a period of treatment with effective
drugs to which the organisms were sensitive, but there are in¬
sufficient cases to establish whether in fact such treatment
would have any effect on the reversion rate.
If /
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If reversion to full sensitivity occurs in a patient, it
would be of importance to know if the bacilli would react to re-
treatment in a similar way to organisms which had never been in
contact with the drug. This is difficult to assess. If isoniazid,
to which reversion has occurred, is combined with a standard drug,
such as P.A.S. or streptomycin, to which the organisms are still
sensitive, failure to protect against the development of resistance
to the standard drug would demonstrate that reversion was of no
clinical significance. But in such a case, the patient would have
lost a valuable therapeutic weapon. If, however, isoniazid is
combined with standard drugs to which the organisms are known to
be resistant, it is probable that the patient is in effect being
treated with isoniazid alone. Such treatment might be expected
to fail in many cases, and isoniazid resistance would be likely
to emerge in four to six: weeks after the start of treatment.
Therefore probably the most informative treatment would be five
grams of oxytetracycline daily with isoniazid. This was shown
to delay the emergence of isoniazid resistance in fully sensitive
cases (Stewart et al. 1954) and to reduce the positivity in 5 of
the 10 cases reported, but would not be expected to have any effect
if the organisms were resistant to the drug, since oxytetracycline
has little or no affect per se (U.S. Veterans Administration, 1951;
Pfefer et al. 1952}. Unfortunately this treatment was not used on
the two oases with complete reversion reported here. It was
however used on a case in which reversion had occurred on the
routine /
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routine test although 15 percent of the population was still found
to he of a low degree of resistance by the population study. In
this case resistant organisms reappeared in the routine test two
and a half months from the start of treatment after temporary sputum
conversion. This sort of result might have been expected with this
combination of treatment. liovaever, in the three cases reported
(Stewart et al. 1954) who received 5 g. of osytetracycline with
isoniazid and in whom isoniazid resistance developed, this was
not detected until at least the fifth month of treatment. Therefore
in the case reported here, resistant organisms emerged earlier
than in those cases whose bacilli were fully sensitive at the
start of treatment. It is not possible to determine from these
findings whether reversion to complete sensitivity, by the routine
test and population study, does in fact render the bacterial
population as susceptible to isoniazid as if the patient had never
received the drug.
It has been suggested (Barnstt et al. 1953a) that
reversion may occur as a result of the overgrowta of resistant
organisms by those of a lower degree of resistance. Mitehison
showed that bacilli of low degrees of resistance or full sensitivity
grow more rapidly than those of a high degree of resistance (Mitchison
1952). la the presence of the drug the resistant organisms would
be at a biological advantage, but when the drug is withdrawn the
more rapid growth rate will give the advantage to bacilli of a
lower degree of resistance. It is not possible from the results
of /
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of tlie present study to draw any conclusions as to the mechanism
of the reversion of isoniazid resistance in tubercle bacilli,, The
presence of varying degrees of resistance in the sputum of patients
whose organisms are known to be reverting could be due to the
occurrence of reversion irregularly within the aescendents of
resistant bacilli, or to the gradual overgrowth of resistant baoilli
by more sensitive ones, either diffusely throughout the lung or
in certain lesions.
In conclusion, these investigations into isoniazid-
resistant baciliary populations in lung lesions and in sputum have
shown that there may be wide differences in the composition of
such populations. A follow-up of patients who were re-treated
with isoniazid after the population study was carried out suggests
that where only a low percentage of the bacilli are resistant an
effect on sputum positivity may occur, but it will probably only
be transient. It has been shown that reversion to lower degrees
of resistance or to sensitivity can occur although it was not-
possible to determine whether this enabled the patient to obtain
full benefit frcrn further treatment with isoniazid.
S3en ON III
SOME 0BSSRYATIQNS ON THE VIRULENCE OF ISONIAZID -
RESISTANT TUBERCLE BACILLI
Outline.
Introduction and review of the literature.
Scope of the present work.
Methods.
Results.
Size of inoculum and virulence.
Correlation of animal virulence with the pattern of
isoniazid resistance in the sputum.
Correlation of oatalase activity with guinea pig
virulence.
Comparison of the degree of isoniazid resistance in
cultures frcaa the sputum and from the guinea
pig spleen.
Analysis of avirulent cultures.
Virulence tests on strains from three patients




There have been a number of reports of variations in the
virulence for laboratory animals of strains of tubercle bacilli
which have never been in contact with anti-tuberculous agents
(Patiala, 1948; Stewart, 1951; Steankan and wolinsky, 1953). In
the series of Patiala. and of steenken and wolinsky all of the
strains froa untreated patients caused some dissemination of
disease although in many oases the virulence was markedly reduced.
In oontrast to these results many workers (Barnett et al., 1953a,
b; Middlebrook and Cohn. 1953; Steenken and Wolinsky, 1953; and
others) found that strains that were of a high degree of isoniazid
resistance were often completely avirulent for guinea pigs.
Most of the original work was carried out on cultures
which had either been made resistant in the laboratory (Barnett et
al., 1953a; Middlebrook and Cohn, 1953) or which had been grown
on medium containing isoniazid prior to the inoculation of the
guinea pig (Barnett et al., 1953b; Peizer et al., 1954). These
strains would be expected to be of a more unifoxmly hi^i degree of
resistance than those freshly isolated from patients.
In some of the reports the strains used were not culti¬
vated in the presence of isoniazid before animal inoculation (KLoch
et al., 1953; Middlebrook and Cohn, 1953; Peizer et al., 1953;
Steenken and Wolinsky, 1953; Morse et al., 1954). In these series,
the correlation between the degree of isoniazid resistance of the
strains /
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strains and the virulence for guinea pigs was less marked than in
the series in which, artificially - induced strains were used. The
variable virulence in these latter cases was probably due to the
heterogeneous nature of the strains (Morse et al., 1954; Feizer
et al., 1954), the dissemination of the disease being due to the
less highly resistant bacilli. Cultures from patients are likely
to contain bacilli of low degrees of resistance which have been
shown by Mitchison (1954) to be virulent for laboratory animals.
Further, Meissuer (1953, 1954) demonstrated that when mixtures of
resistant and sensitive organisms were injected into guinea pigs,
the bacilli isolated from the disseminated lesions were often
fully sensitive to isoniazid, although those from the site of
inoculation were of the same degree of resistance as the original
resistant strain.
Certain in vitro tests haire been correlated with the
virulence of strains for laboratory animals. The loss of animal
virulence was found to be associated with a decrease in the
catalase activity of the bacilli (Middlebrook, 1954; Oolm et al.,
1954) . It wa3 also su^ested that the formation of serpentine
cords in liquid medium was an indication of the virulence of the
strain (Middlebrook et al., 1947; Dubos, 1948).
The question arises, from these reports of strains of
tubercle bacilli with reduced virulence for laboratory animals,
as to whether such strains are of reduced virulence for man.
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SCOPS OF THE PRESBST WORK
In the present work the animal virulence has been
correlated with the resistance pattern of the bacilli in the
patient's sputum. In order to avoid any alteration of the
resistance pattern in the inoculum during sub-culture, the sputum
concentrate was inoculated into the guinea pig. Population
studies, including a viable count, were made on an aliquot of the
concentrate. In this way any apparent diminution in virulence
due to a low inoculating dose would be detected. Furthermore
the proportions of the bacilli in the inoculum, resistant to the
varying concentrations of isoniazid were assessed. In order
to ascertain whether the dissemination was due only to organisms
of a low virulence, cultures were made from the individual lesions
post mortem, and these were tested for isoniazid resistance. Routine
isoaiazid resistance tests and teats for eatalase activity and
cord formation were also made on cultures from the sputum concentrate.
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Guinea pig virulence teat.
The sputuia was concentrated by the method described
for the population studies (see page ,?7.), The homogenate
was prepared in 2*0 ml. sterile distilled water. 1*0 ml. of
this suspension was iaoeulated into the left thigh muscle of
the guinea pig. Isoniazid population studies were made on
part of the homogenate, and the remainder was used to inoculate
two L'dwenstein-Jensen cultures.
In the three patients who had been apparently infected
with isoniazid resistant bacilli, a culture on Lowenstein-Jensen
medium was used for the virulence test. Approximately 0*5 mg,
wet weight of a 14 to 21 dayst growth was injected into the left
thigh muscle.
Mantoto: testing of guinea pigs. Three to four weeks
after inoculation, 0-1 nil. of a 1 in 25 dilution of a solution
of protein-purified derivative of mammalian tuberculin containing
2 mg. tuberculin per ml. was inoculated intra-dermally 24 hours
after depilation. The diameter of induration at right angles
to the needle track was read after 48 hours.
Post mortem examinations:- The animals were killed
eight weeks after inooulation. Post mortem examinations were
carried /
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carried out on any animals that lied earlier* The degrees of
poaitivity of the inoculation site, inguinal and lumbar glands,
spleen, liver and lungs were assessed macroseopically. They
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The virulence of the strains was graded as follows:*
Hilly virulent - Widespread dissemination in all lesions
Moderate virulence - Uissemination limited to two of the
three organs examined, or positivity of the spleen
only
Low virulence - Only one organ involved.
Avirulent * Ho macroscopical dissemination.
Cultures were prepared from all the lesions with
macroscopic disease by the same method as that used for the
culturing of bacilli from the lung lesions (see page . .6P. section
II). The glands, spleen, lungs and liver were macerated with
scissors before treatment with the concentrating agents. Cultures
were set up in duplicate.
Isoniazid resistance tests:- Cultures from all positive
lesions /
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lesions were tested for isoniazid resistance by the method
described for sputum on page .A7. . The concentrations used ware
0*2, 1*0, 5, 10 and 50>ug. Isoniazid per ml.
LSwenstein-Jensen cultures prepared from the sputum
concentrates vere also tested for isoniazid resistance by the
same method.
In vitro assessments of virulence.
The following tests were carried out on the Lowanstain-
Jensen cultures from the sputum concentrates.
Cord Fojosation. A sub-culture frcaa the primary growth
on Lowenstein-Jensen medium was made into Dubos and Davis liquid
medium with Tween 80 at pH 7*0 (see page .A2.). After 10 days'
incubation at 57°C, approximately 0*1 ml. cf the culture was
transferred into approximately 3>0 ml. cf the following medium
(Dubos and Middlebrook, 1947) in a oz. screw-capped bottle.






MgSOx *7HpO 0*01 g«
1&m© ammonium citrate 0*05 g.
Enzymatic digest of casein - 2 g.
»Tween 80"' 0*02^
Distilled water 2,000 ml.
pB adjusted to between 6«5 and 6*8.
The medium was sterilised by autoclaving at 10 lb. per




After incubation at 37°C. for 10 days, stained smears of the
cultures were examined for the presence of cord formation.
The results were classified as follows:-
+ Tight cords present
+ Cords formed but baoillary forms still readily
detectable.
-ve Mo evidence of cording.
Catalase Activity.
A loopful of growth from a 14 to 21 days' culture on
Lowenstein-Jensen medium was added to 0*5 ml. of a solution
containing equal parts of 100 vols, hydrogen peroxide and 10
percent "Tween 80" in a 3 x test-tube. Twenty minutes after
the addition of the culture, the tubes were examined for the
presence of oxygen bubbles.
++ A continuous ring of bubbles round the meniscus.
+ Although bubbles had risen to the meniscus, no
complete ring was present
+ Bubbles on clumps of bacilli in tube.
-ve Mo bubbles discernible with the hand-lens.
In vitro tests to detect saprophytic strains.
In order to detect any strains of saprophytic Mycobacteria,
the following tests were carried out on cultures from the sputum.
AJKsri-sulphatase - 0*2 ml. of a 10 days sub-culture in
Bubos and Davis me&itmi with Tween, pH 7*0, was inoculated into
4*5 ml. of Dubos and Davis medium with Tween 80, pH 7-0, to which
had been added 0-2 ml. 10 percent bovine albumin fraction 7 and
0-5 ml. of 0*01 M seitz-filtered solution of phenol-phthalein
disulphate. After incubation at 37°C for 14 days, 2M NaOE was
added to the cultures drop by drop. The production of a red
colouration indicated the presence of free phenol-phthalein.
Colony /
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Colony type on solid medium. Plates were prepared in
(
3 am. Petri dishes containing the follovdng solid medium:-
Basal medium - As given for the tests for cord formation
(see above) excluding the Tween 80 and serum albumin, but with the
addition of 1*5 g. soluble agar. The oleic-acid-albumin complex
was prepared by dissolving 0-12 ml. oleic acid in 10 ml. li/ZQ
NaOH. 5 ml. of this solution were added to 95 ml. of a neutral 5
percent solution of bovine albumin fraction 7 in 0*85 percent
saline. The solution was sterilised by seitz filtration. 10
ml. of the oleic-acid-albumin compound were added to 95 ml, of the
base.
After incubation at 37°C. for 14 days, the colonies were
examined under a plate microscope.
Resistance to thiosemicarbazones. Although it has been
suggested that this test might be of use in differentiating between
pathogenic and saprophytic strains of Mycobacteria, it had to be
discarded in the present series, since the bacilli from a number
of patients who had been treated with thiossmicarbazones at some
time appeared to be resistant to the drug. In other tests these
strains behaved as true Mycobacterium tuberculosis.
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RESULTS
Table 61 gives the detailed results of the population
studies on the sputa from 21 patients together with the results
of tests for Isonlazid resistance, oatalase activity and cord
formation on cultures from the same specimens. The results of
the guinea pig virulence tests and of isoniazid resistance tests
on cultures from the sites of disease in the animals together
with the mantoux reaction 3 to 4 weeks after inoculation are
detailed in table 62, Only one specimen is included from each
patient. The results given in the tables are further analysed
and discussed below,
Effect of size of Inoculum on guinea pig virulence,
A comparison of the size of inoculum, as expressed by
the viable count per ml. of sputum concentrate, and the virulence
for the guinea pig for the 21 strains tested is given in table
83.
Sixteen of the strains were of moderate or high virulence
for the guinea pig, although in three of these the inoculating dose
was less than 1(# bacilli. Of the five remaining strains, two
(G 2 and G 8) were of low virulence and three (G 15, G 18 and G 18}
were avirulent. In the two cases with low virulence-, the infecting
doses were 1 x 1Q3 and 6 x 103 bacilli respectively. A second
specimen collected from each of these patients, within two days
of /
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of that reported, was also tested for virulence. In one of the
-
cases (case G S) the repeat specimen was also of low virulence in
A spite of an infecting dose of 5 x 104. The second strain from
.M0
the second case {case G 8) was of full virulence although only
j
6 x 10s organisms were inoculated. Therefore only one of these
y £* : ...two strains was of diminished virulence.
Further specimens from two (cases G 15 and G 16) of the
three cases in which avirulence was demonstrated for the guinea
pig were also avirulent in spite of inoculating doses of 10^ and
106 respectively. In the third case (case G 18), the inoculum
of the repeat specimen was only 5 x 102. This strain again
appeared avirulent. In this strain, the lack of virulence may-
have been due to the small numbers of bacilli inoculated, though
it should be noted that three strains (Gl, G 11 and G 19) showed
moderate or high virulence in spite of an inoculating dose of less
than 10^ organisms.
Therefore although a low inoculum migat have accounted
for lowered virulence in one case, two of the strains with a high
inoculum were also avirulent for the guinea pig.
Correlation of the results of animal virulence tests with the
pattern of isoniazid resistance In the sputum.
A summary of the results of the population studies
correlated with those of animal virulence tests is given in table
64. It will be seen that all the strains that were avirulent
contained /
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contained organisms of varying degrees of resistance, including
some highly resistant bacilli. Strains showing a moderate degree
of virulence tended to be more highly resistant than those that
were fully virulent, although the numbers are too small for
statistical analysis.
Correlation of catalase activity with guinea pig virulence.
The results of animal virulence tests and the catalase
activity of the strains are compared in table 65. All of the
three strains found to be avirulent in the guinea pig showed a
reduction In catalase activity. All but two of the remaining 18
strains were of normal activity. The two exceptions were of
moderate virulence.
Comparison of the degree of _isoniaaid resistance incultures from
the sputum and from the guinea pig spleen.
Table 66 shows a comparison of the isoniazid resistance
of cultures isolated from the sputum and from the guinea pig spleen
for 17 of the strains. In the remaining four cases (G-2, G15,
CIS and G13) cultures from the spleens were negative (see table
62). Allowing a one-tube variation as being inherent in a
dilution technique, there was agreement within the experimental
error between the two cultures in 14 of the strains tested. In
each of the remaining three cases (eases Gil, G13 and G19), the
resistance of the culture from the spleen was of a lower degree
than /
100
than that from the sputtoa. In no case was the culture from the
spleen of a higher degree of resistance than that from the sputum.
An analysis of the three cases in which the disseminated
lesions in the spleen seemed to he caused by organisms of a lower
degree of resistance than those predominating in the sputum is
given in table 67. In two of these strains {eases (113 and G19)
there was a variation in the degree of resistance in the bacilli
in the sputum. In the first of these, (case G13) only 0*4
percent of the bacilli were highly resistant. Therefore it is
possible that the dissemination occurred due to the more numerous,
but less resistant, bacilli.
In the second case {case G19), 64 percent of the bacilli
in the sputum were resistant to 16 jug. per ml. but the bacilli
isolated from the spleen were only resistant to 1*0 pg. per ml.
In the third (Gil) the inoculating dose of 450 organisms
was very small. All the bacilli appeared to be resistant to 1*0
Ug. isoniazid per ml., but the method is not sufficiently accurate
to detect a small percentage of sensitive organisms in such a
population. Nevertheless, if this were the case, the results
would suggest that the resistant bacilli, present in overwhelming
numbers, were less virulent than the few sensitive bacilli. It
was not possible to attest to reproduce these results, as the
patient was operated on shortly after the examination was made
and his sputum converted to negative immediately afterwards.
Analysis /
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Analysis of avirulent cultures.
Table 08 shows a further analysis of the three strains
whioh were avirulent for the guinea pig. It will be seen that
in each. case the avirulenoe for the guinea pig was confirmed, on
at least one further specimen of sputum. In none of these
oases were the organisms all highly resistant to isoniazid,
although it was not known whether they had been so at some time.
All the three patients were receiving a second course of isoniazid,
or an isoniaaid derivative, at the time the specimen was examined
and in each ease this course had lasted for at least 19 months.
Of the 18 oases whose strains were virulent, 10 had received
treatment including isoniazid for 2 to 11 months immediately prior
to the examination of the sputum and two had received SI and 31
months treatment respectively. Of the remaining 5 cases, four
had not been treated with the drug for 11 to 35 months, in one
details of treatment were not available} the sixth case was
infected with isoniazid - resistant bacilli.
In all three eases with avirulent strains there was
a depression of catalase activity, but cord formation was
demonstrated. In every case the aryl-sulphatase tests were
negative and the colonial formation on solid Bubos was typical
of strains of Myco-tuberouloais.
Clinical fate of the three patients whose strains were aviruient.
All of the three patients whose strains were avirulent
for the guinea pig had extensive chronic disease with bilateral
cavitation. /
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cavitation. Jtollowing the examinations of the sputum reported
above they were treated vdth isoniazid or vdth isoniazid derivatives.
No clinical or radiological deterioration has occurred to the
present time. However, the clinicians concerned consider that
the lack of deterioration is consistent vdth the chronic fibro-
c&seous type of disease, and that this does not therefore
necessarily indicate the presence of bacilli of low virulence for
man.
Virulence tests on strains from three patients infected with
isoniazid-reslstant bacilli.
Table 69 shows the results of animal virulence and
isoniazid resistance tests on three strains from patients who
were infected with isoniazid-resistant bacilli having never
previously received the drug. It will be seen that two of these
strains (cases G22 and 025) both of which were resistant to 50
ug. isoniazid per ml., were avirulent for the guinea pig. The
f
third strain (0 24) was of moderate virulence and a low degree of
resistance. In all eases the Mantoux test at three weeks was




It has been shown in section II of this thesis that
strains of tubercle bacilli resistant to isoniazid isolated from
patients treated with the drug in a aose of 200 mg. daily usually
consist of organisms of varying degrees of resistance. That
such strains give less consistent results on animal virulence tests
when these are correlated with the degree of resistance of the
original strain has been pointed out by Morse et ai. (1954) and
Pei^er et al. (1954). That dissemination of disease following
the inoculation into guinea pigs of cultures containing both
resistant and sensitive bacilli can be due to the sensitive
organisms has been demonstrated by Meissner (1955, 19 54)andKarlson
and Ikerni (1954). Direct cultures from such mixtures would show
a high degree of resistance. But cultures from the disseminated
lesions were sensitive, although those from the site of inoculation
were highly resistant. Similarly, with mixtures of bacilli of
low and high degrees of resistance, the dissemination may only
be due to the organisms with low degrees of resistance. Other
factors may however complicate the results.
First, It is possible that the more highly resistant
bacilli may be present in the spleen although they may not multiply
there. The organisms of lower resistance might have given rise
to the macroscopic lesions, but cultures from the organ might
appear highly resistant due to the isolation in vitro of the highly
resistant /
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resistant bacilli. The second factor affeoting the correlations
of -virulence and resistance in mixed populations is that
dissemination of the disease due to organisms of low degrees of
resistance may occur by chance if these organisms are more numerous
in the population. The cultures from the original sputum are
still likely to appear highly resistant.
Therefore the final tests of virulence of strains from
patients can only fee made on strains of a unifoma high resistance
to isoniazid, It would also be necessary to prove that the
disease in the organs was due to highly resistant bacilli. as
has already been shown, uniformity of high degrees of resistance
is not found very frequently in sputum froia patients with pulmonary
tuberculosis treated with isoniazid in doses of approximately 300
mg. daily, even though the sputum tests show a high degree of
resistance. In no case in the present series tested for animal
virulence were 100 percent of the organisms of a high degree of
resistance. Therefore it was not possible to assess the virulence
of such a strain.
In four of the eight cases in which highly resistant
bacilli were isolated from the sputusa, cultures frcm the disseminated
lesions were also highly resistant. But since organisms of low
degrees of resistance were also known to be present in these cases,
the development of macroscopic lesions cannot with certainty be
attributed to the highly resistant bacilli.
None /
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None of the three avirulent strains were of a uniformly
high degree of resistance on the population study, although in
two the sputum cultures and cultures from the inoculation sites in
the guinea pigs were both highly resistant. The evidence on these
strains therefore suggests that the low virulence was common to
organisms of all degrees of resistance, and that it was not confined
to the highly resistant bacilli. There was no evidence that the
low virulence was due to a low inoculum.
It has bean suggested that the eatalase activity of
tubercle bacilli is correlated with the loss of animal virulence
(Middlebrook, 1954; Cohn et al., 1954). In the present series
diminished activity was found in the three avirulent strains and
in two strains with moderate virulence. Cord formation (Middle-
:brook et al., 1947; Dubos, 1948) was present in both virulent
and avirulent strains.
The question arises as to whether strains of tubercle
\
bacilli avirulent for laboratory animals might also be avirulent
for man. If this were the case, it might be an advantage from
the epidemiological aspect to induce such strains in patients who
could not be made sputum negative (Oestreicher et al., 1955),
since it would reduce the spread of the disease. The findings
of avirulent strains in patients who have been infected with
isoniazid resistant bacilli, and the low incidence of avirulence
fbr animals in strains isolated from patients whose organisms were
known to be highly resistant, would suggest that such an advantage
is /
106
is unlikely to be found, in clinical practice if doses of 200 lag.
isoniazid daily have been used. It has not however been possible
to confirm this in the present series. These oases were however
not receiving high doses of isoniazid and therefore the avirulent
strains referred to in the work of Gestreicher et al. (1955) were
not likely to develop.
If the isoniazid-resistant strains are not of reduoed
virulence for man, an increase in the number of patients harbouring
isoniazid-resistant baoilli might lead to a greater incidence of
sputum-positive cases and possibly therefore to increased risks of
infection in the community. Treatment of such cases of primary
infection with isoniazid in combination with streptomycin or P.A.S.
might lead to the development of resistance to streptomycin or
P.A.S. in cases in which such combinations with fully sensitive
organisms would normally bring about sputum conversion and probably
complete sterilisation of the lung lesions (Stewart et al., 1956).
In conclusionj these investigations have shown only a
low incidence of avirulent strains in a series of patients treated
with low doses of isoniazid (200 mg. daily), chosen at random, the
only criterion being that their organisms were resistant to
isoniazid. The two cases of primary infection in man with strains
that were avirulent for guinea pigs suggest that even though strains
are avirulent for laboratory animals, they may nevertheless be
capable of causing disease in man.
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FINAL DISCUSSION
The object of a bacterial resistance test in a clinical
laboratory is to detect organisms which are capable of multiplying
in the presence of a chemotherapeutie agent. When a patient
bacteria are reported by such a test to be resistant to a drug,
further treatment with that drug would no longer be expected to
be effective in controlling the disease. But even when no
further benefit is being derived from the drug, the patientfs
defences may be capable of dealing with the residual population,
1/p
so that clinical failure is not always obvious. Such oases may
cause confusion in the interpretation of the clinical significance
of drug resistance. It is therefore perhaps preferable to consider
the problem in another way, namely that if the organisms are re-
sported as sensitive to the drug, that drug should be clinically
effective in every case.
There are a number of methods available for the demon¬
stration in vitro of the presenoe of resistant organisms. Within
each method there are also variations in technique, which may
significantly alter the results. If the method to be used is
decided solely on the bacteriological data, the bacteriologist
will have no means of deciding which of these variations is the
most efficient from the elinical stand-point, and may therefore
choose a technique and criteria for resistance which would fail
to detect some of the levels of resistance that are of clinical
significance.
In the past most tests for drug resistance have been
evolved largely as a result of bacteriological considerations and
significant /
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significant levels of drug-resi stance have often "been arbitrarily
decided on such criteria as resistance to the highest drug level
detectable in the blood serum of patients on customary dosage.
As far as is known no previous attempt has been made to establish
criteria of drug resistance which are closely correlated with
clinical failure to respond to treatment with the drug. Such a
study has required close co-operation between bacteriologists and
clinicians but it is submitted that the levels of ding sensitivity
suggested in this thesis are now well correlated with the only
criterion of vital importance to the patient - successful arrest
of the disease.
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In the treatment of pulmonary tuberculosis with strepto¬
mycin alone the emergence of strains of tubercle bacilli
resistant to the drug is well known. That the same thing
happens when isoniazid is used alone is now established
(Medical Research Council, 1952a). But the possibility
of resistant strains emerging when cases of pulmonary
tuberculosis are treated with sodium or calcium para-
aminosalicylate (P.A.S.) alone has received much less
attention. This is perhaps partly because of the less
rapid emergence of resistant organisms when an attempt
is made to induce P.A.S. resistance in vitro (Steenken
and Wolinsky, 1950) and partly because of the greater
technical difficulty of the resistance tests. Nevertheless,
the emergence of P.A.S.-resistant strains in a large pro¬
portion of treated cases has been reported in the litera¬
ture. Some of these reports are summarized in Table I.
The results suggest that P.A.S.-resistant strains may
emerge at a later period of treatment than is usual when
streptomycin or isoniazid is used alone, but that, with
prolonged treatment, they are isolated from a notable
proportion of patients who remain sputum-positive. It
is logical to imply that if these patients are later treated




Table I.—Some Previous Reports of the Emergence of P.A.S.-
resistant Tubercle Bacilli in Cases Treated with P.A.S. Alone
Total Percentage from Period
Authors No.
which P.A.S.- of
of resistant T.B. Treatment
Cases Isolated (Days)
Delaude et al. (1949) 5 100 157-251
Medical Research Council (1950) 37 32 <84
Carstensen (1950) 79 13 184-435
V6ran et al. (1950) 20 75 56-182
Veterans Administration (1951).. 36 20 <62
Espersen (1951) .. 11 73 40-354
Tempel et al. (1951) 37 51 <120
with streptomycin and P.A.S. in combination P.A.S. will
no longer prevent the emergence of streptomycin-
resistant tubercle bacilli. This probability has often
been emphasized but is still ignored by many clinicians,
partly perhaps because no direct evidence has, so far as
we know, been provided. In addition it has been sug¬
gested that resistance to P.A.S. is transient and, by impli¬
cation, not of importance to later combined treatment
(Tempel et al., 1951). It is the purpose of this paper
to provide evidence that P.A.S.-resistant organisms may
be isolated from a high proportion of patients treated
with the drug alone and whose sputum remains positive,
that the resistant organisms may persist in the sputum
for many months after treatment has ceased, and that
streptomycin-resistant organisms may emerge rapidly if
such cases are later treated with both streptomycin and
P.A.S.
Material and Methods
The first group consists of nine patients with pulmonary
tuberculosis who were treated with streptomycin, 1 g. daily,
and P.A.S., 20 g. daily, for at least three months. (In one
the daily dose of P.A.S. had to be reduced to 15 g. daily
for five days a week at the end of two months, but her
organisms were already streptomycin-resistant.) All had
elsewhere had treatment with P.A.S. alone for periods vary¬
ing from 6 weeks to 16 months, the exact daily dosage
being in most cases unknown. The interval between the
end of the course of P.A.S. alone and the beginning of
the course of streptomycin and P.A.S. in combination varied
from a few days to 39 months. Estimations of the drug
sensitivity of the tubercle bacilli isolated from these patients,
and the results of serial cultures and sensitivity tests while
under treatment with streptomycin and P.A.S., were com¬
pared with similar results from a second group of five
patients who began streptomycin and P.A.S. in the same
doses about the same time, but who had not previously
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10 0 Afebrile 44 44
11 0 Moderate 444 444
12 0 Afebrile 4 4 4 4
13 0 Moderate 444 444
14 0 Afebrile 4 4
•Graded as follows: At least 1 reading in pre-treatment week over
101° F. (38.3° C.)=High, over 99° F. (37.2° C.)«=Moderate, none over
99° F.=Afebrile.
t Total diameters of cavities present 5 cm. or above«= 4 4 4, 2 to 4.9 cm.
=»4 4, less than 2 cm.= +.
$ Shadows confluent over three-quarters or more of one zone=4 4 4,
one-quarter to three-quarters of one zone=4 4, less than one-quarter of
one zone= 4.
received P.A.S. alone. All the patients were initially in¬
cluded in the current chemotherapeutic trials organized by
the Medical Research Council (1953).
Cultures of the sputum were obtained on Lowenstein-
Jensen medium before the beginning of the course of
streptomycin and P.A.S. in combination. Further cultures
were made at least at monthly intervals for six months.
Streptomycin- and P.A.S.-sensitivity tests were carried out
in liquid medium according to accepted techniques (Medical
Research Council, 1948, 1950). Tubercle bacilli were re¬
garded as drug-resistant if they were inhibited only by at
least eight times the concentration which prevented growth
of the sensitive control organism H37Rv ; that is to say, if
their " resistance ratio " was eight or above.
Comparability of the Two Groups.—The patients in the
two groups were investigated with respect to factors in the
pre-treatment state known to affect tht? emergence of resis¬
tant organisms. For this purpose we recorded the pre-
treatment temperature and the extent of cavitation and con¬
fluence of shadows in the radiograph. The radiographic
assessments were made by an independent panel unaware
of the group to which the patient belonged, and the films
were placed in previously defined categories. The results
are recorded in Table II. It will be seen that the groups
are roughly comparable, though in the first group gross
cavitation was commoner.





























































































































































Sputum- negative after 90days
Sputum- negative after 44days
Sputum- negative after 31days
P=P.A.S.S=Streptomycin.Timesaregiv ninmonths.Resistancefigureare is anci(st x ) *Nopre-treatmentsensitivitytes ;figu eoirsubs qu ntc ltu , tPre-treatments nsitivityonolidm diumonly. tTwodaysafterfirstesistantcultur .
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P.A.S. Resistance
it will be seen that in eight out of the nine patients
who had previously been treated with P.A.S. alone tubercle
bacilli isolated before beginning the combined streptomycin -
P.A.S. course were P.A.S.-resistant, the resistance ratio vary¬
ing from 16 to greater than 256 in different cases. In some
cases there was a further substantial rise in the resistance
ratio while on combined treatment. In the one patient,
Case 9, whose bacilli were P.A.S.-sensitive before treatment,
no P.A.S.-resistant organisms were subsequently isolated.
In three out of live of the patients who had not received
previous P.A.S., bacilli isolated before the start of combined
treatment were P.A.S.-sensitive. In the other two cases, for
technical reasons, no pre-treatment culture was available
for testing, but subsequent cultures were P.A.S.-sensitive.
In none of these patients were P.A.S.-resistant bacilli isolated
up to the end of the six months' observation period, though
in three the sputum became negative.
It is clear, therefore, that P.A.S.-resistant tubercle bacilli
emerged in a high proportion of those patients who had
been treated with P.A.S. alone, and that the organisms might
remain resistant for up to three years and more after stop
ping the drug.
Streptomycin Resistance
In 13 out of the 14 patients the tubercle bacilli were
streptomycin-sensitive before the start of the combined
course ; in the thirteenth case (No. 10) the pre-treatment
culture was contaminated but the bacilli were shown to be
sensitive a month later.
Of those who had received previous P.A.S. alone, the one
patient (Case 9) whose organisms were P.A.S.-sensitive before
starting combined streptomycin arid P.A.S. continued to ex¬
crete bacilli sensitive to both drugs up to the last available
test, six months after starting the combined treatment. In
all the eight other patients streptomycin-resistant organisms
were isolated, in the first six cases within three months of
starting treatment. In Case 7 the resistance ratio was 4,
the upper limit of normal, after two and three months' treat¬
ment ; at four months a culture slightly but definitely resis¬
tant (resistance ratio 8) was obtained for the first time, the
ratio reaching 32 a few days later. In the remaining patient
(Case 8) a resistance ratio of 4 was found at three months,
the culture was contaminated at four months, and the first
definitely resistant strain was isolated at five months. This
last patient was the only one of the group whose bacilli
attained only a low degree of streptomycin-resistance (resis¬
tance ratio 8); in the other seven the organisms became
moderately or highly resistant.
Of the five patients who had not had previous P.A.S.
alone, the sputum became negative in three (Cases 10, 12,
and 14). In each case the last positive culture, on the 90th,
6
44th, and 31st days of treatment, remained streptomycin-
sensitive throughout the six months' observation. In only
one patient (Case 11) were slightly resistant organisms, with
a resistance ratio of 8, isolated after five months' treatment.
Streptomycin-resistant tubercle bacilli, therefore, emerged
in all of eight patients who had been previously treated with
P.A.S. alone and whose organisms were P.A.S.-resistant
before starting combined treatment with streptomycin and
P.A.S. Of the six patients whose organisms were P.A.S.-
sensitive before starting combined treatment, including one
who had had previous P.A.S. alone, bacilli slightly resis¬
tant to streptomycin were isolated from only one, although
in three the sputum became negative during the period of
observation.
Discussion
The control group of patients who had not previously
received P.A.S. alone was, of course, small. It was made
smaller in the later stages of the investigation by a number
of patients becoming sputum-negative. But a good deal of
information is elsewhere available about the proportion of
cases from which streptomycin-resistant organisms are likely
to be isolated if streptomycin and P.A.S. are given in the
same doses as in our patients. In the earlier Medical
Research Council series the proportion did not exceed 10%
(Medical Research Council, 1952b). In our group treated
with previous P.A.S. alone the organisms were P.A.S.-
resistant before combined treatment in eight out of nine,
and in all of these streptomycin-resistant bacilli were isolated
when they were later treated with streptomycin and P.A.S.
in combination.
The implications of these findings are obvious. P.A.S.,
like streptomycin and isoniazid, should never be given alone
to tuberculous patients. There is evidence that the use of
streptomycin prevents or diminishes the emergence of P.A.S.-
resistant organisms, just as P.A.S. prevents or diminishes
the emergence of streptomycin-resistant organisms (Medical
Research Council, 1950 ; Veterans Administration, 1951). If
a patient is known to have had a long course, perhaps more
than a month, of P.A.S. alone, it should be assumed, until
the results of sensitivity tests become available, that his
bacilli are P.A.S.-resistant. If chemotherapy is necessary
he should be treated with streptomycin and isoniazid in
combination. Finally, it is clear that tests for P.A.S. sensi¬
tivity are as important to the patient as those for sensitivity
to streptomycin or isoniazid.
Summary
Tubercle bacilli from eight out of nine patients who
had previously received sodium pora-aminosalicylate
(P.A.S.) alone for pulmonary tuberculosis were found
to be resistant to the drug. The original course of treat-
7
ment lasted from 6 weeks to 16 months in different cases
and the interval between the finish of the course and the
resistance tests varied from a few days to 39 months.
When treated with daily streptomycin and P.A.S.,
streptomycin-resistant tubercle bacilli emerged in all the
eight patients whose bacilli were P.A.S.-resistant before
the start of the combined treatment. The streptomycin-
resistant bacilli were obtained in six out of the eight
cases within three months on combined treatment, in the
seventh after four months, and in the eighth after five
months.
By contrast a slightly streptomycin-resistant organism
was isolated, after five months' treatment, from only one
out of six similar cases whose organisms were P.A.S.-
sensitive at the start of the combined course. Five of
the cases had had no previous treatment with P.A.S.
alone.
It is concluded that P.A.S.-resistant tubercle bacilli are
likely to emerge if patients with pulmonary tuberculosis
are treated with P.A.S. alone ; that the resistant orga¬
nisms may persist for long periods ; and that, if the
patients are later treated with P.A.S. and streptomycin,
P.A.S. will then no longer prevent or diminish the
emergence of streptomycin-resistant bacilli.
This work was generously supported by the Royal Victoria
Hospital Tuberculosis Trust. We should also like to thank Drs.
N. W. Home, I. W. B. Grant, and J. D. Ross for allowing us
to investigate their patients, for making the radiographic assess¬
ments, and for their keen interest in the work. Unstinting help
was received in this and other investigations from the registrars,
house-physicians, nursing staff, and laboratory technicians of the
Edinburgh Royal Victoria and associated group of hospitals.
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INTRODUCTION
Pyle (1) and Mitchison (2) have shown that tubercle bacilli of varied degrees
of streptomycin resistance can be present in any one sample of sputum. Varia¬
tions in isoniazid resistance have been demonstrated by Tompsett (3). The
present report deals with similar investigations of the isoniazid resistance of
bacterial populations in sputum and cavities of patients with pulmonary tuber¬
culosis who had been treated with isoniazid. Estimations of the percentage of
the organisms resistant to the various concentrations of isoniazid were made
directly on the material examined. These estimations have been termed isoniazid
population studies.
METHOD
The method consisted essentially of inoculating a series of Lowenstein-Jensen plates
containing varying concentrations of isoniazid with serial dilutions of the sputum con¬
centrate. A plate which did not contain any drug was included in each series in order to
give a total viable count. The numbers of organisms resistant to the various drug concen¬
trations were thus determined. Owing to the tendency of M. tuberculosis to clump, the
colony counts represent "viable units" rather than individual organisms.
Preparation of plates: Fourfold dilutions of isoniazid in sterile distilled water were added
to Lowenstein-Jensen medium in the proportion of one part of dilution to 100 parts of
medium to give final drug concentrations of 0.06 to 64.0 y per ml. The isoniazid-egg medium
mixture was then poured into 9.0 cm. Petri dishes, approximately 30 ml. being used for
each plate. The plates were inspissated at temperatures between 75° and 80°C. in a hot air
inspissator for half an hour on each of two successive days. Before use, the plates were dried
in an incubator at 37°C. A disc of sterile filter paper was then placed in the lid of the Petri
dish to prevent any water of condensation from dropping onto the surface of the medium.
Preparation of the sputum dilutions: A morning specimen of sputum, to which had been
added an equal volume of 4 per cent sodium hydroxide (4) was mechanically shaken with
glass beads for ten minutes at room temperature. The mixture was then kept at 37°C. for
twenty to thirty minutes, depending on the nature of the sputum. It was subsequently
centrifuged at 2,500 r.p.m. for thirty minutes. After the supernatant fluid had been removed
and the deposit made neutral to phenol red with 8 per cent hydrochloric acid, approximately
25 ml. of sterile distilled water were added to the container and the mixture was re-eentri-
fuged as before. The resulting concentrate was homogenized by shaking with 2 ml. of sterile
distilled water in a mechanical shaker for ten minutes. A series of tenfold dilutions of the
homogenate in sterile distilled water was then prepared, from which the plates were inocu¬
lated immediately.
1 From the Department of Tuberculosis and Diseases of the Respiratory System, Uni¬
versity of Edinburgh, Edinburgh, Scotland.
2 This work was supported by a generous grant from the Royal Victoria Hospital Tu¬
berculosis Trust.
3 Royal Victoria Hospital Tuberculosis Trust Research Fellow in Bacteriology.
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Fig. 1. Photograph showing the appearance of a plate of Lowenstein-Jensen medium
after the inoculation with serial dilutions of a sputum concentrate and subsequent incuba¬
tion at 37°C. for eight weeks. The highest concentration of the sputum concentrate was
placed on the top left quadrant of the plate, the next on the top right, the next on the bot¬
tom left, and the lowest concentration on the bottom right quadrant.
The contents of lung cavities were treated in the same way as the sputum.
Inoculation of the plates: The plates were inoculated with Pasteur pipettes which de¬
livered 50 drops to the ml. Two plates of each drug concentration and two control plates
were inoculated from each specimen of sputum. One drop of one of four consecutive sputum
dilutions was placed on the surface of each of the four quarters of every plate. The actual
dilutions of the sputum concentrate used depended on the relative abundance of tubercle
bacilli in the sputum. In most cases, dilutions of 1 in 10 to 1 in 10,000 were used for the
control plates and the undiluted homogenate, and dilutions of 1 in 10 to 1 in 1,000 were used
for the plates containing the drug. After inoculation the plates were left undisturbed at
room temperature for twenty-four hours. The plates were then inverted, the filter papers
removed, and paraffin wax was poured into the rim to prevent subsequent evaporation.
The plates were incubated for eight weeks at 37°C. The photograph (figure 1) shows the
appearance of a plate after eight weeks' incubation.
Recording of results: Counts were made from each plate at the lowest dilution of the
sputum giving discrete colonies. The numbers of organisms resistant to the various drug
concentrations were expressed as percentages of the total viable bacterial population.
Routine drug-susceptibility tests: Cultures were set up on Lowenstein-Jensen slopes from
the neat sputum homogenate. All positive cultures were tested for isoniazid susceptibility
in Lowenstein-Jensen medium at concentrations of 0.2, 1.0, 5.0, 10.0, and 50.0 y per ml. (5).
RESULTS
Isolated, Results on a Number of Patients
Studies on 'patients who had never received isoniazid: The results of investiga¬
tions on sputum from patients who had never received isoniazid are given in
table I. It may be seen that in only one of the 8 cases (Case 6) was any growth
found on the lowest concentration tested, i.e., 0.06 y per ml. In that case only
four colonies grew from 0.02 ml. of the undiluted sputum concentrate, i.e., only
one in 4,000 of the organismswas resistant to 0.06 y of the drug per ml. No growth
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TABLE 1
The Results of Population Studies on Sputum from Patients Who Had Never
Received Isoniazid
Percentage of Tubercle Bacilli Resistant to
Case Total Viable Count per Isoniazid Resistance of
Number Ml. of Concentrate Lowenstein-Jensen Culture*
0.06 0.25 1.0 4.0 16.0 64.0
1 12.5 X 106 0 0 0 0 0 0 Susceptible!
2 1.5 X 103 0 0 0 0 0 0 Susceptible
3 2.0 X 105 0 0 0 0 0 0 Susceptible
4 2.5 X 103 0 0 0 0 0 0 Susceptible
5 6.0 X 105 0 0 0 0 0 0 Susceptible
6 8.0 X 105 0.025 0 0 0 0 0 Susceptible
7 4.0 X 103 0 0 0 0 0 0 Susceptible
8 7.0 X 106 0 0 0 0 0 0 Susceptible
* By the method used in the Medical Research Council of Great Britain Trials of Iso¬
niazid (5).
f Susceptible = fewer than 20 colonies on the slope containing 0.2 7 of isoniazid per
ml. in Ldwenstein-Jensen medium.
occurred at the higher concentrations. I11 all these cases the routine test showed
the organisms to be susceptible to isoniazid concentrations of 0.2 7 per ml., the
lowest concentration tested.
Studies on patients who had received isoniazid therapy and whose organisms were
known to be resistant to the drug by the routine test: The results of the population
studies on the sputum of 7 patients whose organisms were known to be resistant
to isoniazid are shown in table 2. It will be noticed that in only one case (Case 9)
were all of the organisms resistant to the highest concentration allowing growth.
In many cases less than 1 per cent was resistant to the higher concentrations
of the drug.
In the one case (Case 9) in which all of the tubercle bacilli appeared to be of
the same degree of resistance, the organisms in the sputum were known to have
been resistant to isoniazid for 516 days before the population study was carried
out. The patient had not received any isoniazid for 471 days and, during this
time, cultures from the sputum had shown a reduction in resistance from isoni¬
azid concentrations of 50.0 7 per ml. to concentrations of 0.2 to 1.0 7 per ml.
This low degree of resistance was maintained for eight months before the ex¬
amination of the sputum. The population study showed all of the organisms in
the sputum to be resistant to isoniazid concentrations of 4.0 7 per ml.
In 2 cases (Cases 10 and 11) the cultures from the sputum were resistant to
10.0 and 50.0 7 per ml., respectively, at the time of the population study. In
each case, at least one-third of the tubercle bacilli was shown to be resistant
to isoniazid concentrations of 16.0 7 per ml. These patients had been given
isoniazid for 353 days and two years, respectively, and they were both receiving
the drug at the time the microbial population study was carried out.
Population studies 011 the sputum from the remaining 4 patients all showed
a marked variation in isoniazid resistance. Two of these (Cases 12 and 13) had
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TABLE 2
The Results of Population Studies on Sputum from Patients Wiio Had Received
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0.06 0.25 1.0 4.0 16.0 64.0
days days days 7 perml,
9 196 471 516 5.5 X 104 100 100.00 — 100.00 0 0 1.0




0 Not known 8.5 X 105 100 100.00 100.0 100.00 33.00 4.10 50.0
12 180 420 Not known 3.5 X 106 29 36.00 1.3 0.42 0.16 0.04 50.0
13 42 264 Not known 3.5 X 10s 86 57.00 11.0 1.40 0 0 5.0
14 3281 0 350 5.5 X 10* 100 60.00 8.0 0.13 0 0 1.0
15 144 0 82 2.0 X 106 50 0.75 0.4 0.50 0.75 0.37 50.0
* By the method used in the Medical Research Council of Great Britain Trials of Iso-
niazid (5); cultures tested on Lowenst.ein-Jensen medium containing 0.2, 1.0, 5.0, 10.0,
and 50.0 y of isoniazid per ml.
t This patient received two courses of isoniazid of 168 and 160 days' duration, respec¬
tively, with a break of 63 days between.
received no isoniazid for 264 and 420 days, respectively. Frequent resistance
tests had not been carried out on cultures from the sputum of these patients.
In the third patient (Case 14) the organisms from the sputum had shown a
reduction in degree of isoniazid resistance during the period in which the patient
was not receiving the drug; during a second course of isoniazid the results on
the sputum cultures varied considerably. The fourth patient (Case 15) had
received continuous isoniazid therapy combined with oxytetracycline, 2 gm.
daily, for 144 days before the population study was done. Sputum cultures
before the population study had shown a low degree of resistance, but on later
readings an increase was found.
The results of the routine resistance tests agreed well with the results of the
population studies.
Weekly Investigations on Two Patients
It is known from the weekly routine testing of the isoniazid resistance of
tubercle bacilli isolated from patients who received the drug alone that in most
cases a high degree of resistance develops rapidly after the first appearance of
resistant organisms (6). In an attempt to determine whether, with this rapid
development of resistance, all of the organisms were affected simultaneously or
whether only a few became highly resistant, weekly population studies were
carried out on 2 patients.
By the time this work was begun it was already known that bacterial resistance
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Fig. 2. Chart showing the approximate numbers of tubercle bacilli in the sputum and
their isoniazid resistance during the first and second courses of isoniazid treatment of a
patient (Case 16) on whom weekly population studies were made during the second course
of isoniazid.
* DS 4- = Direct smear and culture positive for tubercle bacilli
DS Sc. = Direct smear with scanty number of bacilli (positive after more than five
minutes' search) and culture positive
Cone. + = Concentrate film and culture positive
Cone. Sc. = Concentrate smear with scanty number of bacilli (positive after more than
five minutes' search) and culture positive
Cult. + = Direct and concentrate films negative; culture positive
Cult. neg. = Direct and concentrate films and culture negative
Dotted lines indicate a positive smear with negative culture
to the drug would develop in a large proportion of patients treated with isoniazid
alone (7-9). It was therefore not the usual practice to use such treatment if the
patient's organisms were still susceptible to the drug. Nevertheless, there were
2 patients in the present series who had been treated with isoniazid alone in the
original Medical Research Council of Great Britain Trials of Isoniazid and
whose organisms were drug resistant. In neither case was any definitive therapy
possible. Treatment had been stopped after the organisms had been found to
be resistant to isoniazid concentrations of 50.0 y per ml. by the routine test.
During the subsequent months the tubercle bacilli from the sputum of both
patients showed a marked decrease in isoniazid resistance. By the seventh month
after stopping treatment in one case (Case 16) and the ninth month in the other
(Case 17), the organisms were resistant only to considerably lower concentrations
of isoniazid, i.e., 0.2 to 1.0 y per ml. It was therefore decided to re-treat these
patients with isoniazid alone in a dose of 100 mg. twice daily and to follow the
changes that occurred in the resistance of their tubercle bacilli.
Case 16: The approximate number of tubercle bacilli in the sputum of the first
patient and the results of the routine isoniazid-susceptibility tests are shown in
figure 2. It will be seen that during the first course of isoniazid therapy there was
some reduction in the population of tubercle bacilli in the sputum. Six weeks
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CASE 16 (M M.)
DAYS OF SECOND COURSE OF IS0N1AZID THERAPY
Fig. 3. Chart showing the results of the weekly population studies on the sputum during
the second course of isoniazid treatment, together with the results of the routine resistance
tests over this period (Case 16).
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TABLE 3
The Results op the Weekly Population Studies of the Sputum During the Second
Course of Isoniazid Treatment, Together with the Results of the Routine











per Ml. of Sputum
Concentrate
Percentage of Organisms Resistant to Isoniazid
7 per ml.
0.06 0.25 1.0 4.0 16.0 64.0
7 per ml.
0 1 .0 2.9 X 105 3.8 0.38 0.07 0.02 0 0
5 1.0 3.0 X 105 — 0.67 0.50 0.07 0.05 0.01
12 1.0 2.5 X 104 4.8 12.00 - 0.20 0.20 0
26 5.0 1.5 X 10' 24.0 12.00 1.70 1.40 0 0
33 1.0 7.5 X 10' - 17.00 13.00 11.00 11.00 6.00
40 10.0 7.5 X 10' 57.0 — 46.00 9.30 4.70 3.10
47 50.0 1.8 X 10' 86.0 78.00 25.00 28.00 21.00 10.00
53 50.0 5.0 X 10' 100.0 90.00 70.00 3.00 1.00 0
61 50.0 2.0 X 10' — 30.00 15.00 2.00 4.00 1.00
68 50.0 9.0 X 10' 100.0 17.00 12.00 18.00 0
75 50.0 5.0 X 10' 80.0 28.00 — 6.00 8.50 0.45
89 50.0 2.0 X 10' — 100.00 75.00 10.00 2.50 1.00
110 50.0 0.7 X 10' 100.0 30.00 23.00 2.00 — 11.00
124 50.0 7.0 X 10s 57.0 23.00 8.00 3.30 5.00 1.00
130 50.0 3.3 X 105 35.0 28.00 17. (X) 2.00 2.00 0
138 50.0 6.0 X 105 100.0 75.00 29.00 2.50 2.50 1.80
152 50.0 2.0 X 105 80.0 37.50 12.50 7.50 5.70 3.70
159 50.0 6.0 X 105 92.0 42.00 38.00 1.70 1.50 0.33
165 50.0 7.5 X 105 28.0 64.00 15. (X) 2.70 1.30 0.02
172 50.0 2.5 X 10' 40.0 20.00 18.00 — 1.00 0
186 50.0 7.0 X 105 27.0 19.00 12.00 0.30 0.60 0.01
193 50.0 2.5 X 10s — 64.00 28.00 — 1.10 0.16
200 50.0 2.7 X 105 63.0 50.00 27.00 7.30 5.50 5.50
214 50.0 5.5 X 106 100.0 82. (X) 27.00 0.55 0.10 0.01
235 50.0 5.0 X 10' 100.0 100.00 100.00 75.00 10.00 2.80
* By the method used in the Medical Research Council of Great Britain Trials of Iso¬
niazid (5); cultures tested on Lowenstein-Jensen medium containing 0.2, 1.0, 5.0, 10.0,
and 50.0 y of isoniazid per ml.
after the beginning of isoniazid therapy, the patient's strain of tubercle bacilli
was found to be resistant to isoniazid concentrations of 50.0 7 per ml. A disap¬
pearance of the more highly drug-resistant bacilli from the sputum occurred in
the subsequent five months but, with a second course of isoniazid, there was no
effect on the discharge of tubercle bacilli in the sputum. Moreover, by the sixth
week of treatment, tubercle bacilli resistant to isoniazid concentrations of 50.0 7
per ml. were again present in the sputum.
The results of the weekly microbial population studies of this patient's sputum
are shown in figure 3, along with the results of the routine drug-resistance tests
over this period. The actual percentages of the organisms resistant to the various
concentrations of isoniazid are shown in table 3. At the beginning of re-treat¬
ment, only 3.8 per cent of the tubercle bacilli were resistant to 0.00 7 of isoni-
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azid per ml., and less than 0.1 per cent to concentrations of 1.0 7 per ml. or
higher. By the fifty-third day of re-treatment, 100 per cent of the organisms were
resistant to 0.00 7 per ml. About this time an increase also occurred in the number
of organisms resistant to the higher concentrations, but at 110 time were 100 per
cent of this patient's strain resistant to isoniazid concentrations of 4.0 7 per
ml. or higher. Indeed, the percentage of the population which was resistant to
10.0 7 per ml. was never greater than 21.0 and the percentage resistant to 64.0 7
per ml. was never greater than 11.0 in spite of continuous treatment for 235 days.
Examination of 17 individual lesions obtained at post-mortem examination
of this patient twenty-one weeks after the end of the second course of treatment
by methods described elsewhere (10) showed a marked variation in the degrees
of resistance of the tubercle bacilli cultured from the various sites.
Case 17: In figure 4 may be seen the approximate numbers of tubercle bacilli
in the sputum and the resistance studies made of the strain from the second pa¬
tient who was studied at weekly intervals. There was some reduction in the num¬
ber of tubercle bacilli in the sputum during the first course of isoniazid until
resistant organisms appeared in approximately the sixth week. A more pro¬
nounced reduction in the number of tubercle bacilli discharged in the sputum
occurred during a short course of streptomycin and sodium p-aminosalicylate
CASE 17 (J. G.)
cult nec-
Fig. 4. Chart showing the sputum positivity and the isoniazid resistance of the tubercle
bacilli during the first and second courses of isoniazid treatment of a patient (Case 17) on
whom weekly population studies were carried out during the second course of isoniazid.
* DS + = Direct smear and culture positive
DS Sc. = Direct smear with scanty number of bacilli (positive after more than five
minutes' search) and culture positive
Cone. + = Concentrate film and culture positive
Cone. Sc. = Concentrate film with scanty number of bacilli (positive after more than
five minutes' search) and culture positive
Cult. -f- = Direct and concentrate films negative; culture positive
Cult. neg. = Direct and concentrate films and culture negative.
Dotted lines indicate a positive smear with a negative culture
** sp = Streptomycin, 1 gm. daily, with PAS, 20 gm. daily.
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Fig. 5. Chart showing the results of the weekly population studies on the sputum of a
patient (Case 17) during the second course of isoniazid treatment. On specimens to the left
of the vertical dotted line the undiluted sputum concentrate was not inoculated onto any
of the plates.
(PAS), to which drugs the patient's strain was susceptible. At this time the prog¬
nosis in this case was considered hopeless. Accordingly, streptomycin-PAS
treatment was stopped after three months and the number of tubercle bacilli
discharged in the sputum showed a considerable increase. The second course of
isoniazid had no effect on the number of bacilli in the sputum and had only slight
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effect on the level of isoniazid resistance of the strain. At no time were bacilli
resistant to isoniazid concentrations of 50.0 7 per ml. observed in contrast to the
situation during the first course of isoniazid therapy.
The results of the weekly population studies on the sputum from this patient
may be seen in figure 5, and the detailed results are presented in table 4. It will
be noticed that only 25 per cent of the organisms were resistant to isoniazid
TABLE 4
The Results of the Weekly Population Studies on the Sputum During the Second
Course of Isoniazid Treatment (Case 17)
(On specimens above the dotted line the undiluted sputum concentrate was not inoculated







Total Viable Count per
Ml. of Sputum
Concentrate
Percentage of Organisms Resistant to Isoniazid
7 per ml.
Isoniazid Culture* 0.06 0.25 1.0 4.0 16.0 64.0
7 per ml.
0 0.2 3.5 X 107 25 0.06 0 0 0 0
11 0.2 2.7 X 107 22 0 0 0 0 0
32 0.2 3.4 X 106 60 0 0 0 0 0
41 1.0 1.6 X 104 44 0 0 0 0 0
46 0.2 3.3 X 10° 42 0.15 0 0 0 0
63 1.0 1.4 X 105 18 0.36 0 0 0 0
67 1.0 1.9 X 106 47 0.13 0 0 0 0
74 1.0 2.2 X 106 32 0.25 0.005 0 0 0
81 5.0 1.9 X 105 65 7.00 0.650 0.150 0.03 0
88 0.2 3.3 X 104 14 — 0.150 0 0 0
95 1.0 2.3 X 10s — 0.74 0 0 0 0
102 5.0 2.5 X 105 30 0.35 0.090 0 0 0
109 1.0 1.5 X 106 65 0.70 0.170 0 0 0
116 1.0 0.7 X 106 100 2.60 0 0 0 0
123 1.0 2.8 X 104 56 0.90 0 0 0 0
130 1.0 0.5 X 104 100 2.00 0 0 0 0
136 1.0 1.5 X 106 100 1.60 0 0 0 0
144 1.0 5.0 X 105 — 7.00 4.600 0.700 0.09 0.01
151 0.2 2.5 X 106 65 5.10 0.020 0 0 0
158 1.0 2.4 X 10s 84 2.10 0 0 0 0
165 1.0 5.0 X 106 100 0.55 0.004 0 0 0
186 1.0 1.0 X 105 — 3.75 0.275 0 0 0
193 1.0 6.5 X 104 100 23.00 0 0 0 0
200 5.0 3.6 X 10« 100 17.00 0.050 0.001 0 0
207 0.2 8.0 X 106 — 0.80 0.001 0 0 0
213 1.0 1.3 X 105 72 0.88 0.840 0 0 0
221 1.0 2.6 X 106 77 1.50 0.030 0 0 0
242 1.0 6.3 X 106 100 0.72 0 0 0 0
249 1.0 3.1 X 107 11 0.02 0 0 0 0
257 1.0 6.0 X 106 100 0.63 0 0 0 0
271 1.0 1.2 X 106 70 0.15 0 0 0 0
* By the method used in the Medical Research Council of Great Britain Trials of Iso¬
niazid (5); cultures tested on Lowenstein-Jensen medium containing 0.2, 1.0, 5.0, 10.0,
and 50.0 7 of isoniazid per ml.
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TABLE 5
The Results of Population Studies on the Contents of Lung Cavities


























Culture*0.06 0.2s 1.0 4.0 16.0 64.0
days days days 7 per ml.
18 154 209 316 6.5 X 106 100 100 11 1.7 0 10.0
19{b 152 512 Not. known 5.0 X 1063.0 X 10s 100100 100100 100100 10025 50.013.0 36.06.7 50.050.0
20 236 8 86 5.0 X 105 100 100 18 0 0 0 2.5
* By the method used in the Medical Research Council of Great Britain Trials of Iso¬
niazid (5); cultures tested on Lowenstein-Jensen medium containing 0.2, 0.5, 1.0, 2.5,
5.0, 10.0, 25.0, and 50.0 y of isoniazid per ml.
concentrations of 0.0(i y per ml. before the beginning of the second course of
isoniazid. It was not until approximately the one hundredth day after the re-
institution of isoniazid therapy that 100 per cent of the organisms were found
to be resistant to 0.00 y per ml. About this time there was a tendency for the
results of the routine tests of this patient's organisms to rise from 0.2 y per ml.
to 1.0 7 per ml. The undiluted sputum homogenates were not used in these
observations until the seventy-fourth re-treatment day. Organisms resistant to
isoniazid concentrations of 0.25 y per ml. and higher may have been present
before this time but in such small numbers that they were not detected. At no
time during the 270 days of re-treatment did the percentage of organisms re¬
sistant to 0.25 7 per ml. rise above 2.3 per cent, and this value was generally
below 10 per cent. The number of organisms resistant to 1.0 7 per ml. was
extremely low; at the higher concentrations of isoniazid, only a very few resistant
organisms occurred, and those very infrequently.
Studies on the Contents of Lung Cavities
The results of the investigations on the contents of lung cavities from 3 pa¬
tients whose organisms were known to be isoniazid resistant are shown in table 5.
It will be noted that, in the cavity of the patient whose isoniazid therapy was
discontinued only eight days before the population study was carried out, the
resistance of the organisms was more uniform than in the other 2 patients. It
should be noted, however, that this patient had received a longer course of
isoniazid than had the other 2 patients. In 110 case were 100 per cent of the
organisms resistant to the highest isoniazid concentration at which growth
occurred.
DISCUSSION
Pyle (1) and Mitchison (2) have shown that organisms with varying degrees
of resistance to streptomycin can be found in a single specimen of sputum from
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a patient whose organisms are resistant to the drug. Tompsett (3) has demon¬
strated a similar variation with regard to isoniazid. His investigations were
carried out on liquid medium cultures from the sputum of patients who were
receiving the drug alone for the first time. He found that in many cases only a
low percentage of the organisms were resistant to the higher concentrations of
the drug in spite of continuous treatment for seven months. The results in the
present series using undiluted sputum confirm these earlier results.
It appears that the proportion of highly resistant bacilli found in the sputum
of patients with isoniazid-resistant organisms may be rather lower than is the
case with streptomycin. In only one case (Case 9) in the present series were all
of the organisms resistant to the highest concentration of the drug allowing
growth (tables 2-4). In none of the contents of lung cavities was uniformity of
resistance found (table 5), although the degree of variation among the individual
bacilli in these lesions was less marked than among the bacilli in the sputum of
other patients (table 2).
In 2 cases in the present study (Cases 10 and 11) all of the organisms were
highly resistant to isoniazid. The patients had received the drug for 353 days
and two years, respectively, and in both cases the organisms in the sputum were
known to be highly resistant. It seems likely that in these cases the prolonged
treatment had resulted in the development of a high degree of resistance through¬
out the lung.
In one case (Case 9) the organisms were all equally resistant, although not to
a high degree. The organisms from the sputum in this patient were known to
have been resistant to isoniazid concentrations of 50 y per ml. during treatment.
After the drug was stopped, however, a marked reduction occurred and, subse¬
quently, the tubercle bacilli in the sputum were shown repeatedly to be resistant
to 1.0 to 0.2 y per ml. The uniformity of the resistance of the organisms in the
sputum at the time of the population study suggests that a reduction in the
number of bacilli resistant to high concentrations of the drug may have occurred
throughout the lungs as has been shown to occur by the examination of indi¬
vidual lung lesions (10). Alternatively, the drainage from the lesions containing
highly resistant bacilli may merely have become blocked.
An increase in the degree of isoniazid resistance of the organisms in the sputum
was known to have occurred after the population study was done in one case
(Case 15). The variation in the degree of isoniazid resistance of the organisms
in the sputum may have been due to the fact that all of the organisms in the
lung had not yet reached their maximum resistance (10).
Three patients (Cases 14, 16, and 17) received two courses of isoniazid. In
each case, cultures from the sputum were highly resistant by the end of the
first course of treatment, but there was a marked reduction in the degree of
resistance during the time when no isoniazid was being given. In 2 cases (Cases 14
and 16), with the second course of isouiazid, highly resistant organisms were
again isolated. In the third patient (Case 17), however, the organisms showed
only a moderate degree of isoniazid resistance. In none of these 3 cases did all
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of the organisms become resistant to the maximum concentration of isoniazid
allowing growth in spite of second courses of the drug of 160, 235, and 270 days,
respectively. In one of these patients (Case 16) the varied degree of resistance
of the organisms in the sputum was probably a reflection of the marked variation
of resistance of the tubercle bacilli from different lesions in the lung. The second
courses of isoniazid treatment were shorter than either of the initial courses
given to the 2 patients (Cases 10 and 11) in whom all of the organisms became
highly resistant. Had the isoniazid been continued for a longer time it is pos¬
sible that a greater uniformity in the degree of isoniazid resistance might have
developed.
In the remaining 2 patients, resistance tests on the cultures from the sputum
were obtained too infrequently to correlate them with the results of the popula¬
tion studies.
Canetti and Saenz (11) have shown that tubercle bacilli of varied degrees of
streptomycin resistance may be isolated from different lesions within the same
lung. Recent investigations in this unit have shown that a similar wide varia¬
tion in isoniazid resistance can occur (10). It is therefore reasonable to suppose
that sputum derived simultaneously from various sites may contain organisms
of various degrees of resistance and that the proportion of the organisms resistant
to the different concentrations of the drug may depend on the sources of the
sputum. This may account for the marked fluctuations seen in the results shown
in tables 3 and 4 and may also explain the variations which sometimes occur in
a series of routine tests for isoniazid resistance on consecutive cultures from the
same patient.
The clinical improvement which may occur in a patient on isoniazid therapy
after the appearance of isoniazid-resistant tubercle bacilli in the sputum may
be due to the greater ability of the patient's defenses to deal with the much re¬
duced bacterial population. The results in Cases 12, 15, 16, and 17, however,
suggest that for a time the improvement may be due in part to the presence of
a high percentage of isoniazid-suscept.ible organisms although the patient's
strain appears to be resistant by a routine test.
The detailed studies on the 2 patients who were receiving a second course of
isoniazid therapy gave similar results to those found by Tompsett (3) during
first courses of the drug. Therefore, it may be that increases in the degree of
resistance which occur with re-treatment with the drug after apparent reversion
follow the same pattern as in the original development of resistance. The low
percentage of organisms resistant to the higher concentrations of the drug and
the similarity of these results to those found by Mitchison (2) with streptomycin-
resistant organisms are consistent with the suggestion that isoniazid resistance
may develop by "jump" mutations, as Bryson and Demerec (12) postulated
for streptomycin.
There is a close correlation between the results of the bacterial population
studies and the routine resistance tests on cultures from the same sputum
(table 2). It would appear that the routine test will detect as few as 0.1 per cent
of resistant organisms present in the sputum. This may be compared with a
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figure of 3 per cent given by Mitchison (2) as the lowest percentage of strepto¬
mycin-resistant organisms in a liquid medium culture detectable by the routine
liquid medium test. The close correlation between the highest isoniazid con¬
centration allowing growth in the population studies and that allowing growth
on the routine test would suggest that, during the normal incubation period of
a primary culture of tubercle bacilli from sputum, there is no appreciable loss of
isoniazid resistance.
In conclusion, these investigations show that there is usually a marked varia¬
tion in the degree of isoniazid resistance in the bacilli present in the sputum of
patients whose organisms have become resistant under treatment. Although
this variation is also present in the organisms from individual lung lesions, it is
not so marked as that in the tubercle bacilli discharged in the sputum.
SUMMARY
The percentage of tubercle bacilli in the sputum resistant to various concen¬
trations of isoniazid was determined in 8 patients who had never received the
drug. Not more than one in 4,000 of the organisms were resistant to 0.00 y
isoniazid per ml. of Lowenstein-Jensen medium.
In 5 of the 7 patients whose organisms were known to be resistant, a marked
variation in the degree of resistance of individual organisms was found.
Weekly investigations were carried out during a second course of isoniazid in
2 patients whose organisms had become resistant during isoniazid therapy but
had shown a reduction in the degree of isoniazid resistance following cessation
of the therapy. In neither case did all of the organisms show the same degree of
resistance in spite of re-treatment with isoniazid for 235 and 270 days, respec¬
tively.
Variation in the degree of isoniazid resistance among individual tubercle bacilli
was present in the contents of lung cavities although the phenomenon was
observed to occur to a lesser extent than in sputum.
A close correlation was found between the results of the bacterial population
studies and the routine resistance tests.
SUMARIO
Grados Variables de Resistencia a la Isoniacida en Cepas de Bacilos Tubercidosos Procedenles
del Esputo y de Cavernas Pulmonares
En 8 enfermos que jamais hablan recibido isoniacida, se determino en el esputo el porcen-
taje de microbios resistentes a varias concentraciones de la droga. No hubo m&s de uno en
4,000 que fuera resistente a 0.06 y de isoniacida por ml. de medio de Lowenstein-Jensen.
En 5 de los 7 enfermos cuyos microbios se sabia que eran resistentes, observose una no¬
table heterogeneidad en la intensidad de la resistencia.
Durante una segunda serie de isoniacida, llev&ronse a cabo investigaciones semanales
en 2 enfermos cuyos gdrmenes se hablan vuelto resistentes durante la primera serie, pero
que hablan mostrado despuds disminucion en la intensidad de su resistencia a la isoniacida.
Ni en uno ni en otro caso, mostraron todos los microbios el mismo grado de resistencia a
pesar de una terapdutiea continua durante 235 y 270 dlas, respectivamente.
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Notose tambien heterogeneidad do la resistencia en el contenido de las cavernas pul-
monares, aunque en menor grado que en el esputo.
Observose notable correlation entre los result ados de los estudios de la poblacion bac-
teriana y las pruebas habituales de la resistencia.
RESUME
Les divers degres de la resistance a I'isoniazide dans des souches de bacilles luberculeux extraits
de crachats el de cavernes pulmonaires
Le pourcentage de germes extraits de crachats qui prdsentaient une resistance a diverges
concentrations d'isoniazide a 6te ddtermind chez 8 malades n'ayant jamais regu Pantibio-
tique. Parmi 4.000 de ces bacilles, un seul prdsentait une resistance a 0,06 y d'isoniazide par
ml. du milieu de Lowenstein-Jensen.
Chez 5 des 7 patients porteurs de germes reconnus resistants, une hdtdrogdnditb marquee
dans le degrd de resistance a dtd observde. Des investigations hebdomadaires out dtd pour-
suivies durant une seconde cure d'isoniazide chez deux patients dont les bacilles avaient
acquis la rdsistance au cours de la premiere cure, mais qui avaient ulteriourement prdsentd
une rdduction de degre de l'isoniazide-rdsistance. En depit d'un t raitement continu de 235
et 270 jours, respectivement, les germes ne prdsentaient pas tous le memo degrd de rd¬
sistance.
L'hdtdrogeneite de la rdsistance existait dans le contenu des excavations pulmonaires,
mais elle dtait moins marqude que dans l'expectoration.
Une dtroite correlation a dtd observde entre les resultats des etudes sur la population
bactdrienne et les tests de rdsistance classiques.
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INTRODUCTION
When bacterial resistance to streptomycin or to isoniazid occurs in cases of
pulmonary tuberculosis, organisms of various degrees of resistance may be
isolated from a single sample of sputum (1-3). Variations may also be found in
the degree of resistance of tubercle bacilli from different lesions within the same
lung (3-8). The present report deals with a detailed study of the distribution of
streptomycin- and isoniazid-resistant tubercle bacilli in specimens of lung tissue.
MATERIALS AND METHODS
Lung tissue was examined from 13 patients whose organisms were known to be resistant
to both streptomycin and isoniazid. These patients had been treated with these drugs on
regimens which would not now be used, as they are known to be ineffective in preventing
the appearance of drug-resistant organisms. Isoniazid-resistance tests were carried out in all
13 cases, but streptomycin-resistance tests were only done in 8 of them. Eight patients
(Cases 1,4, S, 6, 7, 9, 11, and 12) were examined post mortem, and specimens of lung tissue
were obtained from the other 5 patients (Cases 2, 3, 8, 10, and 13) at operation. All cases
were classified as far advanced pulmonary tuberculosis with cavitation.
Sampling of lesions: The specimens were examined within six hours of the operation or
within twenty-four hours of the patient's death, except in one case (Case 11) in which post¬
mortem examination was delayed for seventy-two hours. The main sites of the disease were
located by means of a recent roentgenogram and samples were taken from each of these. In
addition, a number of lesions were sampled which were not visible on the roentgenogram.
Precautions were taken to minimize the spread of tubercle bacilli from one site of infection
to another. A small incision was made through the wall of the cavities and the contents
were removed. Caseous foci were cut out and macerated with scissors.
Isolation of tubercle bacilli: The specimens were suspended in a small volume of sterile
distilled water and an equal volume of 4 per cent sodium h3rdroxide was added. After the
addition of glass beads, the mixture was shaken mechanically for ten minutes and then
placed at 37°C. for twenty minutes. After centrifuging at 2,500 r.p.m. for twenty minutes,
the supernatant fluid was poured off and the deposit was made neutral to phenol red with
8 per cent hydrochloric acid. Twenty-five milliliters of sterile distilled water were added
and the material was centrifuged as before. The supernatant fluid was poured off. A Ziehl-
Neelsen film was made from part of the deposit and the remainder was inoculated onto three
Lowenstein-Jensen slopes by means of a Pasteur pipette. Cultures were incubated at 37°C.
They were examined weekly and only discarded as negative after twelve weeks' incubation.
Before the addition of the alkali, the aqueous suspensions of some of the specimens were
injected into guinea pigs. All of the animals were killed twelve weeks after inoculation and
cultures were made from the lesions.
1 From the Department of Tuberculosis and Diseases of the Respiratory System, Uni¬
versity of Edinburgh, Edinburgh, Scotland.
2 This work was supported by a generous grant from the Royal Victoria Hospital Tu¬
berculosis Trust.
3 Royal Victoria Hospital Tuberculosis Trust Research Fellow in Bacteriology.
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Bacterial drug-resistance tests: In all cases, positive cultures were tested for resistance
to isoniazid and in 8 cases streptomycin-resistance tests were also done. When all three
cultures from a lesion were positive, the slope with the heaviest growth was used. When
primary cultures were negative but guinea pig inoculation was positive, resistance tests
were carried out on the tubercle bacilli isolated from the animal organs.
The streptomycin-iesistance tests were done by the method recommended by the Medical
Research Council of Great Britain (9), using the liquid medium of Davis and Dubos. The
actual concentrations of streptomycin added to the medium were 128, 32, and 8 y, and then,
by twofold dilutions, to 0.125 y per ml. In 2 of the cases, the organisms from the sputum were
found to be susceptible by this test, but resistant when tested on Lowenstein-Jensen medium
by a method already reported (10). Therefore, in these cases both liquid and solid medium
drug-susceptibility tests were done on the cultures from the lung lesions. The actual con¬
centrations of streptomycin added to the solid medium were 64.0 to 1.0 y per ml. by twofold
dilutions. The results of both methods were expressed as resistance ratios, that is, the ratio
of the minimum inhibitory concentration for the test organism to the minimum inhibitory
concentration for the standard H37Rv strain of M. tuberculosis.
The method for detecting isoniazid resistance was that recommended by the Medical
Research Council of Great Britain (9), using Lowenstein-Jensen medium. The isoniazid
concentrations were 50.0, 25.0, 10.0, 5.0, 2.5, 1.0, 0.5, and 0.2 y per ml. The results were
expressed as the highest concentration allowing the growth of 20 or more colonies.
Streptomycin- and isoniazid-resistance tests were also done on the last culture of
tubercle bacilli isolated from the sputum before examination of the lungs. For the sputum
cultures, the range of streptomycin concentrations used was 8.0 to 0.125 y perml. by twofold
dilutions. The isoniazid resistance was only tested at 50.0, 10.0, 5.0, 1.0, and 0.2 y per ml.
Cultures were considered to be resistant to streptomycin when a resistance ratio of 4 or
more was obtained. This means that growth was inhibited by at least 1.0 y per ml. of liquid
medium, or at least 16.0 y per ml. of solid medium. A resistance ratio of 4 by either method
has been shown to be outside the normal range at the 1 per cent level (10). Clinical evidence
of the significance of this degree of resistance will be published elsewhere. A growth of 20
or more colonies on the slope containing 0.2 y of isoniazid per ml. was taken as indicating
"doubtful" resistance, and a similar growth on 1.0 y per ml. as "definite" resistance (9).
RESULTS
Streptomycin
Resistance of tubercle bacilli from the lung lesions: In table 1 may be seen the
results for 8 patients of streptomycin-resistance tests in liquid medium on cul¬
tures from the lung lesions and from the last available culture of the sputum.
Details are also given of the courses of chemotherapy, the times since strepto¬
mycin was last administered, and the duration of streptomycin resistance
before the examination of the lung.
Owing to the experimental errors of the resistance test, cultures from the
lesions were considered to show a significant variation in the degree of strepto¬
mycin resistance only if there was at least a fourfold difference between the
results. This difference between the maximum and minimum degrees of resistance
of the lung cultures was present in 6 cases. The resistance ratios varied from
64 to greater than 256 in one case (Case 10); from 1 to greater than 256 in another
(Case 11); from 1 to 16 in a third (Case 3); and from 1 to 8 in a fourth (Case 7).
In 2 cases (Cases 1 and f) the readings varied from 16 to 256. In the remaining
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Iii 2 cases (Cases 8 and 7) the last available cultures from the sputum were
drug susceptible when tested in the liquid medium, the resistance ratios being
1 and 2, respectively. Both of these cultures were resistant when tested on solid
medium, a resistance ratio of 8 being obtained in each case. Furthermore, in
each case, cultures from two lesions which were drug susceptible by the liquid
medium test were shown to be resistant when tested on the solid medium. In
Case 5, the culture from a third lesion, which was drug susceptible in liquid
medium, did not grow on the solid medium test.
Comparison of the degree of resistance of cxdtures from cavities and caseous foci:
It will be seen in table .1 that in 2 cases (Cases 1 and 7) there was no difference
between the degree of streptomycin resistance of tubercle bacilli isolated from
the cavities and caseous foci. In Cases 6, 10, and 11, no difference could be
demonstrated since organisms from both types of lesions were isolated which
were resistant to the maximum concentration tested. In the sixth case (Case f)
the maximum degree of resistance was present in cultures from a cavity. In the
seventh case (Case 3) the maximum degree of resistance was present in cultures
from a caseous focus. In the eighth case (Case 5) resistance tests were not avail¬
able on cultures from the cavities.
Isoniazid
Drug resistance of tubercle bacilli from the sputum: The results of isoniazid-
resistance tests on cultures from the sputum of the 13 patients, together with
the duration of therapy with isoniazid alone or along with other drugs are shown
in figure 1. When available, the results are given from the beginning of the first
course of isoniazid to the time of examination of the lung specimens. The range
of resistance of cultures from the lungs is also given.
Resistance of cultures from the lung lesions: In table 2 and figure 1 are shown
the results of the resistance tests on cultures from the individual lung lesions.
In each of the first 9 patients it will be seen that the degree of resistance of
cultures from the lesions lay within three consecutive concentrations of isoniazid.
This variation is inherent in the method used for detecting isoniazid resistance
and, therefore, in these patients the resistance of the cultures from the lesions
are considered to be uniform. In terms of the highest isoniazid concentrations
permitting growth, the readings were 0.2 to 1.0 y per ml. in one patient (Case 6),
1.0 to 2.5 y per ml. in 3 patients (Cases 1, 2, and 5), 0.5 to 2.5 y per ml. in a
fifth patient (Case 3), 2.5 to 5.0 y per ml. in a sixth (Case 4), and 10.0 to 50.0 y
per ml. in a seventh patient (Case 7). In the other 2 patients (Cases 8 and 9),
the tubercle bacilli isolated from all of the lesions were resistant to isoniazid
concentrations of 50.0 y per ml., the highest concentration tested.
In the remaining 4 patients, the degrees of resistance within the lungs showed
greater variation than could be accounted for by the method. In one patient
(Case 10), the tubercle bacilli from one lesion were completely susceptible; in
the other four lesions, the isoniazid resistance of the bacilli ranged from 5.0 to
50.0 y of the drug per ml. Cultures from the lung of a second patient (Case 11)
varied in isoniazid resistance from 0.2 to 25.0 y per ml. The tubercle bacilli
TABLE2
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Figure 1
Graphs showing the result of isoniazid-resistance tests on cultures from the sputum of
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The range of resistance of cultures from th» lungs is given in parentheses after the case
number, and the distribution of resistance is shown in the diagrams at the end of each graph.
The blocks indicate duration of therapy. The degree of isoniazid resistance is given in 7 of
isoniazid per ml. of Lowenstein-Jensen medium, the concentrations tested being 50.0, 10.0,
5.0, 1.0, and 0.2 7 of isoniazid per ml. The method used was that of the Medical Research
Council of Great Britain Trials of Isoniazid (9). The figure 0 indicates a growth of less than
20 colonies at 0.2 7 per ml., that is, complete susceptibility.
SM—streptomycin; PAS—para-aminosalicylic acid; INH—isoniazid; Oxyt.—oxytetra-
cycline. The dosage of streptomycin is indicated by the numeral after the letters SM,
e.g., SM2 = streptomycin twice weekly. SM alone indicates daily streptomycin.
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from a third patient (Case 12) were resistant to isoniazid concentrations of 1.0
to 50.0 7 per ml., and in a fourth patient (Case 13) the degrees of resistance
varied from 1.0 to 25.0 7 of isoniazid per ml.
Allowing for experimental error, the degree of resistance of the last culture
of the sputum which was tested was in agreement with the maximum degree
of resistance of the cultures from the lung in each of the 1.3 patients.
Comparison of the degree of resistance of tubercle bacilli obtained from cavities
and from caseous foci: A comparison of the degree of isoniazid resistance of
tubercle bacilli from cavities and from caseous foci is shown in table 2. I11 the
9 cases in which a uniform degree of resistance was present in the lung lesions,
it was evident that no difference could occur between the degree of resistance in
the two types of lesion. I11 2 (Cases 11 and 12) of the 4 patients showing a varied
degree of resistance, the maximum degree of resistance was found in both the
cavities and the caseous foci. In the third patient (Case 10) the maximum degree
of resistance was found in the cavities; and in the fourth (Case 13), in the caseous
foci.
Comparison of the degree of streptomycin and isoniazid resistance within the
same lesion: In only 2 of the patients who showed a varied degree of isoniazid
resistance (Cases 10 and 11) were streptomycin-resistance tests also done on
tubercle bacilli from the same lesions. In neither case was the maximum degree
of resistance to one drug found only in cultures from lesions containing organisms
with the maximum degree of resistance to the other drug.
DISCUSSION
Saenz and Canetti (4, 5) have shown that tubercle bacilli with various degrees
of streptomycin resistance can be found within the same lung. Other workers
((5-8) have confirmed these findings, and similar results have been found in the
present series of cases.
Canetti and Saenz (5) reported that a high degree of streptomycin resistance
is more often found in cavities than in caseous foci. It has not been possible to
confirm this in the present study. I11 the Canetti-Saenz studies, the incidence of
highly resistant organisms in the two types of lesion was expressed as the per¬
centage of the total number of each lesion examined. Owing to the wide variety
of chemotherapeutic regimens used in the present study, it was of little use to
summate the results from all cases. Consequently, a comparison was made of
the degree of streptomycin resistance of tubercle bacilli isolated from the two
types of lesion in the individual lungs. I11 one of the 7 cases in which both cavi¬
ties and caseous foci were examined, the tubercle bacilli with the maximum
degree of streptomycin resistance were isolated from a cavity, but in a second
case the maximum degree of resistance was found in a caseous focus. In the
remaining 5 cases there was 110 difference in the degree of resistance found in
the two types of lesion.
The finding of higher degrees of streptomycin resistance in cavities may
depend 011 the duration of streptomycin therapy. Of the eleven cases reported
by Canetti and Saenz (5) in which the duration of streptomycin therapy is
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given, all but two had less than four months' treatment. In these two cases the
degree of resistance of the organisms in the cavities was not higher than that of
those in the caseous foci. In the present series, all of the patients had received a
minimum of five months' treatment and the majority had received treatment
for a considerably longer period.
It has been reported that, within the same lung, some lesions may contain
tubercle bacilli susceptible to streptomycin although tubercle bacilli from other
lesions may be resistant to this drug (5-7). In the lungs from six patients, all
of whom had been treated with streptomycin for at least one hundred and
twenty days, Fisher (11) did not find any foci containing streptomycin-suscepti¬
ble organisms.
In the present series, tubercle bacilli susceptible to streptomycin by the liquid
medium test were isolated from six lesions (Cases 3, 7, and 11). The cultures of
bacilli from four lesions (Cases 3 and 7) were shown to be resistant when tested
on solid medium. The remaining two cultures were not tested by this method
and, therefore, it is not certain whether they were actually drug susceptible.
Organisms with various degrees of isoniazid resistance may be isolated from
several lesions within the same lung (3). Such variation in the degree of isoniazid
resistance was found in 4 of the 13 cases in the present series. In the remaining
9 cases, no variation in the degree of resistance was found.
There are a number of factors that may influence the uniformity of isoniazid
resistance in the various lesions which merit discussion.
It has been shown that tubercle bacilli of various degrees of resistance may
be present in the sputum during the development of isoniazid resistance (12).
At this stage it is unlikely that the organisms within the various lung lesions
would have reached a uniform degree of resistance. This is seen in Case 10. The
marked variation in the degree of resistance present in this case may be due to
one or more of the following factors:
The duration of isoniazid therapy after the emergence of resistant tubercle bacilli
might influence the degree of variation of resistance within the lung. With prolonged
isoniazid therapy, a uniformly high degree of resistance in the lung lesions might
occur. With shorter courses of the drug, variation in the degrees of resistance might
be more likely.
Different concentrations of isoniazid in lesions might result in the production of
organisms of various degrees of resistance. Manthei and associates (13) have shown
that different concentrations of isoniazid may be found in lesions within the same
lung. In one experiment. Singh and Mitchison (14) found that, when organisms were
exposed to varied concentrations of isoniazid in vitro, the higher the concentration
of the drug, the greater the degree of resistance of the organisms which survived.
These findings may explain the varied degrees of isoniazid resistance within the lung.
Schaeffer (15) has shown that isoniazid has no effect on tubercle bacilli which are
not multiplying. Such dormant organisms may remain viable for a considerable
period in contact with the drug and on transference to a culture medium might prove
to be fully susceptible. This could explain the presence of susceptible tubercle bacilli
in some lesions in spite of the existence of resistant organisms in others.
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In 4 of the present cases, the tubercle bacilli in the sputum showed a constant
high degree of resistance even for some months after isoniazid therapy had been
stopped. In 3 of the patients (Cases 7, 8, and 9), a high degree of resistance was
found in all of the lung lesions. In the fourth patient (Case 12), marked variation
in the degree of resistance was present. There is no obvious explanation for the
inconsistency of these results. It might have been thought that the duration of
isoniazid therapy after the development of resistance or the time since the drug
was last given would influence the degree of uniformity of resistance in the
tubercle bacilli in the lung. No confirmation of this supposition has been found
in the particular cases studied from this standpoint.
In 5 other cases (Cases 2, 3, 4, 5, and 6) sputum cultures, although at some
time highly resistant, subsequently showed a constant low degree of resistance.
In each of these cases cultures from all of the lung lesions showed a uniformly
low degree of resistance. In another case (Case 11) examination of cultures of
the sputum had shown that reversion to a lower degree of resistance was taking
place shortly after the second course of isoniazid had been stopped. A wide
variation was found in the degree of resistance of the lung cultures. One or more
of the following factors might explain these results:
If resistance to isoniazid develops by an adaptive mechanism, it might be expected
that the whole bacterial population would subsequently become less resistant when
no longer in contact with the drug.
Mitchison has suggested that reversion of streptomycin resistance may be due to
the replacement of resistant organisms by more rapidly growing susceptible ones
(16). It has been shown that, within an individual lesion, organisms of low degrees of
isoniazid resistance can be present although by the routine susceptibility test the
culture is highly resistant (12). If organisms of a low degree of resistance grow more
rapidly than highly resistant strains, the more resistant bacilli may ultimately be
replaced by the less resistant ones after the patient has stopped isoniazid therapy.
When completely susceptible organisms remain at the end of treatment, reversion
to complete susceptibility could occur.
It is difficult to explain the results in 2 of the cases (Cases 1 and 13). In Case 1,
isoniazid resistance was of recent onset and there was uniformity in the degree
of resistance among the bacilli from the separate lung lesions. This is in contrast
to the findings in Case 10 in which, although drug-resistant tubercle bacilli had
likewise appeared only recently, the organisms from the lung lesions showed
marked variations in the degree of isoniazid resistance. In Case 13 there was
evidence of a lowering to a constant low level of the degree of isoniazid resistance
of the bacilli in the sputum. Nevertheless, highly resistant organisms were
isolated from some of the lung lesions. Presumably the lesions which contained
these organisms were not contributing to the sputum.
In the 4 cases in which there was a variation in the degree of resistance of
the organisms in the lung lesions, there was no evidence that the degree of re¬
sistance was dependent upon the nature of the lesion. Although in one case
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(Case 10) the maximum degree of resistance was found in the cavities, in one
of the lungs from another patient (Case 13) the maximum degree was found
among tubercle bacilli from the caseous foci.
In conclusion, it is evident that many factors might have an influence on the
distribution of drug-resistant bacilli within the lung, but much further work
will have to be done before the exact part each plays can be elucidated.
SUMMARY
An examination was made of the distribution of streptomycin- and isoniazid-
resistant tubercle bacilli in specimens of lung tissue from 13 patients.
Marked variation in the degree of resistance of tubercle bacilli from the lesions
within the same lung was found in 6 of the 8 cases examined for streptomycin
resistance, and in 4 of the 13 examined for isoniazid resistance.
There was no apparent difference in the degree of streptomycin or isoniazid
resistance of tubercle bacilli isolated from cavities and caseous foci.
SUMARIO
Estudios de la Distribution de Radios Tuberculosos Farmacorresistentes Dentro del Pulmon
En los ejemplares de tejido pulmonar procedente de 13 enfermos, lnzose un estudio de
los bacilos tuberculosos estreptomicino- e isoniacido-resistentes. En 6 de los 8 enfermos
estudiados en cuanto a resistencia a la estreptomicina y en 4 de los 13 estudiados en euanto a
resistencia a la isoniacida, descubriose notable variacion en la intensidad de la resistencia
de cultivos procedentes de lesiones del mismo pulmon.
No hubo diferencia aparente en la intensidad de la resistencia a la estreptomicina y la
isoniacida en los microbios aislados de cavernas y focos caseosos.
Disctitense los factores que pueden afectar la uniformidad de la resistencia a la isonia¬
cida en el pulmon.
RESUME
Recherches sur la repartition dans le poumon des bacilles antibiotiques-resistants
II a 6te procdde it l'examen de la repartition des bacilles streptomycino et isoniazide-
resistants dans des pieces de tissu pulmonaire provenant de 13 patients. Des differences
marquees dans le degre de resistance de colonies provenant de lesions situees dans un meme
poumon ont ete decouvertes chez 6 des 8 malades etudids pour rechercher la streptomycino-
resistance et chez 4 des 13 malades etudies pour l'isoniazide-resistance.
II n'existait aucune difference apparente dans le degre de la streptomycino ou isoniazide-
resistance des germes isoies de lesions excavees ou de foyers caseeux.
Les facteurs susceptibles d'influencer l'uniformite de l'isoniazide-resistance sont etu¬
dies.
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It has been shown (Dye, Lynch, and Brees,
1953 ; Medical Research Council, 1953a and b ;
Pitts, Tempel, Miller, Sands, Fitzpatrick, and
Weiser, 1953) that the treatment of tuberculosis
with two drugs simultaneously markedly reduces
the incidence of bacterial resistance provided that
the organisms are fully sensitive to both drugs.
If, however, the organisms are resistant to one
of the drugs, resistance will develop to the second
as quickly as if that drug were being given alone
(Turnbull, Wallace, Stewart, and Crofton, 1953).
Evidence obtained in this unit (to be published
elsewhere) suggests that it is important to use a
routine sensitivity test which will detect even low
degrees of resistance. In Great Britain the
generally accepted routine test for detecting
streptomycin resistance in tubercle bacilli is that of
serial dilution in Dubos and Davis liquid medium
as recommended by the Medical Research Council
(1953c). But in this unit we have had a number
of patients excreting organisms which appeared to
be sensitive by the routine test, although other
factors in the cases suggested that streptomycin-
resistant bacilli had emerged. In the present report
an alternative method is described for the detec¬
tion of streptomycin resistance in Myco. tuber¬
culosis which appears to be more sensitive than
the previous routine test.
Material
All strains of Myco. tuberculosis used were obtained
from the sputa of patients with pulmonary tuber¬
culosis. The sputa were homogenized by the alkali-
acid or tri-basic sodium phosphate method, and cul¬
tured on Lowenstein-Jensen medium. The time be¬
tween the inoculation of the culture and the testing
for streptomycin resistance varied from four weeks to
five months.
The cultures used are grouped as follows :
(1) Twenty-nine cultures from 29 patients who had
never received streptomycin, to show the normal
variation of the method.
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(2) Thirty-four cultures which on the routine test
appeared to be sensitive to streptomycin although
they came from 22 patients whose organisms were
suspected of being resistant for one or more of the
following reasons : (a) Streptomycin was known to
have been given previously alone or in combination
with other drugs to which the patients' organisms
were known to be resistant. (b) Isoniazid (iso-
nicotinic acid hydrazide) resistance had developed dur¬
ing combined treatment with streptomycin and iso¬
niazid. All of these patients had previously received
streptomycin alone or in combination with p-amino-
salicylic acid (P.A.S.), when their organisms had
already become resistant to P.A.S. (c) The occur¬
rence of apparent sensitivity to streptomycin in spite
of the fact that on previous occasions resistance to
the drug had been found by the routine test.
(3) Fifteen cultures from 15 patients from whom
previous cultures had been shown to be resistant to
streptomycin by the routine test to determine whether
any of these cultures might appear sensitive by the
new test.
Methods
The streptomycin sensitivity of the cultures was
tested by the routine liquid medium method and by
a solid medium method simultaneously. In both
cases the standard H37Rv strain of Myco. tuber¬
culosis was used as the control organism. The results
were reported as a resistance ratio, that is the ratio of
the minimum inhibitory concentration for the test
organism to the minimum inhibitory concentration for
the control strain.
Routine Liquid Medium Test.—The routine method
was that recommended by the Medical Research
Council (1953c) using Dubos and Davis' " Tween 80 "-
albumin medium (Dubos and Davis, 1946). The
drug concentrations used were 8, 4. 2, 1, 0.5, 0.25, and
0.125 pg. per ml. of medium. The tubes were in¬
oculated from a second subculture of the organisms
in Dubos and Davis medium. All tests were read after
10 days' incubation and some were also read after
28 days.
Solid Medium Test.—The organisms were tested for
resistance to streptomycin on Lowenstein-Jensen medi¬
um at concentrations of 64, 32, 16, 8. 4, 2, 1, and 0.5
rg./ml. These concentrations represent the actual
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amount of streptomycin added to the medium. After the
addition of the streptomycin approximately 2 ml. quan¬
tities were dispensed into I oz. screw-capped bottles.
These were inspissated in the horizontal position for
one hour at 75 to 80° C. A suspension of a loopful
of the growth of the primary culture of the organism
was made in 0.3 ml. sterile distilled water by shaking
with glass beads in a mechanical shaker. Using a
nichrome wire loop of 3 mm. diameter, a loopful of
the suspension was streaked up the centre of the
slope. The slopes were incubated at 37° C. Read¬
ings were made at three, four, five, and six weeks.
Growth was considered to be inhibited by the drug
if fewer than 20 colonies appeared on the slope.
Solid Medium Test from the Liquid Medium
Culture.—In order to ascertain whether resistance
detected by the solid medium test but not by the liquid
medium method was due to a failure of the resistant
organisms to grow in the liquid medium subculture
used for the routine test, a series of tests on solid
medium was carried out using a loopful of the liquid
medium subculture instead of the suspension. The
number of organisms present in these two inocula is
approximately the same.
Liquid Medium Tests without " Tween 80."—In
order to ascertain whether the failure to detect resis¬
tance was due to the presence in the routine medium
of "Tween 80," a series of tests was carried out in
medium which did not contain any of this substance.
The method used for these tests was exactly the same
as for the routine test in all other respects. The liquid
medium subculture from which the tests were inocu¬
lated contained " Tween 80."
Results
Cultures front Patients Who Had Never Re¬
ceived Streptomycin.—Table I shows the three and
four weeks' readings of the solid medium tests on
the 29 pre-treatment cultures. The results are
expressed as resistance ratios. It will be seen that
Table I
normal distribution of resistance ratios on
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at three weeks the readings fell within the range
} to 4. At four weeks this range was narrowed to
i to 4. Results at five and six weeks were similar
to those found on the four weeks' reading. The
range of inhibition for the test organisms varied
from 1 to 16 jug./ml. and for the standard H37Rv
strain from 4 to 8 /tg./ml.
From the normal distributions the standard
deviation of the three weeks' readings is 1.217 and
of the four weeks' readings is 1.013. The limiting
resistance ratio for P = 0.01 is 8 for the three
weeks' results and 4 at four weeks. In view of
these results it was considered that a four-week
reading would be the most satisfactory to use.
The 29 pre-treatment cultures were also tested
by the liquid medium method. The results of
both methods, expressed as resistance ratios, are
compared in Table II. By each method 28 of the
29 cultures tested gave a resistance ratio of 2 or
less. By each method one strain gave a resistance
Table II
comparison of results of liquid and solid media
tests on 29 cultures from 29 patients who





































Total 8 19 1 1 29
"Resistance ratio " = the ratio of the minimum inhibitory con¬
centration for the test organism to the minimum inhibitory concen¬
tration for the standard H37Rv strain.
The standard strain was inhibited by concentrations varying from
0.25 to 0.5 fig/ml. in the liquid medium and from 4 to 8 ^g./ml. in
the solid medium.
The liquid medium tests were read at 10 days and the solid medium
tests at four weeks.
ratio of 4. Both the patients from whom these
latter two strains were isolated have subsequently
been treated with streptomycin in combination
with another drug. In neither case has their sub¬
sequent progress suggested that the organisms
were resistant to streptomycin.
By the routine liquid medium test the minimum
inhibitory concentration for the test organisms
varied from 0.125 to 1.0 ,ug./ml. and that of the
standard H37Rv strain from 0.25 to 0.5 jug./ml.
From the normal distributions of the 29 cultures
also tested by the solid medium method, the
standard deviation is 0.591 and the limiting resis¬
tance ratio for P= 0.01 is just over 2. Utilizing
a further 41 cultures tested by the liquid method
only, the limiting resistance ratio is again just over
2. Since the tests are carried out with twofold
differences between the concentrations, this means
that the lowest resistance ratio giving a 99 to 1
probability of resistance is 4.
Although the numbers in these series are rather
small for statistical analysis, the results suggest
that by either method a resistance ratio of 4 will
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only be obtained with one pre-treatment culture
in 100. Therefore a ratio of 4 by either method
has been taken as indicative of the emergence of
a resistant strain.
Cultures Appearing Sensitive by Routine Test
although Suspected of Resistance.—Table III gives
the results of the solid medium test on 34 cultures
which were sensitive on the routine liquid medium
test. In every patient from whom these cultures
were obtained streptomycin resistance was sus¬
pected for the reasons shown. It will be seen that
in only one culture was a sensitive result found
on the solid medium test. Of the remaining 33
cultures, 10 gave a resistance ratio of 4, nine of 8,
seven of 16, and seven of greater than 16.
Table 111
results of solid medium tests on 34 cultures
from 22 patients with suspected streptomycin
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Total 5 2 2 6 15
reason to suspect the emergence of resistance, were
all found to be sensitive by both methods.
Effect of Prolonged Incubation on Results of
Liquid Medium Tests.—Table V shows the results
of the liquid medium test after 10 and 28 days'
incubation on 19 cultures which were resistant
on the solid medium. It will be seen that in no
Table V
results of liquid medium test after 10 and 28
days' incubation on 19 known resistant cultures
10 Days' Reading Resistance Ratio
Reading
Resistance Sensitive Resistant Total








































































Total 1 3 2 8 1 0 0 4 19
Cultures Resistant by the Routine Test.—A com¬
parison of the degree of streptomycin resistance
found by the liquid and solid medium tests on
cultures resistant by both methods is shown in
Table IV. It will be seen that all the cultures
showing resistance by the routine test also showed
resistance when tested on the solid medium.
Table IV
comparison of degree of resistance by liquid
and solid medium tests on 15 cultures of known
resistance by liquid medium test
case was the resistance ratio at 28 days more than
twice that found at 10 days. No culture that gave
a sensitive reading at 10 days appeared to be resis¬
tant at 28 days.
Effect of " Tween 80" on Results of Liquid
Medium Tests.—A comparison of the liquid
medium tests carried out with and without " Tween
80 " on 27 cultures that were resistant to strepto¬
mycin on the solid medium is shown in Table VI.
Table VI
results of tests in liquid medium with and
without "tween 80 " on 27 known resistant cul¬
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Total .. 5 10 6 1 1 4 27
Cultures from Patients not Expected to Yield
Streptomycin-resistant Organisms.—Twenty-four
cultures, from patients in whom there was no
Assuming that a resistance ratio of 4 indicates
resistance by either method, it will be seen that
of the 27 cultures tested two appeared to be sen¬
sitive when " Tween 80" was absent from the
medium and 15 when " Tween 80 " was present.
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Comparison of Results of Solid Medium Test
Inoculated from a Suspension of Primary Culture
or Liquid Medium Subculture.—Table VII gives
a comparison of the degrees of resistance found
on solid medium tests inoculated from a suspen¬
sion of the primary culture or from the subculture
in the liquid medium. It will be seen that 37 of
the 38 cultures were resistant by both methods.
From only one culture was a sensitive result
obtained from the liquid medium subculture,
where a resistant result was found on the direct
test.
Table VII
results of solid medium tests on 38 cultures on
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Total .. 1 0 7 8 8 14 38
Incidence of Resistance to P.A.S. and Isoniazid.
—Of the 33 strains resistant to streptomycin on
the solid medium test but not by the liquid medium
method, 25 were resistant to P.A.S. and 22 to
isoniazid.
Discussion
It is now well known that to use streptomycin
in combination with isoniazid or P.A.S. in the
treatment of tuberculosis only reduces the inci¬
dence of bacterial resistance to the second drug if
the organisms are fully sensitive to streptomycin.
It was therefore a little disturbing to find that in a
number of cases the organisms appeared sensitive
by the accepted routine liquid medium test,
although other factors suggested that the organisms
had developed streptomycin resistance. The value
of streptomycin therapy in these cases was doubt¬
ful. A solid medium test was therefore tried in
order to determine whether or not these cultures
were in fact resistant to streptomycin. The results
of these investigations are reported in this com¬
munication.
From the normal distribution curve of 29
cultures from patients who had never received
streptomycin, it appears that in only one case in
a hundred would a resistance ratio of 4 be found
by the solid medium method. It therefore seems
reasonable that for clinical practice a reading of
4 or above should be taken as indicating the
development of resistance.
It was suggested by the Medical Research
Council (1953c) that by the liquid medium test
a resistance ratio of 8 was the lowest indicating
resistance. The results of the present series suggest
that a ratio of 4 is indicative of resistance 99
times out of 100. In fact the limiting resistance
ratio is only just above 2 and if a narrower
bracketing were used for the streptomycin con¬
centrations a lower level might be found to be
significant.
Tests on both solid and liquid medium were
made on 34 cultures from patients in whom the
existence of resistant tubercle bacilli was suspected
either because of previous unsatisfactory chemo¬
therapy, or because of resistance having been
known to have been present on a previous occa¬
sion, or because resistance developed to a second
drug during treatment with that drug and strepto¬
mycin in doses known to prevent the emergence
of drug-resistant bacilli. All these cultures were
sensitive by the liquid medium test. On solid
medium 33 gave a reading of 4 or above, 23 of
those being 8 or over. On only one culture from a
case where there was reason to suspect the presence
of streptomycin resistance was a sensitive result
obtained on solid medium. Therefore in cases
where resistance was shown by the solid medium
method there was other evidence that resistance
had developed. These results are in agreement
with those reported by Holt and Cruickshank
(1949) although they inoculated the solid medium
tubes direct from the sputum concentrate.
All of the 15 cultures which showed resistance
by the liquid medium test also appeared resistant
by the solid medium test. It would therefore
seem unlikely that by using the solid medium
method a culture would be reported as sensitive
which would have been resistant by the routine
method.
The solid medium was not used as a screening
method, and therefore there was less chance of
detecting cultures resistant on the liquid medium
but sensitive on the solid medium test. But of
24 cultures from patients in whom there was no
reason to suspect the emergence of streptomycin
resistance all were sensitive to the drug by both
methods.
The question arises as to why there is this
difference in the results of the two methods. It
has been suggested that the detection of resistance
by the solid medium test is due to the longer
incubation period which allows of the appearance
of the organisms with a slower growth rate. Re¬
sults of the prolonged incubation of the liquid
medium test do not support this theory. Of the 19
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cultures tested, no culture giving a sensitive read¬
ing at 10 days appeared resistant after 28 days.
It has previously been found that the presence
of "Tween 80" in the liquid medium enhances
the inhibitory activity of streptomycin. Fisher
(1948a) showed that of 20 strains tested in two
types of liquid medium, 25% were resistant in
Dubos and Davis' medium containing "Tween 80"
whereas 55% were resistant when tested in You-
mans medium where no "Tween" was used.
This was also shown by testing strains for strepto¬
mycin sensitivity in a basal medium with the addi¬
tion of " Tween 80 " and of albumin singly and
together (Fisher, 1948b). It was suggested that the
use of 0.3% albumin in the Dubos and Davis'
medium was sufficient to inactivate the "Tween
80" (Medical Research Council, 1948). In the
present series only two of the 27 cultures resistant
on solid medium were sensitive in the absence of
"Tween 80," while 15 were sensitive when
" Tween " was present, in spite of the addition of
0.3% of bovine albumin to the medium. Further
work on this is being carried out.
It was possible that the differences in the results
obtained in the liquid and solid media were due to
a failure of the resistant organisms to grow in the
liquid medium subculture from which the routine
tests were inoculated. But resistance was demon¬
strated in 37 out of 38 cases where solid medium
tests were inoculated from these subcultures.
The main disadvantage in using the Lowenstein-
Jensen medium is the alleged breakdown of the
streptomycin during inspissation. This might
result in sensitive strains appearing resistant if a
fixed minimum inhibitory concentration is used as
indication of resistance. But the problem is largely
overcome if the results are expressed as resistance
ratios.
Of the 33 strains resistant to streptomycin on the
solid medium but sensitive when tested in liquid
medium, 25 were resistant to P.A.S. and 22 to
isoniazid. The differences between the results of
the streptomycin sensitivity tests by the two
methods do not therefore seem to be related to
resistance to either of these drugs.
In conclusion, it would seem that the solid
medium test described will detect streptomycin
resistance in tubercle bacilli more readily than will
me routine liquid medium test.
Summary
A method is described for testing the strepto¬
mycin sensitivity of tubercle bacilli in Lowenstein-
Jensen medium. The results are compared with
those obtained in Dubos and Davis' liquid
medium.
It is concluded that a resistance ratio of 4 by
either method indicates resistance. Using this
criterion, 33 of the 34 cultures tested from patients
whose organisms were suspected of being resistant,
were resistant by the solid medium test, although
none were resistant by the liquid medium test.
There was no evidence that the solid medium
test failed to detect resistance in cultures resistant
by the liquid medium test.
The differences in the results of the two methods
were not accounted for by the prolonged incuba¬
tion of the solid medium test nor by the failure of
the resistant organisms to grow in the liquid
medium subculture.
The failure to demonstrate streptomycin resist¬
ance in the liquid medium may be due to the
presence of " Tween 80."
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